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ABSTRACT 
Dose-Response Models of Rickettsiae and Other Biological Agents of Concern 
Sushil B. Tamrakar 
Supervisor: Dr. Charles N. Haas 
A dose-response relationship describes the relationship between the level of microbial 
exposure (doses) and likelihood of occurrence of an adverse health effects. It is a key 
ingredient of microbial risk assessment paradigm. Dose-response modeling now appears 
to be widely used for food and water microbial risk assessments. The thesis focuses on 
development of dose-response models of Rickettsiae and some other pathogens listed as 
bioterrorism agents by CDC.  
Rickettsial diseases are a group of infections to humans caused by rickettsiae. The 
rickettsiae are small, Gram-negative, aerobic, coccobacillary bacteria  that are obligate 
intracellular parasites of eucaryotic cells with a life cycle involving both vertebrate and 
invertebrate hosts.  Among several rickettsial diseases, Rocky Mountain spotted fever 
caused by R. rickettsii and endemic typhus caused by R. typhi are diseases of concern in 
the thesis. Besides classical dose-response models of rickettsial diseases, development of 
multi-routes dose-response models, interspecies susceptibilities and outbreak analysis of 
rickettsial diseases have been analyzed and presented in the study.  
Moreover, the study also includes dose-response models of Coxiella burnetii (Q 
fever), Burkholderia pseudomallei (Melioidosis) and Lassa virus fever.  The development 
and analysis of dose-response models will help to the concern authorities and decision 
makers to cope emergency situation and formulating guidelines such as minimum 
detection limits, evacuation volume etc.  
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1. INTRODUCTION 
 
 
1.1 Quantitative Microbial Risk Assessment 
 
The goal of risk assessment is to estimate the probability of possible consequences due to 
exposure to specific risk agents. The fields of chemical risk assessment and ecological risk 
assessment provided the foundations for microbial risk assessment (Parkin 2008). 
Quantitative microbial risk assessment (QMRA) is a formal probabilistic process for 
estimating the microbial risks associated with defined scenarios and thus is an ideal 
adjunct to the health impact assessment process (Fewtrell and Kay 2007). An early 
approach was proposed in the 1970s by Mossel and Drion, and Haas (1983) ,who set forth 
methods for dose-response relationships (Parkin 2008). 
 
The four phase approach of the National Academy of Sciences- National 
Research Council (NRC1983) for the risk assessment process can be used for microbial 
risk assessment(Haas, Rose et al. 1999). The four phases of risk assessment are shown in 
Figure 1.1. 
18 
 
 
Figure 1.1 Risk Assessment Paradigm (Source: EPA) 
 
   
1. Hazard Identification- In QMRA, hazard identification entails identification of the 
microbial agent(s) that may pose a risk in a given scenario and illness endpoints  
associated with them(Haas, Rose et al. 1999).    For some scenarios such as transmission 
of a pathogen from one infected person to another, a single pathogen and health effect 
may be identified.  In other cases such as incidence of gastrointestinal illness from 
ingestion of treated groundwater, multiple pathogens and a single endpoint may be 
identified.  In some cases such as risk scenarios involving Yersinia pestis (the causative 
agent of pneumonic, bubonic and septicemic plague), a single pathogen and multiple 
disease endpoints may be identified. 
2. Dose–response assessment- In QMRA, dose-response assessment is the quantitative 
study of the relationship between the dose administered or exposed (number of 
organisms) and probability of infection in the exposed population (Haas, Rose et al. 
1999).   
19 
 
3. Exposure assessment- The exposure assessment is the estimation of specific exposure to 
the agent (Lipton, Galbraith et al. 1993). It entails determining the size and nature of 
exposed population, the route of exposure, and the distributions of concentrations and of 
microorganisms for the exposed population during the exposure period (Haas, Rose et al. 
1999). 
4. Risk characterization- The risk characterization is the process of estimating the health 
risk (Lipton, Galbraith et al. 1993). It  links the quantitative dose-response model 
predictions from the experimental data to the exposure doses (step 3) to quantitatively 
predict the risks of the adverse effect in the target population (Armstrong 2005).  This 
step entails essential steps that determine how the risk assessment may be interpreted.  
Critical elements of the risk characterization include the manner in which risk is 
communicated (individual- or population-level risk, 50
th
 percentile or another risk 
estimate) and the uncertainty around the risk estimate. 
 
The United States experienced
 
an unprecedented set of Bacillus anthracis 
(anthrax) attacks in September 2001 through the postal system. A total of 22 persons 
developed
 
anthrax and 5 died.  More than 30,000 persons were advised to take antibiotic 
treatment
 
because they were at known or potential risk for inhalational
 
anthrax. 
(Gerberding, Hughes et al. 2002). This type of bioterrorism threat can be addressed using 
formal risk assessment approach (Haas 2002).  Since then the federal agencies as well as 
scientific communities have focused on development of quantitative microbial risk 
assessment. The use of QMRA in different fields is increasing day by day. The QMRA 
has been extensively used in food safety (Pouillot, Miconnet et al. 2007; Barlow, Chesson 
20 
 
et al. 2009) ,  water and recreational water quality(Yanful, Razzolini et al. 2009), and 
biosolids risk (Chaney, Ryan et al. 1996).   
 
1.2 QMRA and Rickettsial pathogens  
 
The Center for Advancing Microbial Risk Assessment (CAMRA) was established in 
2005 to develop advanced techniques for quantitative microbial risk assessment, establish 
data bases that may serve as resources for QMRA practitioners, and provide education in 
the QMRA field.  Within CAMRA, I have been working in dose-response modeling of 
biological agents of concern as a part of CAMRA’s project III. This work has included a 
general survey of dose-response for Rickettsia, a class of pathogens for which there was, 
at the outset of my work, no established human dose-response relations. This work is 
important both because it addresses a pathogen type for which dose-response data are 
lacking and because some Rickettsial pathogens pose serious human health risks.  For 
example, epidemic typhus is caused by Rickettsia prowazekii and is categorized as 
category B bioterrorism agent by Centers for Disease Control and Prevention (CDC) 
(Anonymous 2009). Although other pathogenic ricketssiae are excluded from the CDC 
list based on relatively low morbidity and mortality or exposure mode,  R. typhi ( murine 
typhus ) is one of the rickettsial diseases that fit to the category A bioterrorism agent 
(Azad 2007).  
 
The first goal for developing a QMRA model of Rickettsial diseases is to estimate 
human risk from animal dose-response information. For this purpose, we have to 
21 
 
assemble and evaluate the available data (Armstrong and Haas 2007).  Because they 
associate known dose with a specific response, experimental dose-response data are the 
best basis for developing credible dose-response models.  In experimental dose-response 
studies successive dilutions of stock suspensions of pathogens are administered to a 
group of exposed individuals and specific responses in the exposed population are 
observed.  Ethical and logistical considerations generally mean that the majority of 
experimental dose-response data are from animal dose-response studies and significant 
debate remains in the QMRA community regarding whether and how to extend dose-
response relations based on animal data to humans. 
 
This study has been focused on developing dose-response relationship of some of 
the bioterrorism agents and comparing them with other biological agents of concern.  
Dose-response models are generated using available dose-response data from 
experimental dose-response studies.  These models include relatively novel models such 
as models that allow comparison of response when different exposure routes are used and 
models that incorporate time-to-response (post inoculation) into the model form.  Models 
are generated for both animal and human response to Rickettsial pathogens and compared 
to models developed for the bacterial pathogen Burkholderia psedumallei and the viral 
pathogen Lassa virus. 
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1.3 Dose response assessment 
 
A dose-response relationship describes the relationship between the level of microbial 
exposure (doses) and likelihood of occurrence of an adverse health effects(Haas, Rose et 
al. 1999). Developing a mathematical relationship or descriptive equation is dose-
response modeling.  
 
Haas (1983) first demonstrated the use of dose-response models to estimate 
microbial infection risk in humans at low levels of exposure based on extrapolation from 
experimental data at higher doses (Haas 1983). Since then, dose-response models have 
been developed for bacteria, viruses and protozoa (Rose, Haas et al. 1995). A text book 
by Haas et al. (1999) provides a detailed description of methods for quantitative 
microbial risk assessment, and discusses the derivation and application of dose response 
modeling for microbial data. Dose-response modeling now appears to be widely used for 
food and water microbial risk assessments (Haas, Rose et al. 1999; Armstrong 2005).  
Excerpts from the book will be discussed in subsequent chapters.  
 
1.4 Rickettsial diseases  
 
 
Rickettsioses are among the oldest recognized, most common but least reported vector 
borne zoonoses (Raoult and Roux 1997; Parola, Vogelaers et al. 1998; Parola, Paddock et 
al. 2005). Epidemic typhus is believed to be responsible for the plague of Athens in the 
23 
 
5
th
 century BC (Raoult and Roux 1997). The pathogens responsible for the rickettsial 
diseases, namely rickettsiae are also considered as possible bio-weapons (Azad 2007).  
 
Rickettsial diseases are a group of infections to humans caused by rickettsiae. The 
rickettsiae are small (0.3-0.5 x 0.8-2.0 µm), Gram-negative, aerobic, coccobacillary 
bacteria  that are obligate intracellular parasites of eucaryotic cells with a life cycle 
involving both vertebrate and invertebrate hosts (McLeod, Qin et al. 2004). 
 
Rickettsiae represent a diverse collection of bacteria. The common linkages that 
hold the rickettsiae into a group are their epidemiology, intracellular lifecycle and 
laboratory technologies.  They cannot be cultivated on agar plates or broth in laboratory; 
they can only survive inside live cells (Walker 1996).  
 
The order of Rickettsiales comprises three families, Rickettsiaceae, 
Anaplasmataceae, and Holosporoceae (Garrity, Bell et al. 2004; Anonymous 2009). The 
study hereafter focuses on members of the family Rickettsiacea and genus Rickettsia. The 
taxonomic tree of order Rickettsiales is shown in Figure 1.2 . 
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 Order 
 
Family 
  
 
Genus  
 
 
Species  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Taxonomic Tree (Source: Garrity, Bell et al. 2004) 
Rickettsiales 
Rickettsiacea
e 
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e 
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 Orientia  
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Aegyptianella 
Anaplasma 
Ehrlichia 
Neoehrlichia 
Neorickettsia 
 Wolbachia 
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 Holospora 
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R. aeschlimannii      
R. africae 
R. akari 
R. australis 
R. bellii 
R. canadensis 
R. conorii 
R. felis 
R. heliongjiangensis 
R. helvetica 
R. honei 
R. japonica 
R. massiliae 
R. montanensis 
R. parkeri 
R. peacockii 
R. prowazekii 
R. rhipicephali 
R. rickettsii 
R. sibirica 
R. slovaca 
R. tamura 
R. typhi 
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Rickettsiae depend on hematophagous (feeding on warm blood) arthropods  as 
vectors and primary reservoirs (McLeod, Qin et al. 2004). Rickettsial diseases vary 
considerably in severity from self-limiting mild illnesses to severe life-threatening 
infections, particularly if complications arise. The organisms cause disease by damaging 
blood vessels in various tissues and organs. In severe cases multiple tissues and organs 
are affected.  
 
Rickettsial diseases consist of 3 groups (Azad and Radulovic 2003; McLeod, Qin 
et al. 2004; Azad 2007).  However, some authors classified them into only two groups: 
Spotted fever group and Typhus groups. Moreover, the Bartonellaceae, responsible for 
bartonelloses and Coxiellaceae (C. burnetii), responsible for Q fever have been removed 
from Rickettsiales (Bechah, Capo et al. 2008 a).  
Table 1.1 Summary of Rickettsial Diseases 
Spotted Fever Group 
(SFG) 
Typhus  Group Other Rickettsial 
Diseases 
Disease Etiological 
agent 
Disease Etiological 
agent 
 Tsutsugamushi 
disease -scrub typhus 
(R.tsutsugamushi or 
Orientia tsutsugamushi) 
 
 Q fever (Coxiella 
burnettii)- has been 
moved to order- 
Legionellales 
 
 Ehrlichiosis 
(Ehrlichia spp.) 
 Rocky 
mountain spotted 
fever (RMSF) 
 
 Rickettsialpo
x 
 
 Boutonneuse 
fever 
 
R. rickettsii 
 
 
 
 
R. akari 
 
R. conorii  
 Louse-borne typhus  
 ( Epidemic typhus) 
 
 Brill-Zinsser disease 
(relapsing louse-borne 
typhus) 
 
 Murine typhus 
 
R. prowazekii 
 
 
R. prowazekii 
 
 
R. typhi or  
R. mooserii 
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Many studies have been conducted with rickettsial diseases including vaccine 
development (Richards 2004), genome analysis (Walker and Yu 2005), outbreak 
epidemiological studies (Walker and Fishbein 1991), and histopathological studies 
(Dierberg and Dumler 2006) but to date the quantitative microbial risk assessment of 
rickettsial diseases has not been studied. 
 
Epidemic typhus (R. prowazekii) has been categorized as a category B 
bioterrorism agent (Azad and Radulovic 2003; Anonymous 2009).  As contaminated lice 
feces are stable, can easily be aerosolized, and readily producible, the pathogen could be 
used as bio-weapon (Mooty and Lutwick 2009). 
 
1.4.1 Virulence of Ricketsiae 
 
Ticks are the major vectors of Rickettsia and serve as reservoirs (Raoult and Roux 1997). 
Infection of Rickettsiae occurs through the skin by a tick bite or through damaged skin, 
including conjunctivae, from the feces of lice or fleas or ticks. The pathogens spread 
through the bloodstream and infect the endothelium. Adherence to the host cell is the first 
step of rickettsial pathogenesis (Weiss 1982; Hackstadt 1996; Todar 2008).  
{{ 
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Rickettsiae are phagocytosed by the host cell when they attach to the host cell 
membrane. Then rickettsiae quickly escape from the phagosome membrane and enter the 
cytoplasm (Weiss 1982; Hackstadt 1996; Todar 2008).  
{{{{{ 
Rickettsiae of the typhus group are released from host cells with the destruction of 
the cells. After infection with R. prowazekii or R. typhi, the rickettsiae continue to grow 
inside the cell until the cell is packed with organisms and then bursts (Weiss 1982; 
Hackstadt 1996; Todar 2008).  
 
Spotted fever group rickettsiae rarely multiply in large numbers and do not lyse 
the host cells. They escape from the cell in via a different mechanism, yet to be clearly 
understood (Weiss 1982; Hackstadt 1996; Todar 2008). In general, rickettsiae grow with 
a doubling time of nine to 12 hours within the host cells (Winkler 1990).  
 
1.4.2 Diseases 
 
The clinical severity of rickettsial diseases varies with the virulence of the Rickettsia spp. 
and host factors, such as age, gender, alcoholism, and other underlying diseases. The 
most virulent rickettsiae are R. rickettsii and R. prowazekii, which have high fatality if the 
infected person is not treated sufficiently early in the course of infection with an effective 
treatment (Weiss 1982; Hackstadt 1996; Todar 2008). 
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All rickettsial infections begin with introduction of the organisms into the skin, 
either through a tick bite or cutaneous abrasions and conjunctivae of contaminated flea or 
louse feces (Weiss 1982; Hackstadt 1996; Todar 2008).  
 
The most important pathophysiologic effect is increased vascular permeability 
with consequent edema, loss of blood volume, hypoalbuminemia (abnormally low 
albumin in blood serum), decreased osmotic pressure, and hypotension. These effects can 
be life threatening resulting in pulmonary edema and adult respiratory distress syndrome, 
shock, or acute tubular necrosis (Weiss 1982; Hackstadt 1996; Todar 2008) 
 
Initially, three diseases, namely Rocky Mountain spotted fever (R. rickettsii), 
Epidemic typhus (R. prawozakii) and Murine typhus (R. typhi) were selected to study. 
However, I was unable to find any suitable data to analyze epidemic typhus and this 
pathogen was removed from the final study design. The subsequent chapters will describe 
the diseases and dose-response analyses.  
 
1.5  Dissertation Structure 
 
The dissertation work is presented in ten chapters, each of which includes a general 
introduction and a discussion of general findings and further research areas. The first 
chapter-introduction provides background on microbial risk assessment, dose-response 
assessment and rickettsial diseases.  
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Chapters two and three focus on the dose-response modeling of Rickettsial 
diseases. Chapter two describes the dose-response modeling of Rocky Mountain spotted 
fever for humans and chapter three highlights murine typhus. A time post inoculation 
analysis as well as age dependency analysis is included in murine typhus dose-response 
modeling.  
 
Chapter four introduces the correction factor in multi-route dose-response 
modeling and describes effects of routes in infection. Chapter five describes interspecies 
susceptibility differences.  Chapter six describes analysis of some the outbreaks. 
 
Chapater seven and eight describe dose-response models of the two bacteria:  
Coxiella burnetii( Q fever) and Burkholderia pseudomallei (Melioidosis) respectively. 
Both of them are listed as category B bioterrorism agents.  
 
Chapter nine highlights the dose-response modeling for Lassa virus, a category A 
bioterrorism agent. This chapter provides different dose-response models of one of the 
most infectious hemorrhagic fever viruses. Chapter ten contains overall conclusions and 
prospective research opportunities.  
 
.  
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2. DOSE-RESPONSE MODEL OF ROCKY MOUNTAIN SPOTTED FEVER 
(RMSF) FOR HUMAN
1
 
 
 
2.1 Abstract  
 
Rickettsia rickettsii is the causative agent of Rocky Mountain Spotted Fever (RMSF) and 
is the prototype bacterium in the spotted fever group of rickettsiae which is found in 
North, Central and South America. The bacterium is gram negative and an obligate 
intracellular pathogen. The disease is transmitted to humans and vertebrate host through 
tick bites; however some cases of aerosol transmission also have been reported.  The 
onset of disease follows an infective tick bite by a week (range 2-14 days), beginning 
with fever, severe headache, and muscle pain followed by development of rash. The 
disease can be difficult to diagnose in the early stages, and without prompt and 
appropriate treatment, it can be fatal.  
 
This paper develops dose-response models of different routes of exposure for 
RMSF in primates and humans. The Beta-Poisson model provided the best fit to the dose 
response data of aerosol exposed rhesus monkeys, and intradermally inoculated humans 
(morbidity as end point of response). The average 50 % infectious dose (ID50) among 
exposed human population determined to be N50 is 23 organisms with 95% confidence 
limits of 1 to 89 organisms.  ID10 and ID20 are 2.2 and 5.0 respectively. Importantly, the 
                                                 
1
  This chapter has been accepted to publish by Risk Analysis, January 2011 under the same title. The 
authors are Sushil B. Tamrakar and Charles N. Haas.  
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data on aerosol exposed rhesus monkeys and intradermally inoculated humans can be 
pooled. This indicates that the dose-response models fitted to different data sets are not 
significantly different and can be described by the same relationship.  
 
Keywords: Rocky Mountain spotted fever, dose-response, exponential, Beta-Poisson, 
human, aerosol, rhesus monkey.  
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2.2 Introduction  
 
Rickettsia rickettsii is the causative agent of Rocky Mountain Spotted Fever (RMSF), a 
potentially fatal tick borne disease. It is  the prototype bacterium in the spotted fever 
group of rickettsiae (Walker 1995; Thorner, Walker et al. 1998). It is gram negative, an 
obligatory intracellular bacterium in the family Rickettsiaceae. Like most of the other 
spotted fever group (SFG) rickettsiae, it is transmitted to humans and vertebrate hosts 
through the bite of infected ticks.  R. rickettsii was first described by Howard T. Ricketts 
in 1909 (Thorner, Walker et al. 1998; Warner and Marsh 2002).   
 
RMSF is one of the most severe of human infectious diseases and its fatality rate 
was 20 to 25 percent before the advent of antibiotic therapy (Dick 1978; Jamie 2002).  
Although all humans are susceptible to R. rickettsii, adult nonwhite males with glucose-6-
phosphate dehydrogenase deficiency are the most susceptible population (Walker 1996; 
Jamie 2002; Paddock, Holman et al. 2002; Masters, Olson et al. 2003; Parola, Paddock et 
al. 2005) In the United States, more than 1250 cases were reported between the years 
1993 and 1996 with the annual  incidence rate of 2.2 per million (Lacz, Schwartz et al. 
2006).  
 
The microorganism inhabits various ticks especially hard ticks which are either 
reservoirs or natural hosts. The pathogen initially infects the epithelial cells of the tick’s 
midgut where it multiplies without harming the host (McDade and Newhouse 1986). 
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However, Niebylski et al. found that tick vectors are also lethally infected (Niebylski, 
Peacock et al. 1999).   The disease state begins with attachment of the adult tick to human 
skin. Only the adult stage of the tick feeds on humans. As the attached tick imbibes the 
warm blood of human, the rickettsiae undergo reactivation from an avirulent state to a 
highly virulent state in 24 to 48 hours.  Moreover an unpredictable period of time is also 
required for release of rickettsiae from the tick salivary glands and their inoculation into 
the human skin. Hence removing the ticks immediately from the skin is the simplest way 
to avoid infection. The incidence rate of the disease is very low. It may be due to the 
prevalence of ticks infected with  pathogenic R. rickettsii is less than one infected tick per 
1000 ticks (Walker 1989). 
 
The clinical manifestation of the disease in humans is due to severe damage to 
blood vessels by the pathogens after infection. The pathogens then spread and invade 
vascular cells such as endothelial cells (Silverman and Santucci 1988). Microorganisms 
then escape from the phagosome and begin to replicate by binary fission. The onset of 
disease begins a week (2-14 days) after tick bites with fever, severe frontal headache, and 
myalgia followed by development of rash. A typical rash usually appears in the third or 
fourth days after tick bites (Woodward 1984; Walker 1995; Jamie 2002). 
 
 The disease can be difficult to diagnose in the early stages, and without prompt 
and appropriate treatment, it can be fatal (Silverman and Santucci 1988; Walker 1996). 
The confounding symptoms such as nausea, vomiting, diarrhea, abdominal pain, and 
cough may lead in to misdiagnosis of other diseases such as enterocolitis (inflammation 
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in colon and intestine), acute abdominal pain, or pneumonia (Silverman and Santucci 
1988; Walker 1995).  
 
Although infected ticks generally transmit the disease, there have been several 
laboratory acquired infections reported. Accidental self-inoculation of infectious material 
or unnoticed release of aerosol containing bacteria may be the cause of infection 
(Johnson and Kadull 1967; Calia, Bartelloni et al. 1970; Oster, Burke et al. 1977; 
Kenyon, Kishimoto et al. 1979). Hence, dose-response model of RMSF in primates or 
human in aerosol route will be useful for risk assessors.  
 
2.3 Data and methods  
2.3.1 Dose-response data source 
Many researchers have reported the response of animals to different doses of 
Rickettsia rickettsii in order to develop effective therapy and to study the pathology of 
infected animals. Since there have been no previously reported dose-response relations, 
the aim of this study was to extract usable data from the literature and develop dose-
response curves. Criteria for data used in our analysis are described as:  
 Mode of exposure is explicitly stated (such as inhalation, subcutaneous, 
intradermal, intravenous etc.) 
 Methods for exposure assessment are described clearly 
 The number of subjects for each dose group is stated explicitly 
 The number of positive responses for each exposure route is explicitly stated 
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 The criteria used to define a positive endpoint are stated 
 Pathogen is described in detail (source, strain) 
 The mode of preparation of pathogenic organisms is described 
 
Saslaw and Carlisle in 1966 studied the  aerosol infectivity of R. rickettsii in 
monkeys (Saslaw and Carlisle 1966). Rhesus monkeys were challenged with aerosolized 
pathogens and morbidity as well as mortality was observed. The number of animals per 
dose group was limited (1 to 4) and 24 graded doses were used in their study. 
 
Sammons et al (1976) also explored changes in blood serum constituents and 
hematologic values in Macaca mulatta while infecting with R. rickettsii. Inoculating 
intravenously (i.v.) and subcutaneously (s.c.) with graded doses of pathogens, the number 
of febrile animals and number of deaths were observed (Sammons, Kenyon et al. 1976). 
But there were only two graded doses used in subcutaneously exposed animals and hence 
dose-response analysis was not performed for the data.  
 
Gonder et al in 1979 exposed cynomolgus monkeys to R. rickettsii via two routes 
of infection. The responses from aerosol and subcutaneous challenge were evaluated and 
some of the monkeys were challenged with high doses after vaccination (Gonder, 
Kenyon et al. 1979). 
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DuPont et al (1973) developed an experimental model of RMSF in human 
volunteers. 31 young adults were intradermally inoculated with three graded doses of R. 
rickettsii and clinical symptoms were observed (DuPont, Hornick et al. 1973). 
 
2.3.2 Analysis Method 
 
Dose response relationships were fit to data using the method of maximum 
likelihood estimation (MLE) as described in Haas et al. (1999).  All the data sets are 
shown in Table 2.1. 
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Table 2.1 Data Used 
Data 
set  
Bacteria 
and Strain 
Study Mode of 
inoculation 
 
Test Organism/ 
Reponses end 
point 
 
Dose 
 
Converted dose 
(No. of organisms)
¢
 
Number of Test 
Animals 
Positive 
Responses 
Negative 
Responses 
D1 R. rickettsii 
( R1) 
(Saslaw and 
Carlisle 1966) 
aerosol Rhesus monkey 
(Death)  
1.5(YSLD50) 
# 25 4 1 3 
4 66 2 2 0 
5 83 2 2 0 
6 99 2 1 1 
11 182 7 3 4 
67 1111 2 1 1 
107 1774 2 1 1 
138 2287 2 1 1 
156 2586 2 2 0 
191 3166 2 1 1 
305 5055 7 6 1 
333 5519 2 2 0 
341 5652 2 2 0 
342 5669 1 1 0 
450 7459 2 2 0 
555 9199 2 1 1 
650 10774 2 2 0 
1013 16790 2 1 1 
2475 41023 2 2 0 
2745 45498 3 1 2 
3210 53206 2 2 0 
3330 55195 2 2 0 
7950 131771 2 1 1 
9000 149175 2 2 0 
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Data 
set  
Bacteria 
and Strain 
Study Mode of 
inoculation 
 
Test Organism/ 
Reponses end 
point 
 
Dose 
 
Converted dose 
(No. of organisms)
¢
 
Number of Test 
Animals 
Positive 
Responses 
Negative 
Responses 
D2 R. rickettsii 
( R1) 
(Saslaw and 
Carlisle 1966) 
aerosol Rhesus monkey 
(morbidity)  
1.5(YSLD50
#)  25 4 1 3 
4 66 2 2 0 
5 83 2 2 0 
6 99 2 2 0 
11 182 7 7 0 
67 1111 2 1 1 
107 1774 2 2 0 
138 2287 2 2 0 
156 2586 2 2 0 
191 3166 2 2 0 
305 5055 7 7 0 
333 5519 2 2 0 
341 5652 2 2 0 
342 5669 1 1 0 
450 7459 2 2 0 
555 9199 2 2 0 
650 10774 2 2 0 
1013 16790 2 2 0 
2475 41023 2 2 0 
2745 45498 3 3 0 
3210 53206 2 2 0 
3330 55195 2 2 0 
7950 131771 2 2 0 
9000 149175 2 2 0 
          
D3 R. rickettsii 
( Sheila 
smith) 
(Sammons, 
Kenyon et 
al.1976) 
 
i.v. Macaca mulatta 
(Morbidity) 
0.1 (PFU) 5 3 0 3 
1 45 6 1 5 
10 450 8 6 2 
100 4500 7 7 0 
1000 45000 7 7 0 
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*Failed in test of trend  
¢ Based on (Ormsbee, Peacock et al. 1978) 
#
YSLD50 =50% yolk sac lethal dose, 
@
GPID50= 50% guinea pig infectious dose 
Data 
set  
Bacteria 
and Strain 
Study Mode of 
inoculation 
 
Test Organism/ 
Reponses end 
point 
 
Dose 
 
Converted dose 
(No. of organisms)
¢
 
Number of Test 
Animals 
Positive 
Responses 
Negative 
Responses 
D4 R. rickettsii 
( Sheila 
smith) 
(Sammons, 
Kenyon et al. 
1976) 
i.v. Macaca mulatta 
(Death)* 
 
1(PFU) 45 6 1 5 
10 450 8 5 3 
100 4500 7 6 1 
1000 45000 7 4 3 
          
D5 R. rickettsii 
( Sheila 
smith) 
Gonder, 
Kenyon et al. 
1979 
s.c. Cynomolgus 
monkey 
(Death)* 
10 450 3 3 0 
1000 45000 3 2 1 
100000 4500000 3 2 1 
          
D6 R. rickettsii 
( Sheila 
smith) 
Gonder, 
Kenyon et al. 
1979 
s.c. Cynomolgus 
monkey 
(morbidity)* 
* 
10 450 3 3 0 
1000 45000 3 3 0 
100000 4500000 3 3 0 
          
D7 R. rickettsii 
( Sheila 
smith) 
Gonder, 
Kenyon et al. 
1979 
aerosol Cynomolgus 
monkey 
(Death)* 
10 450 4 2 2 
1000 45000 4 2 2 
100000 4500000 4 2 2 
          
D8 R. rickettsii 
( Sheila 
smith) 
Gonder, 
Kenyon et al. 
1979 
aerosol Cynomolgus 
monkey 
(morbidity)* 
10 450 4 3 1 
1000 45000 4 4 0 
100000 4500000 4 4 0 
          
D9 R. rickettsii 
( Sheila 
smith) 
DuPont, 
Hornick et al. 
1973 
i.d. Human (Clinical 
sign)  
0.1(GPID50
@) 13 6 2 4 
1 126 7 6 1 
10 1260 18 
18 
17 1 
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The statistical programming language, “R” (www.r-project.org) was used for this 
computation. Three dose response models (exponential, Beta-Poisson and Log-probit) 
were used (Haas, Rose et al. 1999).  Exponential and Beta-Poisson MLE estimates were 
made using the BFGS algorithm and Log-probit estimates were made using the Nelder-
Mead algorithm. Confidence intervals to the best fit models were determined via 
bootstrapping with 10000 bootstrap iterations.  
The exponential dose-response model is given by equation 1 
 
kdedP 1)(                                                    (1) 
 
where P (d) is the probability of response at dose d and k is the probability that a single 
organism can survive and initiate infection.  
The Beta-Poisson model is given by equation (2) 
 
1211)(
1
50N
d
dP                                  (2) 
where N50 is the median infective dose and α is the slope parameter for Beta-Poisson 
model. The equation (2) is derived from exact Beta-Poisson equation with certain 
assumptions (Haas, Rose et al. 1999; Teunis and Havelaar 2000). 
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The Log-probit model is given by equation (3) 
12
ln
1
)(
q
d
q
dP                                  (3) 
Where q2 is the probit slope, q1 is the location parameter and  denotes the normal 
cumulative distribution function of the standard normal distribution. 
 
Goodness of fit for all models was determined by comparing the optimal value of 
the deviance from a fit to the critical 
2
 value at degrees of freedom equal to the number 
of doses minus the number of fitted parameters and a 95% confidence.   Assessment of 
the statistical significance of improvement of fit that two parameter models provide over 
single parameter models was made by comparing the reduction in minimized deviance 
with the critical 
2
 value at 1 degree of freedom. Confidence intervals for the best-fit 
model were estimated via bootstrapping (Haas, Rose et al. 1999).  
 
Different investigators have used different units of dose in their experiments such 
as 50% guinea pig infectious dose (GPID50), 50% yolk sac lethal dose (YSLD50), plaque 
forming unit (PFU) and number of organisms per subjects. It is necessary to convert these 
different units to a common unit so that data and results can be compared and analyzed in 
meaningful way. Based on the conversion table developed by Ormsbee and co-authors, 
all the units have been converted into number of organisms (Ormsbee, Peacock et al. 
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1978). Although the conversion factors used in the study have some uncertainties, we 
assumed their effects on the results would be minimal.   
 
Pooling analysis was performed for the different animals and bacterial species to 
ascertain whether the data set had the same underlying distributions. A likelihood ratio 
test was used to determine if data could be pooled. 
 
2.4 Results 
 
2.4.1 Dose-Response Model Fitting 
Dose-response of rhesus monkeys exposed to aerosol containing R. rickettsii, morbidity as the 
end point of response 
Saslaw and Carlisle in 1966 studied the  aerosol infectivity of R. rickettsii in monkeys 
(Saslaw and Carlisle 1966). Rhesus monkeys were challenged with aerosolized pathogens 
and morbidity as well as mortality was observed. In this case, both exponential and the 
Beta-Poisson model provided acceptable fits. Because the difference in deviances of the 
two-parameter beta-Poisson model and the one-parameter exponential model wass 
greater than the 
2
 critical value ( =0.05) at one degree of freedom, the more complex 
model (beta-Poisson) was determined to provide the best fit to the data (Haas, Rose et al. 
1999). Statistics of the three model fits to the animal are summarized in Table 2.2 and the 
best fit model with confidence interval is shown in Figure 2.1. 
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Table 2.2 Model Fit Comparison for Morbidity in Aerosol Exposed Rhesus 
monkey@ 
Data set 
Number 
of  Doses 
Model 
Minimized 
Deviance 
Degrees 
of 
Freedom 
χ2α,n-k
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value 
at 1 
degree of 
freedom 
Aerosol 
exposed 
rhesus 
monkeys, 
morbidity 
as end 
point of 
response 
 
24 
 
Exponential 
 
27.59 
 
23 
 
35.17 
 
k=0.0072 
16.41 3.84 
 
 
24 
 
Beta-Poisson* 
 
11.176 
 
22 
 
33.92 
α =0.86 
N50=19.10
 
 
24 
 
Log probit 
 
11.78 
 
22 
 
33.92 
q1=2.279 
q1=14.10 
*Best fit model @  
(Saslaw and Carlisle 1966) 
 
Figure 2.1 Dose Response Data and Beta-Poisson Model Fits for Morbidity in 
Aerosol Exposed Rhesus monkey to R. rickettsii (R1) and Bootstrapped Beta-Poisson 
parameters with 10,000 iterations.  
44 
 
Dose-response of rhesus monkeys exposed to aerosol containing R. Rickettsii,   
mortality as the end point of response 
 
Beta-Poisson is the best fit model for the rhesus monkeys exposed aerosol containing R. 
rickettsii with mortality as the end point of response. The minimized deviance of the 
exponential model exceeds the Chi-square value for one degree of freedom and that of 
Beta-Poisson model is well within the critical value. Moreover, difference in deviances 
provides statistical significance of improvement of the Beta-Poisson over the exponential 
model.   The statistics of the three model fits to the animal are summarized Table 2.3 in 
and the best fit model with confidence interval is shown in Figure 2.2. 
Table 2.3 Model Fit Comparison for Mortality in Aerosol Exposed Rhesus 
monkey@ 
 
Data set 
 
Number 
of  Doses 
 
Model 
 
Minimized 
Deviance 
Degrees 
of 
Freedom 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree of 
freedom 
Aerosol exposed 
rhesus monkeys, 
mortality as end 
point of response 
 
24 
 
Exponential 
 
136.59 
 
23 
 
35.17 
 
k=0.0010 
112.55 3.84 
 
 
24 
 
Beta Poisson* 
 
24.042 
 
22 
 
33.92 
α =0.144 
N50=50.12
 
 
24 
 
Log probit 
 
24.262 
 
22 
 
33.92 
q1=8.12 
q1=31.42 
*Best fit model   
@(Saslaw and Carlisle 1966) 
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Figure 2.2 Dose Response Data and Beta-Poisson Model Fits for Mortality in 
Aerosol Exposed Rhesus monkey to R. rickettsii (R1) and Bootstrapped Beta-Poisson 
parameters with 10,000 iterations. 
 
Dose-response model for Macaca mulatta exposed intravenously to R. rickettsii morbidity as 
end point of response 
 
The best fit dose response model for morbidity in intravenously exposed Macaca mulatta 
was the exponential model. The two parameter models failed to provide a statistically 
significant improvement in fit.  Statistics of the three model fits to the animal are 
summarized in Table 2.4 and the best fit model with confidence interval is shown in 
Figure 2.3. 
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Table 2.4 Model Fit Comparison for Morbidity in Intravenously Exposed Macaca 
mulatta 
 
Data set 
 
Number 
of  Doses 
 
Model 
 
Minimized 
Deviance 
Degrees 
of 
Freedom 
 
χ2α,n-k
 
 
Parameters 
 
 
Difference 
in 
deviances 
χ2 Value at 1 
degree of 
freedom 
Intravenously  
inoculated 
Macaca 
mulatta 
 
5 
 
Exponential* 
 
0.145 
 
4 
 
9.48 
 
k=0.145 
0.02 3.84 
 
 
5 
 
Beta Poisson 
 
0.123 
 
3 
 
7.81 
α =5.87 
N50=206.83
 
 
5 
 
Log probit 
 
0.129 
 
3 
 
7.81 
q1=1.30 
q1=172.32 
*Best fit model 
(Sammons, Kenyon et al. 1976) 
 
Figure 2.3 Dose Response Data and Exponential Model Fits for Morbidity in 
Intravenously Exposed Macaca mulatta to R. rickettsii and Bootstrapped 
Exponential parameters with 10,000 iterations (Table I, data set D3) 
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Dose-response model of intradermally exposed human volunteer 
The best fit dose response model for morbidity in intradermally exposed human 
volunteer was the Beta-Poisson model. The deviance of the exponential model (13.57) 
exceeds the critical chi-square value at two degree of freedom i.e. 5.99.  Statistics of the 
three model fits to the host are summarized in Table 2.5 and the best fit model with 
confidence interval is shown in Figure 2.4. 
Table 2.5 Model Fit Comparison for Clinical Signs in Intradermally Exposed 
Human@ 
 
Data set 
 
Number of  
Doses 
 
Model 
 
Minimized 
Deviance 
Degrees 
of 
Freedom 
 
χ2α,n-k 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value 
at 1 
degree of 
freedom 
Intraderm
ally 
inoculated 
human 
volunteers 
 
3 
 
Exponential 
 
13.57 
 
2 
 
5.99 
 
k=0.0046 
13.33 3.84 
 
 
3 
 
Beta Poisson* 
 
0.235 
 
1 
 
3.84 
α =0.668 
N50=23.09 
 
3 
 
Log probit 
 
0.522 
 
1 
 
3.84 
q1=2.292 
q1=23.91 
*Best fit model 
@(DuPont, Hornick et al. 1973) 
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Figure 2.4 Dose Response Data and Beta-Poisson Model Fits for Clinical Signs in 
Intradermally Exposed Human to R. rickettsii and Bootstrapped Beta-Poisson 
parameters with 10,000 iterations. 
 
2.4.2 Pooling Analysis  
 
Pooling analysis is performed to ascertain whether the underlying dose response 
models fitted to the separate data sets are not significantly different from each other.   
Different combinations of strains, routes of infection and hosts were pooled together and 
a likelihood ratio test was used to determine whether the data could be pooled or not. 
 
The intradermally inoculated human volunteers with R. rickettsii (R1) and aerosol 
exposed rhesus monkeys with R. rickettsii (Sheila Smith), morbidity as the endpoint of 
response, could be pooled. The value of difference in deviances between sum of 
individual best fits and pooled best fit was 0.289 which was less than χ2 0.05,2 value (5.99). 
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The summary and statistics of the pooling analysis are shown in Table 2.6. The data of 
Macaca mulatta ( inoculated intravenously) and human exposed ( intradermal) to R. 
rickettsii (data set D3 and D9) morbidity as the end point of response could not be 
pooled. Similarly, data of Macaca mulatta (i.v.) and rhesus monkeys exposed (aerosol)  
to R. rickettsii morbidity as the end point of response could not be pooled (data set D2 
and D3).  
 
However, aerosol exposed rhesus monkeys, intravenously inoculated Macaca 
mulatta and intradermally inoculated humans could be pooled together (data set D2, D3, 
and D9). The difference in deviances between individual best fit and pooled best fit was 
7.789 which was less than critical value at degree of freedom 3 i.e. 7.841. The summary 
and statistics of the pooling analysis are shown in Table 2.7. 
Table 2.6 Summary and statistics of the pooling (Data set D2 and D9) 
Data set 
Number 
of  Doses 
Best fit Model 
Minimized 
Deviance 
D.O.F χ2α,n-k χ2 p-value 
Parameters 
 
Aerosol exposed 
Rhesus monkey 
(D2) 
 
24 
 
Beta-Poisson 
 
11.176 
 
22 
 
33.92 
 
0.972 
α =0.86 
N50=19.10 
        
 
Intradermally 
inoculated 
human 
volunteers (D9) 
 
3 
 
Beta-Poisson 
 
0.235 
 
1 
 
3.84 
 
0.627 
α =0.67 
N50=23.09 
        
Pooled data  
27 
 
Beta-Poisson 
 
11.70 
 
25 
 
37.65 
 
0.988 
α =0.77 
N50=21.01 
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Table 2.7 Summary and statistics of the pooling (Data set D2, D9, D3) 
Data set 
Number of  
Doses 
Best fit Model 
Minimized 
Deviance 
D.O.F χ2α,n-k χ2 p-value 
 
Parameters 
 
Aerosol 
exposed 
Rhesus 
monkey (D2) 
 
24 
 
Beta-Poisson 
 
11.176 
 
22 
 
33.92 
 
0.972 
α =0.86 
N50=19.10 
        
 
Intradermally 
inoculated 
human 
volunteers 
(D9) 
 
3 
 
Beta-Poisson 
 
0.235 
 
1 
 
3.84 
 
0.627 
α =0.67 
N50=23.09 
        
Intravenously 
inoculated 
Macaca 
mulatta (D3) 
 
5 
 
Exponential  
 
0.145 
 
4 
 
9.48 
 
0.997 
 
k=0.00318 
        
Pooled data  
32 
 
Beta-Poisson 
 
19.345 
 
30 
 
43.77 
 
0.997 
α =0.84 
N50=40.29 
 
2.5 Discussion  
 
As the Beta-Poisson models developed in this study are based on approximate Beta-
Poisson model with certain assumptions, there are possibilities of higher predictions of 
infection than  that predicted by exact Beta-Poisson model for 95% confidence region 
(Teunis and Havelaar 2000). However, the data sets were fit with the  for exact Beta-
Poisson dose-response model and found that differences between the exact and 
approximate solutions in dose-response are not substantial.  
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Sammons, Kenyon et al. (1976) exposed Macaca mulatta (Rhesus monkey) to R. 
rickettsii (strain Sheila Smith) via different routes to find the changes in blood serum 
constituents. Beta-Poisson model provided best fit to intravenously inoculated Macaca 
mulatta, mortality as end point of response where as morbidity as end point of response 
was fit to exponential model indicating that morbidity has less heterogeneity than 
mortality.  
 
Saslaw and Carlisle (1966) explored the infectivity of R. rickettsii in rhesus 
monkeys via aerosol exposure. The Beta-Poisson model provided best fit to both 
mortality as well as morbidity as end point of the response. The mortality curve as shown 
in Figure 2.2 is shallow one, indicative of heterogeneity in the relative ability of 
pathogens in a given dose to initiate infection; whereas the morbidity curve (Figure 2.1) 
is steeper, indicating the infection process  is relatively homogenous and differences in 
the host-pathogen combination are minor.   
 
Dupont, Hornick et al. (1973) carried out a study of R. rickettsii (Sheila Smith) in 
human volunteers via the intradermal route.  The Beta-Poisson model provided best fit to 
the dose response data. The average 50 % infection dose among exposed population, N50 
is 23 organisms with 95% confidence limits to 1 and 88.79. Similarly, ID10 and ID20 are 
2.16 and 5.0 respectively. The average ID10 and ID20 values support many investigators 
estimation of less than 10 organisms. A single organism is estimated to have a 5% 
probability of causing infection in an exposed individual. Low dose extrapolation of the 
human dose-response model is shown in Figure 2.5.  
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Figure 2.5 Low Dose Extrapolation of Dose-Response model for human 
 
Intradermal route of exposure is the natural mode of infection in human and 
animals. Fortunately we have developed dose-response model for human volunteers 
(intradermal) and now we can predict the risk even at very low dose. However, besides 
tick bite infection, a number of laboratories acquired infections have been reported and 
possible routes of such infections are either aerosol exposure or accidental puncture of 
skin by contaminated sharp materials. There is also possibility of intentional release of 
aerosolized pathogens.  Hence, a dose-response model of aerosol exposure to human 
being will be a useful for the decision makers and first responders.  
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Clinical response in monkeys exposed to aerosols containing R. rickettsii was 
similar to that observed in monkeys infected by other routes of exposure. Infectivity via 
tick bites might be similar to aerosol, given exposure to equal numbers of bacteria. 
Moreover, the clinical and pathological findings in monkeys and those observed in 
human are similar (Saslaw and Carlisle 1966; Saslaw, Carlisle et al. 1966(b); Oster, 
Burke et al. 1977; Keenan, Buhles Jr et al. 1977b; Gonder, Kenyon et al. 1979; Bechah, 
Capo et al. 2008 a).  
 
Price (1953) classified the four different strains of R. rickettsii as R, S, T and U.  
Strain R is the most virulent among the strains based on guinea pigs and embryonated 
eggs (Fuller 1956; Bell, Kohls et al. 1963; Eremeeva, Dasch et al. 2001). In addition to 
that Sheila Smith strain is an R type of R. rickettsii (Shirai, Bozeman et al. 1967). 
Although the pathogenicity of different strains appears to differ widely,  other 
investigators have been unable to correlate virulence, strain and host animals (Chen and 
Sexton 2008). In absence of other data, we assume that the R1 and Sheila Smith strain 
have similar virulence in humans.  
 
The mechanisms of infection via inhalation (aerosol exposure) and tick bite 
(intradermal) are similar.  In aerosol exposure scenario, inhaled rickettsiae invade lining 
cells and endothelial cells of capillaries in alveoli and multiply in the lungs. Within six 
hours of exposure, the pathogens enter the vascular system and spread to lumen of 
pulmonary vessels, spleen and bone marrow (Wolf, Cole et al. 1967).  In a tick bite case, 
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when an infected tick bites an animal or a human, it leaves saliva containing numerous 
organisms. The information regarding quantification of the different rickettsiae in a tick’s 
saliva are not available in open literature except of R. slovaca (Reháçek 1989). The 
pathogens enter through the skin and reach the blood stream through small blood vessel 
and lymphatics, where it grows and multiplies (Silber 1996). In both cases the 
progression from exposure to infection may be described as passage to the blood stream 
through a single barrier followed by multiplication in small blood vessels and lymphatics.  
In both cases only a portion of the dose reaches the target organ and in both cases the 
infection process is the same once surviving pathogens reach the target organ. 
 
The pooling data of aerosol exposed rhesus monkey (morbidity as the end point of 
response) and intradermally inoculated human volunteers as shown in Figure 2.6 shows 
both the dose-response curves and pooled are curve are similar in shape and are very 
close to each other indicative of same underlying distribution. Moreover the data of 
rhesus monkey (aerosol), human (i.d.) and Macaca mulatta (i.v.) could be pooled.  
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Figure 2.6 Human and Rhesus monkey and pooled data 
 
 
2.6 Conclusions 
 
 
Rhesus monkeys exposed to aerosol containing R. rickettsii and intradermally 
inoculated human volunteers with R. rickettsii could be pooled indicating both the dose-
response models fitted to different data sets are not significantly different and can be 
described by the same relationship. It would have been better to compare aerosol 
exposure and intradermal inoculation in the same host, but experimental data for aerosol 
exposure were not available. Although the data of rhesus monkey (aerosol), human (i.d.) 
and Macaca mulatta (i.v.) could be pooled, we believed that intravenous route of 
infection is unlikely to happen in normal circumstances.   
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Assuming the physiopathology of human and rhesus monkey is similar and 
pathogenicity in human and rhesus monkey remains same; we strongly believe that the 
mode of action of the pathogen is similar for both exposure routes and that the dose-
response model for both exposure routes should be similar.  We believed that the 
observed results were not merely coincidental and resulted from opposing effects in host 
and pathogens factors; they were based on available evidences.  
 
In case of terrorist attack or accidental release of aerosol containing pathogens, 
the risk can be estimated based on the best fit model we have developed. The best 
estimate of 50% infectious dose (ID50) is 23 organisms (1 to 88 organisms with 95% 
confidence). A single bacterium can infect an average of 5% of exposed population. This 
estimation will be useful for the first responders and decision makers in case of accidental 
as well as intentional released of Rickettsial pathogens.  
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3. DOSE-RESPONSE MODEL OF MURINE TYPHUS (RICKETTSIA 
TYPHI): TIME POST INOCULATION AND HOST AGE DEPENDENCY 
ANALYSIS
2
 
 
3.1 Abstract  
Background: Rickettsia typhi (R. mooseri) is the causative agent of murine typhus. It is 
one of the most widely distributed tick borne diseases and causes a relatively mild febrile 
illness with six to 14 days of incubation period. The bacterium is gram negative and an 
obligate intracellular pathogen. The disease is transmitted to humans and vertebrate host 
through fleabites. This paper develops dose-response models of different routes of 
exposure for typhus in rodents. 
Methods: Data were obtained from published articles and were analyzed using 
parametric dose-response relationships. Dose-response relationships were fit to data using 
the method of maximum likelihood estimation (MLE).  
Results: Dose-response models of different host age of rats and time post inoculation 
effect in BALB/c were analyzed in the study. Data for both  adult rats (inoculated 
subcutaneously) and newborn rats (inoculated intradermally) were best fit by the 
exponential dose-response model and both the data sets can be pooled to be described by 
a single dose-response relationship. The BALB/C mice inoculated subcutaneously were 
best fit by Beta-Poisson models. The time post inoculation analysis showed definite 
pronounced relationship between time post inoculation and response.   
                                                 
2
 This chapter has been submitted to BMC Infectious Diseases, October 2010 under the same title. The 
authors are Sushil B. Tamrakar, Yin Huang and Charles N. Haas 
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Conclusions: Intradermally or subcutaneously inoculated rats (adult and newborn) 
models suggest that less than 1 PFU (1.33 to 0.38 in 95 % confidence limits) of the 
pathogen is enough to seroconvert 50 % of the exposed population in an average. 
BALB/c mouse’s the When fit with a model that considers time post inoculation, 
BALB/c mouse dose-response data indicate that an average dose of 0.28 PFU (0.75 to 
0.11 in 95% confidence limits) will seroconvert 50% of exposed mice.  
Keywords: Murin typhus, Rickkettsia mooseri, dose-response model, post time 
inoculation model 
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3.2 Introduction  
 
Murine typhus, also known as endemic typhus, is one of the most widely distributed tick 
borne diseases. The causative agent of murine typhus is Rickettsia typhi, previously 
known as R. mooseri. Usually R. typhi produces mild febrile illness with 6 to 14 days of 
incubation period (Azad and Traub 1985; Azad 1990; Houhamdi, Fournier et al. 2003). 
Though, R. typhi is generally considered as less pathogenic  than R. rickettsii and R. 
prowazekii (in terms  of mortality rate), R. typhi is virulent enough to cause severe 
infection  in the elderly population (Houhamdi, Fournier et al. 2003).  The major 
reservoir of the pathogens is the rat (Rattus rattus and R. norvegicus) and rat flea 
(Xenopsylla cheopis) is the main vector. Fleas are infected by transovarian transmission 
or get infected while feeding on an infected animal (Walker 1996).  R. typhi is 
transmitted to human body or vertebrate host by infected fleabites, contamination of the 
broken skin, respiratory tract or conjunctivae of the host with infected feces and tissues 
during and after flea feeding (Azad 1990; Houhamdi, Fournier et al. 2003).  
 
Once infected a flea remains infective for life. Interestingly, neither flea nor rat is 
harmed by the pathogens (Azad 1990). Although humans are infected mainly via rat 
fleas, murine typhus  exists endemically in many places where rat and rat fleas are absent 
(Houhamdi, Fournier et al. 2003).  In the United States, the reported cases of murine 
typhus are focused in south and central Texas, Los Angeles and Orange County, 
California, where the rats and rat fleas are rarely documented. The cat flea/ opossum 
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cycle may be one of the possibilities responsible for  the disease in Texas and California 
(Azad, Radulovic et al. 1997).   
 
The clinical symptoms of infection with R. typhi in humans are fever, headache, 
and myalgia. The fever lasts about 12 days in adults and the temperature ranges from 
102-104 F (McLeod, Qin et al. 2004). In severe cases, the pathogen can cause 
meningoencephalitis, interstitial pneumonia and disseminated vascular lesions (Fergie, 
Purcell et al. 2000).  
 
3.3 Data and Methods  
 
3.3.1 Dose-response data sources  
 
Many researchers have reported the response of animals to different doses of Rickettsia 
typhi in order to develop effective therapy and to study the pathology of infected animals. 
Since there have been no previously reported dose-response relations, the aim of this 
study was to extract usable data from the literature and develop dose-response curves.  
Criteria for data used in our analysis are described as:  
 Route of exposure is explicitly stated (such as inhalation, subcutaneous, 
intradermal, intravenous etc.) 
 Methods for dose estimation are described clearly 
 The number of subjects for each dose group is stated explicitly 
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 The number of positive responses for each exposure route is explicitly stated 
 The criteria used to define a positive endpoint are stated 
 Pathogen is described in detail (source, strain) 
 The mode of preparation of pathogenic organisms is described 
 
Aringo-Jaramillo et al (1984) carried out an experiment with R. typhi infection in adult 
and newborn laboratory rats. Nine different doses of R. mooseri were transdermally and 
subcutaneously inoculated and seroconversion and death were the  responses recorded 
(Arango-Jaramillo, Azad et al. 1984). Animals with an indirect fluorescent antibody titer 
of greater than or equal to 1:40 were considered as seroconverted (Crist, Wisseman et al. 
1984; Arango-Jaramillo, Wisseman et al. 1988). In the study conducted by Aringo-
Jaramillo et al (1984) , some animals seroconverted, but  no animals died.  
 
Crist et al (1984) experimented with R. typhi (R. mooseri) infection in normal and 
immune mice. Female BALB/c mice were subcutaneously inoculated with various doses 
of R. typhi and seroconversions on different days (after inoculation) were observed (Crist, 
Wisseman et al. 1984).   
 
Aringo-Jaramillo et al (1988) conducted experimental inoculation of R. typhi in 
young rats of different age groups. Five different doses were inoculated orally in 3 day, 7 
day and 30 day old rats and seroconversion was recorded as the end point of response 
(Arango-Jaramillo, Wisseman et al. 1988). 
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3.3.2 Dose-Response Analysis  
 
Dose response relationships were fit to data using the method of maximum 
likelihood estimation (MLE) as described in Haas et al. (1999).  All the data sets are 
shown in Table 3.1. 
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Table 3.1 Data Used 
Pathogen/strain 
Study/ 
Reference 
 
Mode of 
 inoculation 
 
 
Test animal /Response  
 
Organism/  
Reponses end point  
 
 
Dose  
 
Number of Test 
Animals 
Positive 
Responses 
 
Negative 
Responses 
 
 
        
R. typhi 
 ( Welmington) 
(Crist, 
Wisseman 
et al. 
1984) 
s.c. BALB/c mice 
(sero-conversion on day 9) 
0.01(PFU) 10 0 10 
0.1 10 0 10 
1 10 0 10 
10 10 0 10 
100 10 0 10 
1000 10 0 10 
10000 10 10 0 
        
R. typhi 
 ( Welmington) 
(Crist, 
Wisseman 
et al. 
1984) 
s.c. BALB/c mice 
(sero-conversion on day 12) 
0.01(PFU) 10 0 10 
0.1 10 0 10 
1 10 0 10 
10 10 0 10 
100 10 7 3 
1000 10 8 2 
10000 10 10 0 
        
R. typhi 
 ( Welmington) 
(Crist, 
Wisseman 
et al. 
1984) 
s.c. BALB/c mice 
(sero-conversion on day 15) 
0.01(PFU) 10 0 10 
0.1 10 0 10 
1 10 1 9 
10 10 5 5 
100 10 9 1 
1000 10 9 1 
10000 10 10 0 
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Pathogen/strain 
Study/ 
Reference 
 
Mode of 
 inoculation 
 
 
Test animal /Response  
 
Organism/  
Reponses end point  
 
 
Dose  
 
Number of Test 
Animals 
Positive 
Responses 
 
Negative 
Responses 
 
 R. typhi 
 ( Welmington) 
(Crist, 
Wisseman 
et al. 
1984) 
s.c. BALB/c mice 
(sero-conversio  on day 21) 
0.01(PFU) 10 0 10 
0.1 10 0 10 
1 10 5 5 
10 10 8 2 
100 10 9 1 
1000 10 10 0 
10000 10 10 0 
        
R. typhi 
 ( Welmington) 
(Crist, 
Wisseman 
et al. 
1984) 
s.c. BALB/c mice 
(sero-conversion on day 28) 
0.01(PFU) 10 0 10 
0.1 10 3 7 
1 10 8 2 
10 10 9 1 
100 10 10 0 
1000 10 10 0 
10000 10 10 0 
        
R. typhi 
 ( Ethiopian) 
(Arango-
Jaramillo, 
Azad et al. 
1984) 
i.d. Adult rat 
(sero-conversion ) 
0.0435(PFU) 5 0 5 
0.435 5 1 4 
4.35 5 5 0 
43.5 5 5 0 
435 5 5 0 
4350 5 5 0 
43500 5 5 0 
        
R. typhi 
 ( Ethiopian) 
(Arango-
Jaramillo, 
Azad et al. 
1984) 
i.d. Newborn  rat 
(sero-conversion ) 
0.0435(PFU) 8 0 8 
0.435 8 2 6 
4.35 8 8 0 
43.5 8 8 0 
435 8 8 0 
4350 8 8 0 
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Pathogen/strain 
Study/ 
Reference 
 
Mode of 
 inoculation 
 
 
Test animal /Response  
 
Organism/  
Reponses end point  
 
 
Dose  
 
Number of Test 
Animals 
Positive 
Responses 
 
Negative 
Responses 
 
 R. typhi 
 ( Ethiopian) 
(Arango-
Jaramillo, 
Wisseman 
et al. 
1988) 
Oral Neonatal  rat  
3 day old  
(sero-conversion ) 
10(PFU) 3 1 2 
100 6 4 2 
1000 3 3 0 
10000 3 2 1 
100000 5 5 0 
       
R. typhi 
 ( Ethiopian) 
(Arango-
Jaramillo, 
Wisseman 
et al. 
1988) 
Oral Neonatal  rat  
7 day old  
(sero-conversion ) 
10(PFU) 3 1 2 
100 3 2 1 
1000 2 2 0 
10000 3 2 1 
100000 3 3 0 
        
R. typhi 
 ( Ethiopian) 
(Arango-
Jaramillo, 
Wisseman 
et al. 
1988) 
Oral Neonatal  rat  
30 day old  
(sero-conversion ) 
10(PFU) 3 0 3 
100 6 1 5 
1000 3 2 1 
10000 3 2 1 
100000 3 2 1 
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The statistical programming language, “R” (www.r-project.org) was used for this 
computation. Two dose response models (exponential, and Beta-Poisson ) were used 
(Haas, Rose et al. 1999).  Exponential and Beta-Poisson MLE estimates were made using 
the BFGS algorithm. Confidence intervals to the best-fit models were determined via 
bootstrapping with 10000 bootstrap iterations.  
The exponential dose-response model is given by equation 1 
 
kdedP 1)(                                                    (1) 
where P (d) is the probability of response at dose d and k is the probability that a single 
organism can survive and initiate infection.  
The Beta-Poisson model is given by equation (2) 
 
1211)(
1
50N
d
dP                                  (2) 
where N50 is the median infective dose and α is the slope parameter for Beta Poisson 
model. The equation (2) is derived from exact Beta-Poisson equation with certain 
assumptions (Haas, Rose et al. 1999; Teunis and Havelaar 2000). 
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Goodness of fit for all models was determined by comparing the minimal value of 
the deviance from a fit to the critical 
2
 value at degrees of freedom equal to the number 
of doses minus the number of fitted parameters and a 95% confidence.   Assessment of 
the statistical significance of improvement of fit that two parameter models provide over 
single parameter models was made by comparing the reduction in minimized deviance 
with the critical 
2
 value at 1 degree of freedom. Confidence intervals for the best-fit 
model were estimated via bootstrapping (Haas, Rose et al. 1999).  
 
Pooling analysis was performed for the different animals and bacterial species to 
ascertain whether the data set had the same underlying distributions. A likelihood ratio 
test was used to determine if data could be pooled. 
 
3.3.3 Time Post Inoculation Analysis  
 
In the experiment conducted by Crist and co-investigators with BALB/c mice inoculated 
subcutaneously with R. typhi, the responses were also recorded in different post 
inoculation time (Crist, Wisseman et al. 1984).  Huang and Haas (2009) developed dose-
response models incorporating the time post inoculation as an additional parameter 
(Huang and Haas 2009). In the exponential model, the k parameter is the probability that 
a single organism can survive and proliferate in order to initiate a response. It is well 
known that this is a time-dependent process, and phenomenological responses of animals 
to bacteria vary not only with the initial dose of microorganisms, but also with the time 
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post inoculation (TPI). In the beta-Poisson model, the N50 parameter is the dose required 
to produce a response in 50% of the exposed subjects. Directly related to the growth 
kinetics of a single organism, the initial dose to elicit response in 50% of the population 
(N50) is also expected to vary with the time when the response is observed. To model 
these effects, Huang et al. (Huang, Bartrand et al. 2009; Huang and Haas 2009) set the 
parameter k and N50 equal to functions of time. 
 
 
3.4 Results 
 
3.4.1 Dose Response Model for Rickettsia typhi (Murine Typhus)  
 
Dose-response model of adult rat exposed intradermally to R. typhi, seroconversion as 
end point of response 
Aringo-Jaramillo et al (1984) studied an experimental infection with Rickettsia mooseri 
and antibody response of adult and newborn laboratory rats. The best-fit dose response 
model for seroconversion in intradermally exposed adult rat was the exponential model. 
The minimized deviance of the exponential model was 0.88, which is well within Chi 
square vale at degree of freedom 7 (i.e. 14.06). The statistics of the two model fits to the 
animal are summarized in Table 3.2 and the best-fit model with confidence interval is 
shown Figure 3.1. 
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Table 3.2 Model Fit Comparison for Seroconversion in Intradermally inoculated 
adult rat 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree of 
freedom
  
(Arango-
Jaramillo, 
Azad et al. 
1984) 
 
8 
 
Exponential* 
 
0.88 
 
7 
 
14.06 
 
k=0.756 
 
0 
 
3.84 
  
8 
 
Beta Poisson 
 
0.88 
 
6 
 
12.59 
α =01.16e8 
N50=0.91
 
*Best fit model 
 
Figure 3.1  Dose Response Data and Exponential Model Fits for Seroconversion in 
Intradermally Exposed Adult rat to R. typhi and Bootstrapped Exponential 
parameters. 
 
Dose-response model of newborn rat exposed subcutaneously to R. typhi, 
seroconversion as the end point of response 
The best-fit dose response model for seroconversion in subcutaneously exposed newborn 
rats was the exponential model. The difference in deviances of the Beta-Poisson and the 
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exponential model was very small. Statistics of the two model fits to the data  are 
summarized in Table 3.3 and the best-fit model with confidence interval is shown in 
Figure 3.2. 
Table 3.3 Model Fit Comparison for Seroconversion in Subcutaneously Exposed 
Newborn rat 
 
 
Data set 
 
Number 
of  Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree of 
freedom
  
 
(Arango-
Jaramillo, 
Azad et al. 
1984) 
 
7 
 
Exponential* 
 
1.12 
 
6 
 
12.59 
 
k=0.831 
 
0 
 
3.84 
  
7 
 
Beta Poisson 
 
1.12 
 
5 
 
11.07 
α =4.2e7 
N50=0.83
 
*Best fit model 
 
 
Figure 3.2 Dose Response Data and Exponential Model Fits for Seroconversion in 
Subcutaneously Exposed Newborn rat to R. typhi and Bootstrapped Exponential 
parameters 
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3.4.2 Dose-response model of rats of different age groups inoculated orally to R. typhi, 
seroconversion as end point of response 
 
Aringo-Jaramillo et al (1988) conducted experimental inoculation of R. typhi in neonatal 
rats of different age groups to study influence of maternal R. typhi in rats on the 
offspring.  Five different doses were inoculated orally in 3 day, 7 day and 30 day old rats 
and seroconversion was recorded as the end point of response. 
 
Dose-response model of neonatal rat (3 day old) exposed orally to R. typhi, 
seroconversion as end point of response 
 
The best fit dose response model for seroconversion in orally exposed neonatal rat (3 day 
old) was the Beta-Poisson model. The minimized deviance of exponential model 
exceeded the Chi square vale at degree of freedom five and that of Beta-Poisson model 
was well within the critical Chi square vale. Statistics of the two model fits to the animal 
are summarized in Table 3.4 and the best-fit model with confidence interval is shown in 
Figure 3.3. 
Table 3.4 Model Fit Comparison for Seroconversion in Oral Exposed Neonatal rat 
(3day old) 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree of 
freedom
  
(Arango-
Jaramillo, 
Wisseman et al. 
1988) 
 
5 
 
Exponential 
 
34.63 
 
4 
 
11.07 
 
k=0.0006 
 
31.60 
 
3.84 
  
5 
 
Beta Poisson* 
 
3.023 
 
3 
 
9.48 
α =0.286 
N50=25.7
 
*Best fit model 
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Figure 3.3 Dose Response Data and Beta-Poisson Model Fits for Seroconversion in 
Oral Exposed Neonatal rat (3 day old) to R. typhi and Bootstrapped Beta-Poisson 
Parameters 
 
Dose-response model of neonatal rat (7 day old) exposed orally to R. typhi, 
seroconversion as end point of response 
The best-fit dose response model for seroconversion in orally exposed neonatal rat (7 day 
old) was the Beta-Poisson model. Statistics of the two model fits to the animal are 
summarized in Table 3.5 and the best-fit model with confidence interval is shown in 
Figure 3.4. 
Table 3.5 Model Fit Comparison for Seroconversion in Oral Exposed Neonatal rat 
(7day old) 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree of 
freedom
  
(Arango-
Jaramillo, 
Wisseman et 
al. 1988) 
 
5 
 
Exponential 
 
66.172 
 
4 
 
11.07 
 
k=0.0149 
 
63.83 
 
3.84 
  
5 
 
Beta Poisson* 
 
2.34 
 
3 
 
9.48 
α =0.241 
N50=28.92
 
    *Best fit model 
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Figure 3.4 Dose Response Data and Beta-Poisson Model Fits for Seroconversion in 
Oral Exposed Neonatal rat (7 day old) to R. typhi and Bootstrapped Beta-Poisson 
parameters 
 
Dose-response model of neonatal rat (30 day old) exposed orally to R. typhi, 
seroconversion as end point of response 
The best fit dose response model for seroconversion in orally exposed neonatal rat (30 
day old) was the Beta-Poisson model. Statistics of the two model fits to the animal are 
summarized in Table 3.6 and the best fit model with confidence interval is shown in 
Figure 3.5. 
Table 3.6 Model Fit Comparison for Seroconversion in Oral Exposed Neonatal rat 
(30 day old) 
 
 
Data set 
 
Number 
of  Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree of 
freedom
  
(Arango-
Jaramillo, 
Wisseman et al. 
1988) 
 
5 
 
Exponential 
 
20.55 
 
4 
 
11.07 
 
K=4.2e-5 
 
19.55 
 
3.84 
  
5 
 
Beta Poisson* 
 
1.0 
 
3 
 
9.48 
α =0.20 
N50=16.17
 
*Best fit model 
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Figure 3.5 Dose Response Data and Beta-Poisson Model Fits for Seroconversion in 
Oral Exposed Neonatal rat (30 day old) to R. typhi and Bootstrapped Beta-Poisson 
parameters 
 
3.4.3 Dose-response model with post time inoculation analysis of BALB/c mice exposed 
subcutaneously to R. typhi, seroconversion as the end point of response  
 
Crist et al (1984) experimented with R. typhi (R. mooseri) infection in normal and 
immune mice to study the immune mechanism. Seroconversion after 12, 15, 21, and 28 
days of inoculation was best fit to the Beta-Poisson models. Seroconversion after 9 days 
had only two responses and day zero to day 6 had no response at all. In all models, the 
minimized deviances were well within the Chi square value at degree of freedom five. 
Statistics of the two model fits to the animal are summarized in Table 3.7 and the best fit 
model with confidence interval is shown in Figure 3.6, Figure 3.7, Figure 3.8 and 
Figure 3.9.  
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Table 3.7 Best fit model for seroconversion on different days after inoculation in 
subcutaneously exposed BALB/c mice 
 
 
Data  
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
 
Seroconversion after 
day 12 
 
7 
 
Beta Poisson* 
 
4.19 
 
5 
 
11.07 
α =0.79 
N50=94.80 
 
Seroconversion after 
day 15 
 
7 
 
Beta Poisson* 
 
1.40 
 
5 
 
11.07 
α =0.57 
N50=10.46 
Seroconversion after 
day 21 
 
 
7 
 
Beta Poisson* 
 
2.77 
 
5 
 
11.07 
α =0.60 
N50=1.67 
Seroconversion after 
day 28 
 
 
7 
 
Beta Poisson* 
 
1.59 
 
5 
 
11.07 
α =0.72 
N50=0.28 
*Best fit model 
 
 
Figure 3.6 Dose Response Data and Exponential Model Fits for Seroconversion (12 
days after inoculation) in Subcutaneously Exposed BALB/c mice to R. typhi and 
Bootstrapped Beta-Poisson parameters 
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Figure 3.7 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (15 
days after inoculation) in Subcutaneously Exposed BALB/c mice to R. typhi and 
Bootstrapped Beta-Poisson parameters 
 
 
 
Figure 3.8 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (21 
days after inoculation) in Subcutaneously Exposed BALB/c mice to R. typhi and 
Bootstrapped Beta-Poisson parameters 
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Figure 3.9 Dose Response Data and Beta-Poisson Model Fits for Seroconversion (28 
days after inoculation) in Subcutaneously Exposed BALB/c mice to R. typhi and 
Bootstrapped Beta-Poisson parameters 
 
3.4.4 Time-dose-response model for Murine Typhus in BALB/c mice 
 
Huang et al. (Huang, Bartrand et al. 2009; Huang and Haas 2009;(Huang 2010) proposed 
a class of time-dose-response models by incorporating the time postinoculation into the 
classical dose-response models for microbial infection. The parameter k in the 
exponential dose-response model and the parameter N50 in the beta-Poisson model were 
set equal to functions of time, which presumably model the in vivo bacterial kinetics for a 
single microorganism. 
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The proposed exponential time-dose-response model from these prior studies can 
be given as: 
dTPIkeTPIdP )(1),(                 (3)                                                                                                  
For beta-Poisson time-dose-response model: 
12
)(
11),(
1
TPIN
d
TPIdP                (4)     
                                                                                           
The models with candidate time dependencies (Huang and Haas 2009)  were fit to the 
data of the time-dependent antibody response of mice after subcutaneous inoculation of 
increasing doses of live R. mooseri (R.typhi) to study the time and dose dependence of 
the antibody response. The models and their deviances are shown in Table 3.8.  
 
The two-parameter Beta-Poisson model with exponential time dependency model 
(equation 6) provided the best (and statistically acceptable) fit to the data. The best-fit 
model was then plotted to compare visually with the antibody response in Figure 3.10.  It 
can be seen that the model is closely aligned with the data.  
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Table 3.8 Expanded models based on TPI dependency and deviances of the fits to the data of the time-dependent antibody 
response of mice after subcutaneous inoculation of increasing doses of live R. typhi. 
Parameter Dependency  Expanded Model Equation 
 
Deviance 
2
,95.0 df  
)
1
/
0
(
)(
kTPIk
eTPIk                   
 
de
kTPIk
eTPIdP
)
1
/
0
(
1,                                     (5) 
109.243 48.602 
)
1
/
0
(
)(
jTPIj
eTPIN
              
 
1
1
2
)
1
/
0
(
11
jTPIj
e
d
TPI)P(d,            (6) * 
26.985 
 
47.400 
]
1
2)/(
0
[
)(
k
k
TPIk
eTPIk           
 
de
k
k
TPIk
eTPIdP
)
1
2)/(
0
(
1,                                (7) 
104.662 47.400 
)
1
2)/(
0
(
)(
j
j
TPIj
eTPIN
  
 
1
1
211),(
)
1
2)/(
0
( j
j
TPIj
e
d
TPIdP       (8) 
26.473 46.194 
*Best fit model ( TPI≠ 0, 0 ≤ P (d) ≤ 1) 
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Figure 3.10 Time-Dependent Model for Antibody Response of BALB/c mice after 
subcutaneous inoculation of increasing doses of live R. mooseri 
 
3.4.5 Pooling analysis 
 
Pooling analysis is performed to ascertain whether different data sets can be described by 
a single dose-response relationship.  Different combinations of species, strains, routes of 
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infection and hosts were pooled together and a likelihood ratio test was used to determine 
whether the data could be pooled or not. A likelihood ratio test was used to determine 
whether data could be pooled.  
 
The intradermally inoculated adult rats and subcutaneously inoculated newborn 
rats with R. typhi (Ethiopian strain) could be pooled. The value of difference in deviances 
between sum of individual best fits and pooled best fit was 0.01 which was less than      
χ2 0.05,1  value (3.841). The summary and statistics of the pooling analysis are shown in 
Table 3.9 and the best fit model is shown in Figure 3.11. 
Table 3.9 Adult rat and Newborn rat Pooled Data 
 
 
Data set 
 
Number 
of  Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
 
Parameters 
 
Adult rat 
exposed 
intradermally   
 
8 
 
Exponential 
 
0.88 
 
 
7 
 
14.06 
K=0.756 
    
1.12 
   
 
Newborn rat 
exposed 
subcutaneously 
 
7 
 
Exponential 
 
1.12 
 
6 
 
12.59 
K=0.831 
    
0.88 
   
Pooled data  
15 
 
Exponential 
 
2.0 
 
14 
 
23.68 
K=0.801 
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Figure 3.11 Best fit model of Adult rat, newborn rat and pooled data 
 
Similarly, neonatal rats of different age groups were exposed to graded doses of 
R. typhi orally. These data could also be pooled indicative of seroconversion in neo natal 
rat after oral exposure is independent of the age of the animals. The value of the 
difference in deviances between sum of individual best fits and pooled best fit was 7.167 
which was less than χ2 0.05,4 value (9.48). Statistics of the pooled data are summarized in 
Table 3.10 and best fit model of the pooled data is shown in Figure 3.12.  
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Table 3.10 Neonatal rat of different ages Pooled Data 
 
 
Data set 
 
Number of  
Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
Parameters 
Neo-natal 
rat 3-day 
old 
 
5 
 
Beta-Poisson  
 
3.023 
 
3 
 
7.81 
α =0.286 
N50=25.7
 
       
Neo-natal 
rat 7-day 
old. 
 
5 
 
Beta-Poisson 
 
2.34 
 
3 
 
7.81 
α =0.241 
N50=28.92
 
       
Neo-natal 
rat 30-day 
old. 
 
5 
 
Beta-Poisson 
 
1.0 
 
3 
 
7.81 
α =0.20 
N50=1616.45
 
       
Pooled data  
15 
 
Beta-Poisson 
 
13.53 
 
13 
 
22.36 
α =0.213 
N50=106.14 
 
 
 
Figure 3.12 Figure 12 Best fit models of Neonatal rat (different age group) and 
pooled data 
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3.5 Discussion  
 
Aringo-Jaramillo et al (1984) studied antibody response of adult and newborn laboratory 
rats exposing them intradermally and subcutaneously with R. typhi. Both newborn (3 day 
old) and adult rat were highly susceptible to Rickettsia mooseri inoculated either 
subcutaneously or intradermally. The ID50 for adult rat is 0.91 PFU and for newborn rat is 
0.88 PFU. Both the routes of infection are considered as similar to the  natural mode of 
infection which is flea bite(Walker 1989). The exponential model provided the best fit in 
both cases indicating that the responses were homogenous in the population. Moreover, 
the data could be pooled and as shown  in Figure 3.11, the best fit lines of each 
individual models and pooled data are overlapping in one another indicating that 
responses in rats are independent of the age factor and mode of inoculation ( intradermal 
and subcutaneous).  The comparative table as shown in Table 3.11 also shows there are 
no significant differences in ID50, ID10 and ID01.  
Table 3.11 Comparative values of ID50, ID10 and ID01 
Pathogen Host  Route  ID01 ID 10 ID50 
R. mooseri  
  
  
Newborn rat  sc 0.012 0.12 0.83 
Adult rat  id 0.013 0.14 0.91 
Pooled data    0.012 0.13 0.86 
  sc= subcutaneous  
  id= intradermal  
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Similarly, Aringo-Jaramillo et al (1988) studied the influence of maternal R. typhi 
in neonatal rats of different age groups inoculating R. typhi orally. All of the individual 
rat data sets (3 days old, 7 days old and 30 days old rats) were best fit by Beta-Poisson 
model and all of the data for the rats of different ages could be pooled. The result 
indicates that the rats inoculated orally show heterogeneity in responses and a single 
dose-response relationship can describe all the age groups. There are no significant 
differences in ID50s of individual age groups but the values for the rats exposed to R. 
typhi orally are significantly higher than rats inoculated intradermally or subcutaneously. 
The reason behind the higher ID50 may be the route of inoculation. The number of 
pathogens reaching the endothelial cells via oral route might be significantly less than 
initial inoculation. 
 
Crist et al (1984) recorded responses at various time post inoculation for BALB/c 
mice inoculated with R. typhi (R. mooseri) via subcutaneous route. In days 0-6, there was 
no response. There was only one response at the highest dose on day 9. From day 12 to 
28, there were systematic responses, with response occurring sooner for higher dose 
groups.  The data of seroconversion of BALB/c mice after day 12, day 15, day 21 and 
day 28 were fit to Beta-Poisson model. The post inoculation effect was analyzed with the 
data set using time post inoculation model as described in prior work (Huang, Bartrand et 
al. 2009; Huang and Haas 2009).  The Figure 3.10 shows the different dose-response 
curves for different time (days) after. The Figure 3.10 shows the different dose-response 
curves for different time (days) after inoculation. The best fit model was Beta-Poisson 
with exponential time dependency model and deviance was 26.895.  
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3.6 Conclusions 
 
It has been stated that murine typhus, caused by Rickettsia typhi (R. mooseri), can be 
initiated via the subcutaneous or intradermal route with a relatively small number of 
pathogens.  The dose-response models developed in this study support that assertion.   
Intradermally or subcutaneously inoculated rats (adult and newborn) models suggest that 
less than 1 PFU (1.33 to 0.38 in 95 % confidence limits) of the pathogen is enough to 
seroconvert 50 % of the exposed population in an average. The BALB/c mouse’s time 
post inoculation model also indicates that an average dose of 0.28 (0.75 to 0.11 in 95% 
confidence limits)  PFU will cause seroconversion in of 50 % exposed population with a 
mean time to effect of 28 days. The difference in 50% infection (seroconversion) in adult 
rat and BALB /c mice is not a significant one and it may be a result of different strains of 
pathogen used to infect the two animal models in the two experimental studies. The TPI 
model shows that a higher dose is associated with earlier seroconversion. Pooling 
analysis of adult and newborn rats exposed via the subcutaneous and intradermal routes 
shows that there is no significant effect of those routes of inoculation in responses.   
However, significant differences in response were noted when rats were orally 
inoculated.  
 
Pooling of orally inoculated neonatal rats of different age groups indicates that 
there is no significant effect of age in serocenversion after exposure to R. typhi. This 
observation is contrary to speculation that there is variation in response among the age 
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groups in human case studies (Al-Awadi, Ai-Kazemi et al. 1982; Brown, Meek et al. 
1988).  . Though human studies have noted differences among age group, they have not 
identified a definite pattern of variation in responses, making reconciliation of the 
observed human and rat age dependences impossible at this time. According to Al-Awadi 
et al., the most susceptible age group was the 15-25 years and followed by 26 to 44 years.  
 
This is also the first study to incorporate time in a dose-response model for 
murine typhus. The outcome may be used for the improved understanding of in vivo 
bacterial dynamics, improved post-exposure decision making or as a component to better 
assist epidemiological investigations. 
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4. MULTI-ROUTE DOSE-RESPONSE MODELS FOR RICKETTSIA 
RICKETTSII IN RODENTS 
 
4.1 Introduction  
 
 
Many researchers use different routes of infection of pathogen in experimental models to 
study pathogenesis of the disease.  Choice of animal model, route of inoculation, species 
or strain of pathogen, endpoint and other features of animal studies is dependent on the 
study objectives and made at the discretion of the researchers.  From a dose-response 
modeling perspective, availability of dose-response data corresponsing to different 
exposure routes presents an opportunity for development of an understanding of the 
pathology of infections and of developing parameters for potenital use in mechanistic 
models of infection that are extensions of the exponeitial or beta-Poisson dose-response 
models. Infection by different routes results in different patterns of exposure to the  host 
immune system and may subsequently influence response (Barnes and Ketheesan 2005).  
For example, the 50% lethal dose (LD50)  in BALB/C mice exposed intranasally  to  
Burkholderia pseudomallei was 45 CFU and LD50 in subcutaneously exposed to B. 
pseudomallei was more than 1000 CFU (Tamrakar and Haas 2008). This difference in 
LD50 may arise from interactions of the pathogen with the host active and pathogen 
immune system or may relate to the conditions experienced by pathogens introduced via 
one exposure route being more adverse to pathogen survival than via another route. 
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Lundgren and Thorpe in 1966 studied experimental infection of R1 and SFR 
isolates of    R. rickettsii, R strain in different rodents (Lundgren and Thorpe 1966). There 
were 31 different rodents inoculated with R1 and SFR isolates of R strain of Rickettsia 
via three different routes of exposure (intraperitoneal, subcutaneous and intracerebral). 
Among the available data, Pinyon mice inoculated with R1 isolate, Pinyon mice 
inoculated with SFR isolate and California mice inoculated with SFR isolates were usable 
for further analysis.  
 
4.2 Data and methods 
Pinyon and California mice inoculated with R. rickettsii R1 isolates by two different 
routes (subcutaneously and intraperitoneally) were used in the analyses which are shown 
in Table 4.1. 
Subcutaneous or intradermal exposure are the  natural routes of infection for 
rickettsial diseases (Saslaw and Carlisle 1966). However, we had data sets with different 
routes of infection to compare and to develop multi-routes dose response model.   
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Table 4.1 Data Used 
Bacteria 
and Strain 
Study 
Mode of 
inoculation 
 
Test Organism/ 
Reponses end point 
 
Dose 
 
Number of 
Test Animals 
Positive 
Responses 
Negative 
Responses 
R. rickettsii 
( R1) 
(Lundgren and 
Thorpe 1966) 
s.c. Pinyon mouse   
(C-F antibody titer)  
0.1 (ELD50) 5 0 5 
1 5 0 5 
10 5 0 5 
100 5 0 5 
1000 7 2 5 
10000 3 2 1 
        
R. rickettsii 
( R1) 
(Lundgren and 
Thorpe 1966) 
i.p. Pinyon mouse   
(C-F antibody titer)  
0.1 (ELD50) 5 1 4 
1 5 4 1 
10 5 5 0 
100 5 5 0 
1000 5 5 0 
10000 5 5 0 
        
R. rickettsii 
( SFR) 
(Lundgren and 
Thorpe 1966) 
i.p. Pinyon mouse   
(C-F antibody titer)  
0.1 (ELD50) 8 0 8 
1 7 0 7 
10 7 0 7 
100 8 0 8 
1000 8 0 8 
10000 8 4 4 
100000 8 6 2 
        
R. rickettsii 
( SFR) 
(Lundgren and 
Thorpe 1966) 
i.p. Pinyon mouse   
(C-F antibody titer)  
0.1 (ELD50) 5 0 5 
1 5 4 1 
10 5 4 1 
100 5 5 0 
1000 5 5 0 
10000 5 5 0 
        
R.rickettsii 
SFR 
 S.C. California  mice 0.1 (ELD50) 12 0 12 
1 10 0 10 
10 10 0 10 
100 8 0 8 
1000 6 2 4 
10000 2 2 0 
100000 2 2 0 
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Bacteria 
and Strain 
Study 
Mode of 
inoculation 
 
Test Organism/ 
Reponses end point 
 
Dose 
 
Number of 
Test Animals 
Positive 
Responses 
Negative 
Responses 
R. rickettsii 
SFR 
 S.C. California  mice 0.1 (ELD50) 8 0 8 
1 8 2 6 
10 8 5 3 
100 8 7 1 
1000 8 8 0 
10000 7 7 0 
i.p.= intraperitoneal, s.c.= subcutaneous  
ELD50= 50% Egg lethal dos
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4.3 Development of Multi-routes Dose-Response models 
 
Starting from the basic exponential dose-response model (Haas, Rose et al. 1999) and 
prior work of Bartrand et al. (2009) (Bartrand and Haas 2009), a correction factor “S” 
was introduced in the basic equations.  
The new exponential dose-response model is given by Equation 1 
kSdedP 1)(                                                   (1) 
where P (d) is the probability of response at dose d ,  k is the probability that a 
single organism can survive and initiate infection and s is the correction factor for 
different route of exposure.  
 
The new Beta-Poisson model is given by Equation (2) 
1211)(
1
50N
Sd
dP                                  (2) 
where N50 is the median infective dose,  α is the slope parameter for Beta Poisson 
model and s factor for different route of exposure.  
 
The Log-probit model is given by Equation (3) 
12
ln
1
)(
q
Sd
q
dP                                  (3) 
93 
 
 
Where q2 is the probit slope, q1 is the location parameter and  denotes the normal 
cumulative distribution function of the standard normal distribution. 
 
Dose response relationships were fit to data using the method of maximum 
likelihood estimation (MLE) as described in Haas et al. (1999).  The statistical 
programming language, “R” (www.r-project.org) was used for this computation. 
Exponential and Beta-Poisson MLE estimates were made using the BFGS algorithm and 
Nelder-Mead algorithm was used for log Probit.  
 
Goodness of fit for all models was determined by comparing the optimal value of 
the deviance from a fit to the critical 
2
 value at degrees of freedom equal to the number 
of doses minus the number of fitted parameters and a 95% confidence.   Assessment of 
the statistical significance of improvement of fit that three parameters models provide 
relative to two parameters models was made by comparing the reduction in minimized 
deviance with the critical 
2
 value at 1 degree of freedom. Confidence intervals for the 
best-fit model were estimated via bootstrapping (Haas, Rose et al. 1999). The modified 
exponential model has two parameters and the Beta-Poisson and log Probit both are 
three- parameter models.  
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4.4 Results 
4.4.1 Dose-response models  
Lundgren and Thorpe in 1966 experimented with R. rickettsii (R1 and SFR isolates) 
using different rodents and routes of exposure (Lundgren and Thorpe 1966). Pinyon mice 
inoculated subcutaneously and intraperitoneally with both the isolates were used in this 
analysis. Similarly California mice inoculated with SFR isolate subcutaneously and 
intraperitioneally were examined.  
 
The best fit dose response model for antibody titer (Complement Fixation Test) in 
subcutaneously (s.c.) inoculated Pinyon mouse with R1 isolate was the exponential 
model. Statistics of the three model fits to the animal are summarized in Table 4.2 and 
the best fit model with confidence interval is shown in Figure 4.1.  Similarly the best fit 
dose response model for antibody titer (Complement Fixation Test) in intraperitoneally 
(i.p.) inoculated Pinyon mouse was the exponential model. Statistics of the three model 
fits to the animal are summarized in Table 4.3 and the best fit model with confidence 
interval is shown in Figure 4.2. 
Table 4.2 Model Fit Comparison for Antibody titer in Subcutaneously Exposed Pinyon 
mouse 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
(Lundgren and 
Thorpe 1966) 
 
6 
 
Exponential* 
 
1.323 
 
5 
 
11.07 
 
k=1.67e-4 
 
6 
 
Beta Poisson 
 
0.454 
 
4 
 
9.48 
α =0.583 
N50=3604.72
 
*Best fit model  
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Figure 4.1 Dose Response Data and Exponential Model Fits for Antibody titer in 
Subcutaneously Exposed Pinyon mouse to R. rickettsii and Bootstrapped 
Exponential parameters 
 
Table 4.3 Model Fit Comparison for Antibody titer in Intraperitoneally Exposed Pinyon 
mouse 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
(Lundgren and 
Thorpe 1966) 
 
7 
 
Exponential* 
 
0.011 
 
5 
 
11.07 
 
k=1.65 
 
7 
 
Beta Poisson 
 
0.00154 
 
4 
 
9.48 
α =7.35 
N50=0.40
 
*Best fit model  
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Figure 4.2 Dose Response Data and Exponential Model Fits for Antibody titer in 
Intraperitoneally Exposed Pinyon mouse to R. rickettsii and Bootstrapped 
Exponential parameters 
 
The best fit dose response model for antibody titer (Complement Fixation Test) in 
subcutaneously (s.c.) inoculated Pinyon mouse with SFR isolate was the exponential 
model. Statistics of the three model fits to the data are summarized in Table 4.4 and the 
best fit model with confidence interval is shown in Figure 4.3.  Similarly the best fit dose 
response model for antibody titer (Complement Fixation Test) in intraperitoneally (i.p.) 
inoculated Pinyon mouse was the exponential model. Statistics of the three model fits to 
the animal are summarized in Table 4.5 and the best fit model with confidence interval is 
shown in Figure 4.4. 
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Table 4.4 Model Fit Comparison for Antibody titer in Subcutaneously Exposed 
Pinyon mouse (SFR) 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
(Lundgren and 
Thorpe 1966) 
 
7 
 
Exponential* 
 
5.24 
 
6 
 
12.59 
 
k=2.13e-5 
 
7 
 
Beta Poisson 
 
1.76 
 
5 
 
11.07 
α =0.57 
N50=17500.76
 
*Best fit model  
  
Figure 4.3 Response Data and Exponential Model Fits for Antibody titer in 
Subcutaneously Exposed Pinyon mouse to R. rickettsii (SFR) and Bootstrapped 
Exponential parameters 
 
Table 4.5 Model Fit Comparison for Antibody titer in Intraperitoneally Exposed 
Pinyon mouse 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
(Lundgren and 
Thorpe 1966) 
 
6 
 
Exponential 
 
8.03 
 
5 
 
11.07 
 
k=0.335 
 
6 
 
Beta Poisson* 
 
3.27 
 
4 
 
9.48 
α =0.77 
N50=0.71
 
*Best fit model  
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Figure 4.4 Response Data and Beta-Poisson Model Fits for Antibody titer in 
Intraperitoneally Exposed Pinyon mouse to R. rickettsii (SFR) and Bootstrapped 
Beta-Poisson parameters 
 
The best fit dose response model for antibody titer (Complement Fixation Test) in 
subcutaneously (s.c.) inoculated California mouse was the exponential model. Statistics 
of the three model fits to the animal are summarized in Table 4.6 and the best fit model 
with confidence interval is shown in Figure 4.5.  
Table 4.6 Model Fit Comparison for Antibody titer in Subcutaneously Exposed 
California mouse 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
(Lundgren and 
Thorpe 1966) 
 
7 
 
Exponential* 
 
0.79 
 
6 
 
12.59 
 
k=0.00037 
 
7 
 
Beta Poisson 
 
0.79 
 
5 
 
11.07 
α =2.45e7 
N50=10844.56
 
*Best fit model  
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Figure 4.5 Response Data and Exponential Model Fits for Antibody titer in 
Subcutaneously Exposed California mouse to R. rickettsii (SFR) and Bootstrapped 
Exponential parameters 
 
The best fit dose response model for antibody titer (Complement Fixation Test) in 
intraperitineally (i.p.) inoculated California mouse was the Beta- Poisson model. 
Statistics of the three model fits to the animal are summarized in Table 4.7 and the best 
fit model with confidence interval is shown in Figure 4.6. 
Table 4.7 Model Fit Comparison for Antibody titer in Intraperitoneally Exposed 
California mouse 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
(Lundgren and 
Thorpe 1966) 
 
6 
 
Exponential 
 
9.50 
 
5 
 
11.07 
 
k=0.045 
 
6 
 
Beta Poisson* 
 
1.06 
 
4 
 
9.48 
α =0.66 
N50=4.82
 
*Best fit model  
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Figure 4.6 Response Data and Exponential Model Fits for Antibody titer in 
Intraperitoneally Exposed California mouse to R. rickettsii (SFR) and Bootstrapped 
Exponential parameters 
 
4.4.2 Multi-route dose-response models 
There is a clear grouping of ID50 by exposure routes. Animals exposed subcutaneously 
had an ID50 2.59 to 4.66 order of log (10) magnitude higher than those inoculated 
intraperitoneally. The summary of ID50 of the different animals and different routes is 
given in Table 4.8.   
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Table 4.8 ID50 and Route of Exposure 
Isolate Host Route ID50 
ID50(s.c.)/ID50 
(i.p.) 
(Log10) 
 R1 Pinyon mouse s.c. 4332 4.01 
 
Pinyon mouse i.p. 0.42 
 
     SFR Pinyon mouse s.c. 32496 4.66 
 
Pinyon mouse i.p. 0.71 
 
 
California mouse s.c. 1873 2.59 
 
California mouse i.p. 4.82 
  
 
Starting from the classical dose-response model, an additional parameter “s”, a correction 
factor is incorporated in the model.  
 
Pinyon mice inoculated subcutaneously and intreperitoneally with R1 isolate of 
the R. rickettsii were analyzed. The intraperitoneal doses were scaled up by a correction 
factor “S” and the new dose-response model was best fit by exponential model. The 
minimized deviance was 1.33 which is less than Chi-square value at degree of freedom 
10 (18.30). Statistics of the three model fits to the animal are summarized in Table 4.9 
and the fitted dose-response models are shown in Figure 4.7. 
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Table 4.9 Modified Model Fit Comparison for Subcutaneously and Intraperitonealy 
exposed Pinyon mice with Correction factors”S” (R1 isolate of R. rickettsia) 
 
 
Data set 
 
Number 
of  Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Correction 
factor”S” 
Pinyon mice 
inoculated sc 
and ip 
 
R1 isolate 
 
12 
 
Exponential* 
 
1.334 
 
10 
 
18.30 
 
k=0.00016 
 
9883.60 
 
12 
 
Beta Poisson 
 
5.36 
 
9 
 
16.91 
α =1.09  
1423.8 N50=1268.31
 
12 Log probit  0.679 9 16.91 q1=1.46  
9105.84 q2=3067.94 
*Best fit model  
 
Figure 4.7 Fitted Dose Response Models for Pinyon mice Exposed Subcutaneously 
and Scaled-up Intraperitoneal Doses by a Correction Factor (R. rickettsia, R1 
isolate)  
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Similarly Pinyon mice inoculated subcutaneously and intreperitoneally with SFR isolate 
of the R. rickettsii were analyzed. Exponential model provides the best fit while scaling 
up intraperitoneal doses  by a correction factor “S”. The minimized deviance was 13.27 
which is less than Chi-square value at degree of freedom 11 (19.67). Statistics of the 
three model fits to the animal are summarized in Table 4.10 and the fitted dose-response 
models are shown in Figure 4.8. 
Table 4.10 Modified Model Fit Comparison for Subcutaneously and 
Intraperitonealy exposed Pinyon mice with Correction Factor”S” (SFR isolate of R. 
rickettsia) 
 
 
Data set 
 
Number 
of  Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Correction 
factor”S” 
Pinyon mice 
inoculated sc 
and ip 
 
SFR  isolate 
 
13 
 
Exponential* 
 
13.27 
 
11 
 
19.67 
 
k=0.335 
 
15734.72 
 
13 
 
Beta Poisson 
 
12.29 
 
10 
 
18.30 
α =0.557  
1994.02 N50=6008.39
 
13 Log probit  5.20 10 18.30 q1=1.788 22286.1 
q2=19446.66 
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Figure 4.8 Fitted Dose Response Models for Pinyon mice Exposed Subcutaneously 
and Scaled-up Intraperitoneal Doses by a Correction Factor (R. rickettsia, SFR 
isolate)  
 
California mice inoculated subcutaneously and intraperitoneally with SFR isolate of the 
R. rickettsii best fit by Beta-Poisson model. The minimized deviance was 13.27 which is 
less than Chi-square value at degree of freedom 11 (19.67). Statistics of the three model 
fits to the animal are summarized in Table 4.11 and the fitted dose-response models are 
shown in Figure 4.9. Pooling data of subcutaneously inoculated California mice and 
scaled up data of intraperitoneally inoculated mice were best fit by Beta-Poisson model. 
The sum of the minimum deviances of individual data set was 1.856 and the deviance of 
pooled data was 3.135. The difference of deviance was 1.279 which was less than chi 
square value at one degree of freedom.  
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Table 4.11 Modified Model Fit Comparison for Subcutaneously and 
Intraperitonealy exposed California mice with Correction factors”S” (SFR isolate of 
R. rickettsia) 
 
 
Data set 
 
Number 
of  Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Correction 
factor”S” 
California mice 
inoculated sc 
and ip 
 
SFR  isolate 
 
13 
 
Exponential 
 
10.29 
 
11 
 
19.67 
 
k=3.73e-4 
 
122.08 
 
13 
 
Beta Poisson* 
 
3.13 
 
10 
 
18.30 
α =0.849  
364.65 N50=1996.58
 
13 Log probit  2.82 10 18.30 q1=1.807 377.98 
q2=2208.46 
 
 
 
 
 
 
Figure 4.9 Fitted Dose Response Models for California  mice Exposed 
Subcutaneously and Scaled-up Intraperitoneal Doses by a Correction Factor (R. 
rickettsia, SFR isolate)  
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4.5 Discussion 
 
As stated earlier, infection by different routes results in  pathogen exposure to different 
components of the host immune system and may subsequently influence response 
(Barnes and Ketheesan 2005). Pinyon  mice and California mice were inoculated with R. 
rickettsia ( R1 and SFR isolates) via different routes for experimental infection of Rocky 
Mountain spotted fever (Lundgren and Thorpe 1966). Data from those experiments were 
analyzed to determine (1) if dose-response models for the two routes of exposure were 
significantly different and (2) whether a simple dose-response model in which doses 
corresponding to one exposure route are scaled allowed pooling of the data. 
 
Pinyon mice inoculated with R1 isolates via subcutaneous and intraperitoneal 
routes were best fit by exponential model. Doses of intraperitoneal exposure were scaled-
up by a correction factors “S” and combined data were again fitted to dose-response 
model and the exponential model provided the best fit again.  The correction factor in this 
model was 9883. Similarly, pinyon mice inoculated with the SFR isolate via the 
subcutaneous route were best fit by an exponential dose-response model, but the Beta-
Poisson model provided the best fit for the animals inoculated via intraperitoneal route. 
The best fit modified model (with scaled-up intraperitoeal doses) was the exponential 
model and the dose scaling factor in this case was 15735. California mice exposed via 
subcutaneous route were best fit by exponential model while, the animals exposed 
intraperitoneal were best fit by Beta-Poisson model. Scaling up doses of intraperitoneal 
route by a factor “S” and the combined new data were best fit by again Beta-Poisson 
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model. The correction factor in this case was 122. The difference in ID50 in two different 
routes of exposure has not been explained yet. One probable reason might be the host 
immune system and another might be the availability of small blood vessels. The 
pathogens primarily target small blood vessels to multiplication and spread into other part 
body via blood vascular system.  The intraperitoneal route provides a more direct route to 
the small blood vessels than the subcutaneously route and is expected to result in higher 
likelihood that pathogens reach their target and initiate infection. The summary of factors 
“S” is given in Table 4.12.   
 
Table 4.12 Summary of Correction Factor "S" 
Data Best fit Model Correction factor “S” 
Pinyon mice inoculated  with R1 isolates  via 
s.c. and i.p routes  
Exponential 9883.60 
Pinyon mice inoculated  with SFR isolates  
via s.c. and i.p routes 
Exponential 15734.72 
California  mice inoculated  with SFR 
isolates  via s.c. and i.p routes 
Beta-Poisson 364.65 
 
 
4.6 Conclusions 
 
Different isolates of pathogens, different routes of infection, and different host animals 
provide different dose-response models. The models may be similar in shape indicating 
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the similar type of distribution but will not be the same. The modified dose-response 
model with a correction factor”S” also provided statistically acceptable fits. This factor 
will provide the information regarding the actual doses at the target organs. A fraction of 
total doses might be retained in particular organ such as nasal cavity in case of intranasal 
and aerosol exposure scenario. Large number of small blood vessels present in peritoneal 
cavity than subcutaneous injected section. The pathogens have greater chances of 
multiplication and spreading into other parts of the body.  Intraperitoneal dose was “S” 
times more effective than subcutaneous dose. The values “S” are different host and 
different isolates. There is no literature available to distinguish R1 and SFR isolates and 
California mice and Pinyon mice.  Moreover, this correction factor also helps the 
investigators to estimate unknown quantity of the pathogens for different route of 
exposure.  
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5. INTERSPECIES SUSCEPTIBILITIES IN ROCKY MOUNTAIN SPOTTED 
FEVER DISEASE 
 
5.1 Introduction  
 
Spotted fever group and typhus group rickettsiae are genetically related and associated 
with arthropod vectors. But some species such as R. rickettsii (Rocky Mountain spotted 
fever) and R. prawozekii (epidemic typhus) cause greater mortality than other species 
(Walker 1990). There are obviously interspecies differences in rickettsial virulence but 
the outcome of an infection with a specific species of rickettsia is strongly influenced  by 
host factors(Walker 1990).  
 
Different investigators have used various host animals in their experimental 
infection with Rickettsia species. Experimental infections of R. rickettsii were observed 
in rodents to most advanced animal primates including human. However, experimental 
studies of infection by R. typhi have been limited to rodents.  
 
Dose-response models of individual species, strain, isolate, and host have been 
developed and described in Chapters 2-4.  This chapter focuses on R. rickettsii infection 
in various hosts and different strains or isolates in a single host were compared to study 
the effect of animal species on dose-response.  
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Several statistical tools have been used to compare the susceptibility. Geometric 
mean and arithmetic mean of LD50 or ID50 were used by some investigators(Aldridge and 
Johnson 1997). Student’s t- test and Duncan’s test were also used in interspecies  and 
interstrain studies on the susceptibilities induced by certain drugs  in animal (Diomede, 
Romano et al. 1991). Analysis of variances (ANOVA) was used to compare insecticide 
susceptibility in humans (Valles and Woodson 2002).  Numerical cluster analysis was 
also used by Dzierzewicz et al. (Dzierzewicz, Cwalina et al. 1996) for intraspecies 
variability of bacterial components. Those mentioned methods were used to compare 
interspecies susceptibility of chemical, carcinogenic or drug in animal and human and 
none of them used in microbial risk assessment. 
 
In this study, pooling analysis was used to compare interspecies susceptibility. 
Pooling data is useful for two primary reasons. Different behavior of a different strain or 
isolate is inferred, if different strain or isolates of pathogens have different dose-response 
relationships. If the same organism has the same dose-response in different animals, 
dose-response for new animal or human could be extrapolated (Haas, Rose et al. 1999).        
 
5.2 Data and Methods  
 
Individual dose-response models which have been developed and described in Chapter 
two and three and some additional dose-response models developed for this Chapter were 
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analyzed. The method used in dose-response model has been described in previous 
Chapters.  
 
Pooling analysis was performed for the different animals and bacterial species to 
ascertain whether the data set had the same underlying distributions. A likelihood ratio 
test was used to determine if data could be pooled(Haas, Rose et al. 1999). 
 
5.3 Results 
5.3.1 Rocky Mountain spotted fever in rodents  
 
Lundgren and Thorpe in 1966 experimented with R. rickettsii R1 and SFR isolates using 
different rodents as host. Altogether 15 different species of squirrel, rat, mouse, guinea 
pig and hamster were used in the experiments. In these experiments they inoculated five 
to eight graded doses with different routes of infection (intraperitoneal-ip and 
subcutaneous –sc) (Lundgren and Thorpe 1966). The responses were recorded as 
antibody titer (Complement Fixation Test).  The summary of the dose-response models 
and statistics is given in Table 5.1.
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Table 5.1 Summary of dose-response models for other animals (Lundgren and Thorpe 1966) 
R. rickettsii 
Isolate 
Host  
Type of animal 
(breeding)  
Route  Best fit model 
Minimum 
deviance  Parameters ID10(ELD50) ID50 (ELD50) 
R1 Ord's Kangaroo rat  
 
Wild trapped  
sc Beta-Poisson  3.73 
α = 0.099 
1.34 731 
N50=731
 
  Harvest mouse  Inbred* sc Beta-Poisson 0.369 
α =0.237 
662 21290 
N50=21290
 
  Deer mouse  Inbred* sc Beta-Poisson 2.99 
α =0.26 
1.03 27.85 
N50=27.85
 
  Desert wood rat  Inbred* sc Beta-Poisson 3.40 
α =0.198 
27.33 1279 
N50=1279
 
  Pinyon mouse  Inbred* sc Exponential  1.323 K=0.000167 628 4332 
  Montane vole  Inbred* sc Exponential 0.85 K=0.792 0.13 0.87 
  Pinyon mouse  Inbred* ip Exponential 0.0764 K=1.72 0.062 0.42 
  
Swiss Webster 
mouse  
Inbred  ip  Beta-Poisson 3.052 
α =0.522 
261.75 3109 
N50=3109
 
  Guinea pig  Inbred ip Beta-Poisson 1.797 
α =0.45 
2.49 34.58 
N50=34.58
 
               
SFR Antelope squirrel  Wild trapped sc Beta-Poisson 3.76 
α =0.194 
18.70 892.6 
N50=892.6
 
  Deer mouse  Inbred* ic Beta-Poisson 5.99 
α =0.29 
0.036 0.84 
N50=0.84
 
  
Deer mouse 
(naked) 
Inbred* sc Beta-Poisson 7.55 
α =0.036 
φ φ 
N50=44258.39
 
  
Deer mouse 
(albino) 
Inbred* ip Exponential  1.357 k=0.0153 6.88 45.30 
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ic= intracerebral 
φ= Average 50% and 10% responses not applicable as average response never exceeds 50% and never  goes down to  10% 
 *Generations removed from live-trapped parent stock 
 
Summary of dose-response models for other animals (Lundgren and Thorpe 1966) 
 
R. rickettsii 
Isolate 
Host  
Type of animal 
(breeding)  
Route  Best fit model 
Minimum 
deviance  Parameters ID10(ELD50) ID50 (ELD50) 
   
 
Pinyon mouse  Inbred* sc Exponential 5.24 k=2.13e-5 4946 32542 
  Pinyon mouse  Inbred* ip Beta-Poisson 3.27 
α =0.77 
0.071 0.71 
N50=0.71
 
  California mouse  Inbred* sc Exponential 0.79 k=0.00037 
284 
 
1873 
  California mouse  Inbred* ip Beta-Poisson 1.06 
α =0.66 
0.45 4.82 
N50=4.82
 
  Polyseian rat  Inbred* sc Exponential 1.15 k=0.092 1.1 7.4 
  Guinea pig  Inbred ip Beta-Poisson 5.23 
α =0.69 
0.521 5.47 
N50=5.47
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Although RMSF infection is naturally and generally transmitted by tick bite 
(intradermal), evidence shows that there is a possibility of aerosol transmission of disease 
to human especially to laboratory workers (Kenyon, Kishimoto et al. 1979). Outbred 
guinea pigs were exposed to aerosolized R. rickettsii by collision atomizer and responses 
were recorded in terms of illness and death, but the size of aerosol was not mentioned in 
the study. Moreover, the animals were inoculated with pathogens via different routes 
including intranasal, conjuctival, intragastric subcutaneous routes.  
 
 The best fit dose response model for mortality in aerosolized exposed guinea pig 
was the Beta-Poisson model. The average 50% lethal dose (LD50) for guinea pigs was 
192 organisms. Similarly, the best fit dose response model for morbidity in intranasally 
exposed guinea pig was the Beta-Poisson model and ID50 was 1998 organisms. However, 
experimental infection via conjuctival and intragastric route were with two doses and one 
dose respectively and data were not suitable for use in dose-response modeling. 
 
 
5.3.2 Rocky Mountain spotted fever in other hosts 
 
Keenan et al (1977) explored pathogenesis of R. rickettsii in dogs.  34 adult beagle dogs 
were intravenously (i.v.) inoculated with 1.0 millimeter (ml) of the suspension of R. 
rickettsii. Beagle dogs inoculated with R. rickettsii developed a disease and some of them 
died (Keenan, Buhles Jr et al. 1977a; Keenan, Buhles Jr et al. 1977b). The best fit dose 
response model for mortality in intravenously (i.v.) inoculated Beagle dogs was the Beta-
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Poisson model and an average lethal dose N50 was 3,027,355. Statistics of the model fits 
to the animal are summarized in Table 5.2  and the best fit model with confidence 
interval is shown in Figure 5.1. 
Table 5.2 Model Fit Comparison for Mortality in Intravenously Exposed Beagle 
dogs 
 
 
Data set 
 
Number 
of  Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
 
χ2α,n-k
 
 
Parameters 
 
Difference 
in 
deviances 
χ2 Value at 
1 degree 
of 
freedom
  
(Keenan, 
Buhles Jr et al. 
1977a; Keenan, 
Buhles Jr et al. 
1977b) 
 
7 
 
Exponential 
 
13.39 
 
6 
 
12.59 
 
K=5.54e-8 
 
10.13 
 
3.84 
  
7 
 
Beta Poisson* 
 
3.26 
 
5 
 
11.07 
α =0.367 
N50=3.03e6
 
 
 
Figure 5.1 Dose Response Data and Beta-Poisson Model Fits for Mortality in 
Intravenously Exposed Beagle dogs to R. rickettsii and Bootstrapped Beta-Poisson 
parameters 
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There were several experimental infections with primates including humans. The dose-
response models and results of the primates were discussed in Chapter 2.  
 
Saslaw and Carlisle in 1966 studied to determine aerosol infectivity of R. 
rickettsii in monkeys (Saslaw and Carlisle 1966). Rhesus monkeys were challenged with 
aerosolized pathogens and morbidity as well as mortality was observed. The number of 
animals per dose group was limited (1 to 4) and 24 graded doses were used in their study. 
 
Sammons et al (1976) also explored changes in blood serum constituents and 
hematologic values in Macaca mulatta while infecting with R. rickettsii. Inoculating 
intravenously and subcutaneously with graded doses of pathogens, the number of febrile 
animals and number of deaths were observed. But there were only two graded doses used 
in subcutaneously exposed animals and hence dose-response analysis was not performed 
for the data.  
 
DuPont et al (1973) developed an experimental model of RMSF in human 
volunteers. 31 young adults were intradermally  inoculated 3 graded doses of R. rickettsii 
and clinical symptoms were observed (DuPont, Hornick et al. 1973). The summary of 
dose-response models is given in Table 5.3. 
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Table 5.3 Summary of dose-response models for other animals 
Study 
Pathogen/ 
strain 
Host 
No. of 
doses 
Route Response Best fit model 
Parameters  ID50/ 
LD50 
(Saslaw and Carlisle 
1966) 
R. rickettsii R1 Rhesus monkey 24 Aerosol Mortality Beta-Poisson α =0.144 50.12 
N50=50.12
 
(Saslaw and Carlisle 
1966) 
R. rickettsii R1 Rhesus monkey 24 Aerosol Morbidity Beta-Poisson 
α =0.86 
19.10 N50=19.10
 
N50=43.03
 
(Sammons, Kenyon 
et al. 1976) 
R. rickettsii 
Sheila Smith 
Macaca mulatta 5 Intravenous Morbidity Exponential k=0.145 4.83 
(DuPont, Hornick et 
al. 1973) 
R. rickettsii 
Sheila Smith 
Human 3 intradermal 
Clinical 
signs 
Beta-Poisson 
α =0.668 
23 
N50=23.09 
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5.3.3 Pooling analysis (RMSF) 
Pooling analysis is performed to ascertain with different combinations of species, strains, 
routes of infection and hosts to determine whether the relationship can be described by 
the same dose-response relation or not. A likelihood ratio test was used to determine if 
data could be pooled. The summary of pooling result is shown in Table 5.4. 
Table 5.4 Summary of pooling results 
Pathogen Pooling combination Factor 
difference  
Result 
R. rickettsii (R1) Subcutaneously exposed all the 
rodents 
Rodent host Data could not 
be pooled   
R. rickettsii (R1) Intraperitoneally exposed all the 
rodents 
Rodent host Data could not 
be pooled   
R. rickettsii (R1) Subcutaneously exposed different 
strain of mouse  
Mouse host Data could not 
be pooled   
R. rickettsii (R1) Subcutaneously exposed different 
rodents excepts mouse 
Rodent host, 
excluding mice 
Data could not 
be pooled   
R. rickettsii (R1) Canyon mice exposed in different 
routes 
Exposure route Data could not 
be pooled   
R. rickettsii (R1) Pinyon mice exposed in different 
routes 
Exposure route Data could not 
be pooled   
R. rickettsii (R1) Subcutaneously exposed Canyon 
and Pinyon mice 
Mouse host Data could not 
be pooled   
R. rickettsii (R1) Intraperitoneally  exposed Canyon 
mice and Pinyon mice 
Mouse host Data could not 
be pooled   
R. rickettsii (R1) Aerosol exposed Rhesus monkey 
responses as mortality and 
morbidity 
Health endpoint Data could not 
be pooled   
R.rickettsii –Sheila 
smith 
Intravenously  exposed Macaca 
mulatta response as mortality and 
morbidity 
Health endpoint Data could not 
be pooled 
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Summary of pooling results 
 
Pathogen Pooling combination Factor 
difference  
Result 
R.rickettsii –Sheila 
smith and R1 
Human volunteers exposed 
intradermally and aerosol exposed 
rhesus monkeys morbidity as end 
point of response  
Host and 
exposure route 
Data could be 
pooled  
R. rickettsii (SFR) Deer mice inoculated  i.p. and i.c  Exposure route Data could not 
be pooled   
R. rickettsii (SFR) Deer mice (naked) inculated s.c. 
and i.p.  
Exposure route Data could not 
be pooled   
R. rickettsii (SFR) Deer mice (naked) and deer mice 
(albino)  
Mouse host Data could not 
be pooled   
 Deer mice with R1isolate and  deer 
mice ( albino) with SFR isolate  
inoculated s.c. 
Mouse host Data could be 
pooled  
R. rickettsii (SFR) Pinyon mice inoculated s.c. and i.p.  Exposure route Data could not 
be pooled   
 Pinyon mice inoculated sc with 
R1and SFR strain 
Pathogen strain Data could not 
be pooled   
 Pinyon mice inoculated i.p with 
R1and SFR strain 
Pathogen strain Data could be 
pooled  
R. rickettsii (SFR) California mouse inoculated sc and 
ip  
Exposure route Data could not 
be pooled   
 Guinea pigs inoculated i.p. ( R1 
and SFR) 
Pathogen strain Data could be 
pooled  
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Deer mouse inoculated subcutaneously with R1 isolate and deer mouse (Albino) also 
inoculated subcutaneously to SFR isolate of the pathogen could be pooled indicating the 
data were from same underlying distribution.  Statistics of the pooled data are 
summarized in  
Table 5.5 and best fit model of the pooled data is shown in Figure 5.2. 
Table 5.5 Deer mouse R1 and SFR isolate Pooling  
 
 
Data set 
 
Number of  
Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
χ2 p-value 
Deer mouse 
(s.c.), R1  
 
6 
 
Beta-Poisson  
 
2.94 
 
4 
 
9.48 
 
0.56 
       
Deer mouse  
( albino ), sc, 
SFR 
 
8 
 
Exponential 
 
1.357 
 
7 
 
14.06 
 
0.98 
       
 
Pooled data 
 
14 
 
Beta-Poisson 
 
7.542 
 
12 
 
21.02 
 
0.909 
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Figure 5.2 Beta-Poisson model of pooled data and Observed data 
Similarly, Pinyon mouse inoculated intraperitoneally to SFR and R1 isolates could be 
pooled. Statistics of the pooled data are summarized in and best fit model of the pooled 
data is shown in Table 5.6 Pinyon mouse (i.p.)  Pooled Data and Figure 5.3.  
Table 5.6 Pinyon mouse (i.p.)  Pooled Data 
 
 
Data set 
 
Number of  
Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
χ2 p-value 
Pinyon 
mouse,R1 
ip 
 
6 
 
Exponential   
 
0.011 
 
5 
 
11.07 
 
0.99 
       
Pinyon 
mouse, SFR 
ip 
 
6 
 
Beta-Poisson 
 
3.27 
 
4 
 
9.48 
 
0.51 
       
Pooled data  
12 
 
Beta-Poisson 
 
4.78 
 
13 
 
22.36 
 
0.40 
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Figure 5.3 Pinyon mouse inoculated intraperitoneally to R1 and SFR isolates of R. 
rickettsii pooled  data 
 
Similarly, Guinea pigs inoculated intraperitoneally to R1 and SFR isolate of R. 
rickettssii could be pooled. Statistics of the pooled data are summarized in and best fit 
model of the pooled data is shown Table 5.7 and Figure 5.4Figure 5.4. 
Table 5.7 Guinea pigs inoculated intraperitoneally to R1 and SFR isolate of R. rickettsii 
 
 
Data set 
 
Number of  
Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
χ2 p-value 
Guinea pigs 
R1 
 
7 
 
Beta-Poisson  
 
1.79 
 
5 
 
11.07 
 
0.88 
       
Guinea pigs  
SFR 
 
 
7 
 
Beta-Poisson 
 
5.23 
 
4 
 
9.48 
 
0.38 
       
Pooled data  
14 
 
Beta-Poisson 
 
10.02 
 
12 
 
21.02 
 
0.61 
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Figure 5.4 Guinea pigs  inoculated intraperitoneally to R1 and SFR isolates of R. 
rickettsii pooled   
Pooling analysis of human volunteers exposed intradermally and aerosol exposed rhesus 
monkeys has been described in Chapter 2.  
 
5.4 Discussion 
 
Rocky Mountain spotted fever is generally caused by infected tick bites and hence the 
natural route of exposure is intradermal or subcutaneous (Walker 1989). However, there 
are rare chances of tick bite just above the veins. Beagle dogs inoculated intravenously 
correspond to that scenario. There have been some cases of aerosol exposure in 
laboratories, and hence it is one of the routes to be studied. Other routes of exposure such 
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as intracerebral and intraperitoneal do not represent natural routes of infection for R. 
rickettsii.  
\ 
Among 13 different rodents inoculated with 2 different isolates of R. rickettsii R 
strain via different routes, there is no definite pattern of responses. As shown in Table 
5.1, harvest mouse inoculated subcutaneously was the most resistant to infection among 
the subcutaneously inoculated (R1 isolate) animals, with ID50 more than 21290 ELD50, 
while Montane vole was the most susceptible one with ID50 0.87 ELD50. In general, 
rodents inoculated by the intraperitoneal route were associated with lower infectious 
doses than subcutaneously inoculated animals. The variation in estimated dose for 50% 
infection for the various hosts via the sc and ip routes is shown in Figure 5.5. There is no 
obvious pattern regarding the impact of animal breeding (inbred or wildcaught)  on 
propensity for infection. The ID50 for wild trapped Ord’s Kangaroo rat was less than that 
for the inbred Desert wood rat, Harvest rat and Pinyon mice (all animals were 
subcutaneously inoculated with R1 isolate). Similarly, ID50 for wild trapped Antelope 
squirrel was less than California mouse and Pinyon mouse (all animals were 
subcutaneously inoculated with SFR isolate).  Together, these observations indicate that 
host species may be a more important determinant of susceptibility than how host 
animals were reared. 
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Figure 5.5 Comparison of ID50 in different rodents 
 
Among the SFR isolate pathogen inoculation cases, subcutaneously inoculated pinyon 
mice were the most resistant animal and intraperitoneally inoculated pinyon mice were 
the most susceptible one. The best fit models were also different in different cases. Out of 
19 dose-response models, 12 were best fit by Beta-Poisson model and 7 by exponential. 
The differences in ID50 were shown in Figure 5.6. However, the ID50s for the 
subcutaneously inoculated hosts were definitely higher than intraperitoneally inoculated. 
Detailed discussion has been described in chapter 4. 
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Figure 5.6 Comparison of ID50 in rodents (SFR isolate) 
 
Pooling assessed for different combinations and the results of pooling analyses 
were listed in Table 5.4 Summary of pooling results. Subcutaneously exposed deer mice, 
pinyon mice and intraperitoneally exposed guinea pigs could be pooled across the 
different isolates of the pathogen.  In some cases of intraperitoneal exposure, the isolate 
of the pathogens did not have significant impact in responses. Intraperitoneally inoculated 
pinyon mice with R1 and SFR isolates could be pooled and hence described by a single 
dose-response relation. Similarly, intraperitoneally inoculated guinea pigs with R1 and 
SFR could be described by the same relationship.  
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The dose-response models for rhesus monkeys showed remarkable differences in 
virulence factor (potential to cause disease) between the two strains of the pathogen. 
Rhesus monkeys exposed to aerosols of the R1 strain were more susceptible (mortality 
and morbidity) than monkeys intravenously exposed to the Sheila Smith strain. Because 
the target R. typhi is small blood vessels, it was anticipated that, the aerosol route would 
require a greater number of pathogens than the intravenous route. The reason behind the 
counter-intuitive finding is not known. However, the average number of pathogens 
required to infect both rhesus monkeys and humans were low. The ID50 for aerosol 
exposed monkeys was 19 organisms and for humans, it was 23. Interestingly, human 
volunteers inoculated intradermally with the Sheila Smith isolate and aerosol exposed 
rhesus monkeys with R1 isolate could be pooled. The implications and interpretation of 
this pooling analysis has been described in Chapter 2.  
 
5.5 Conclusions  
 
The dose-response models of different rodents and primates including humans showed 
remarkable variation in responses. Intradermal or subcutaneous route of exposure is the 
natural mode of infection in human and animals. However aerosol exposure cannot be 
excluded (Johnson and Kadull 1967; Calia, Bartelloni et al. 1970; Oster, Burke et al. 
1977; Kenyon, Kishimoto et al. 1979). The ID10 and ID50 listed in Table 5.1 and Table 
5.3 support the fact that Rocky Mountain spotted fever is a highly infectious disease and 
that requires very few organisms to initiate infection. The risk of infection may vary 
significantly in different population, as shown by the wide variation in dose-response 
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models of different rodents. Epidemiologic studies of populations of patients reported 
with these rickettsial diseases showed that older age, male, black race with glucose-6-
phosphate dehydrogenase (G6PD) deficiency, and chronic alcohol abuse were in higher 
risk groups (Walker 1989).  
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6. OUTBREAKS OF SOME RICKETTSIAL DISEASES 
 
6.1 Introduction  
 
An outbreak report is frequently the first indication that any particular pathogen has been 
present in the environment and that a health hazard existed. Most of the epidemiological 
reports deal with patients with illness linked to suspected pathogens. Exposure is often 
not known quantitatively except in some food or waterborne outbreaks (Teunis, Ogden et 
al. 2008).  
 
Outbreaks of Rickettsial diseases have been reported and analyzed by various 
investigators. But most of them highlighted epidemiological and clinical aspects of the 
diseases and cases. It is very rare to have outbreak doses (quantification of pathogens) 
sampled in the reports.   
 
Matossian et al. in 1963 investigated outbreak of epidemic typhus in the northern 
Saudi Arabia. The report described about clinical and serological results of the  infected 
population (Matossian, Thaddeus et al. 1963). In 1995, Gray et al. studied rickettsial 
infection in Somali refugees (Gray, Rodier et al. 1995). An outbreak was reported in the 
northern part of Costa Rica in 1974. All the 11 members of a family living in a farm 
house developed rickettsial diseases (Campbell, Hobbs et al. 1978).  
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An outbreak of febrile fever in a Khmer camp at Thailand was reported in 1986. 
Out of 33,981 adults, 168 were infected with R. typhi in a four month period  (Brown, 
Meek et al. 1988).  
 
A study on outbreaks of Mediterranean fever (R. conorii) in Marseilles, France in 
three years period showed an attack rate of 2.3 per 100,000 (Raoult, Weiller et al. 1986).  
 
There was an outbreak of rickettsial diseases in the US army deployed in 
Botswana. In 1992, many soldiers among 169 army personnel deployed in the region 
were suffered from severe illness. Later on,  it was confirmed that most of them were 
exposed to R. africae (Smoak, McClain et al. 1996).   
 
A large outbreak of epidemic typhus (R. prowazekii) in three jails of Burundi was 
reported in1995. In Gitega jail, the ratio of number of prisoners and number of typhus 
cases were 213/1300 comprising an attack rate of 16.4 %.  The attack rates of the disease 
in N’Gozi and Bururo jails were remarkably higher than Gitega. The attack rates were 
58% and 48% respectively and the report was based on results surveillance over a  nine 
month period (Raoult, Ndihokubwayo et al. 1998) 
Two counties in North Carolina reported a remarkably higher incident rate of 
RMSF in the years 1979-81. During the two year period, 98 confirmed cases with 3 
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deaths were reported. The attack rate was 14.6 per 100, 000 in excess of the 0.2-0.3 per 
100,000 for US overall (Walker and Fishbein 1991).  
 
6.2 Outbreaks of Rocky Mountain spotted fever 
 
In two counties of North Carolina where the reported of incidences were highest, the 
incidence rate was reported as 14.6/100000(Walker and Fishbein 1991). From the dose-
response model developed for intradermally inoculated humans (as shown in Figure 2.4) 
and back calculating from the best fit model, the average number of bacteria received by 
an infected individual would be 0.00271.  
 
In the rural eastern Arizona area, 16 cases of RMSF were reported among the 
2148 residents (Demma, Traeger et al. 2005). The attack rate was 0.0075. Back 
calculating from the best fit model we have developed, the average dose was 0.141. In a 
second community of the same area, 9 cases were reported out of 10000 populations. The 
average dose  in that outbreak would be 0.017.  
 
Ixodid ticks excrete back about 0.4 ml fluids to host via salivary glands while 
imbibing (Sauer, Essenberg et al. 2000). Rehacek J has succeeded in measuring salivary 
levels of Rickettsia slovaca as 10
4
 EID per ml of saliva in infected female D. marginatus 
(Reháçek 1989). Assuming that the concentration of R. rickettsii in the saliva of an 
infected tick is 10
4
 EID per ml, the number of pathogens excreted by a tick is calculated 
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as 1.26x10
7
. But the estimated numbers of pathogens are far less than that figure. This 
result infers that only very few numbers of ticks carry infective blood. In case of North 
Carolina outbreak, the chance of infection from the bite (infected tick) is 1/442804428. 
Similarly incase of the Arizona outbreak, chances of infected ticks will be 1/8510638.  
 
There were 9 cases of laboratory acquired infection of RMSF in the United States 
Army Research Institute of Infectious Diseases among the laboratory professional and 
support staffs in the years 1971 to 1976. Altogether 13 persons were believed to be 
exposed via aerosols containing R. rickettsii (Oster, Burke et al. 1977). If we assumed the 
exposure was occurred at once, the average numbers of bacteria received by each 
individual were estimated to be 52. The estimate was based on the best fit model of 
pooled data sets of human exposed intradermally (as shown in Figure 2.6) and aerosol 
exposed rhesus monkey (Tamrakar and Haas 2010).  
 
A series of laboratory acquired cases of RMSF was reported in the Fort Detrick 
laboratories over an eleven-year period from 1955 to 1965. Altogether 5 cases infection 
via different routes were recorded. There were four different incidents of accidental self 
inoculation (Johnson and Kadull 1967). Among 4 exposed personnel, 2 of them were 
infected. The estimated dose, accidentally inoculated would be the ID50for human i.e. 23 
organisms. 
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One case was reported as a tick bite infection (Johnson and Kadull 1967). The 
doses received by the person from tick’s saliva were estimated 315 organisms or more at 
95% confidence level. Two cases of respiratory aerosol exposure were reported, both of 
them were infected. The infected persons must have inhaled at least 759 organisms in that 
exposure.  
 
6.3 Outbreaks of Murine Typhus 
 
An outbreak of febrile diseases was reported involving 170 Khmer adults in the Thai-
Kampuchean border in 1986. The incidence rate was 5 in 1000 among the exposed 
populations. The isolated pathogen was R. typhi and the strain was not specified. But the 
standard strain used in assay for rickettsial specific antibodies was R. typhi, Wilmington 
strain. Assuming the population was  exposed to R .typhi, Wilmington strain, response 
may be estimated using the dose-response model for that strain in BALB/c mice. Since 
the initial day of exposure was unknown, the model for 15 days after inoculation was 
used (incubation period is up to 2 weeks). Based on available model (as shown in Figure 
3.7), an average of 0.65 PFU of the pathogens were exposed in the camp. The summary 
of outbreaks is shown in Table 6.1. 
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Table 6.1 Outbreaks Summary 
Pathogen Outbreaks Route Estimated dose 
(No. of organisms) 
Percentage of 
infected 
population 
R.rickettsia  Two counties of North 
Carolina  
Tick bite 
 ( Intradermal )  
0.00271 0.0146 
R.rickettsia 
Eastern Arizona (A) 
Tick bite  
( Intradermal ) 
0.141 0.75 
R.rickettsia 
Eastern Arizona (B) 
Tick bite 
 ( Intradermal ) 
0.017 0.09 
R.rickettsia 
U. S. Army Research 
Institute of Infectious 
Diseases 
Aerosol  
52 69 
 Fort Detrick laboratories 
(A) 
Intradermal/ 
subcutaneous  
23 50 
 
Fort Detrick laboratories (B) 
Tick bite  
( intradermal)  
315 100 
 
Fort Detrick laboratories (C) Aerosol  
759 100 
     
R. typhi  Khmer adults in the Thai-
Kampuchean border 
Fleas bite 
(intradermal)  
0.65 PFU 0.5 
 
6.4 Conclusions 
 
Based on available dose-response models and attack rates, we estimated the number of 
pathogens to which the population was exposed during known outbreaks. This approach 
may be useful in outbreak investigations, since it is almost impossible to collect samples 
quickly and comprehensively enough from outbreak area to estimate the pathogens doses 
to which the population was exposed. 
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7. DOSE-RESPONSE MODEL OF COXIELLA BURNETII (Q FEVER)3 
 
7.1 Abstract: 
 
Q fever is a zoonotic disease caused by the intracellular gram-negative bacterium 
Coxiella burnetii (C. burnetii), which only multiplies within the phagolysosomal 
vacuoles.  Q fever may manifest as an acute or chronic disease.  The acute form is 
generally not fatal and manifestes as self-controlled febrile illness. Chronic Q fever is 
usually characterized by endocarditis.  Many animal models, including humans, have 
been studied for Q fever infection through various exposure routes. The studies 
considered different endpoints including death for animal models and clinical signs for 
human infection. In this paper, animal experimental data available in the open literature 
were fit to suitable dose-response models using maximum likelihood estimation. 
Research results for tests of severe combined immunodeficient (SCID) mice inoculated 
intraperitoneally (i.p) with C.burnetii were best fit with the Beta-Poisson dose-response 
model. Similar inoculation (i.p.) trial outcomes conducted on C57BL/6J mice were best 
fit by an exponential model, whereas those tests run on C57BL/10ScN mice were 
optimally represented by a Beta-Poisson dose-response model.   
Key words:  Q fever, Coxiella burnetii, dose-response, Beta-Poisson, SCID mice, 
intraperitoneal  
 
                                                 
3
 This chapter has been published under the same title in Risk Analysis, 2011, Vol. 30 (1). The authors are 
Sushil B. Tamrakar, Anne Haluska, Charles N. Haas and Timothy A. Bartrand.  
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7.2 Introduction  
 
Q  fever is  a zoonotic disease found worldwide caused by Coxiella burnetii (C. 
burnetii), an obligate intracellular Gram negative bacterium (Leone, Honstettre et al. 
2004; Zhang and Samuel 2004). It was first described by Edward Derrick in 1937 as a 
febrile illness affecting abbatoir workers in Queensland, Australia (Parker, Barralet et al. 
; Maurin and Raoult 1999; Valencia, Rodriguez et al. 2000; Madariaga, Rezai et al. 2003; 
Stein, Louveau et al. 2005).
 The name “Q fever” derives from “Query fever” and was 
given in following the outbreak 1935  in Queensland, Australia (Tissot-Dupont and 
Raoult 2008). 
 
C. burnetii multiplies only within the phagolysosomal vacuoles, particularly the 
macrophages of the host. During natural infections, the organism grows to high numbers 
in placental tissues of animals such as goats, sheep, and cows(Waag 2007). 
 
Sheep, goats, and cattle are the primary reservoirs of the organism which can be 
found in milk, urine, feces, and placenta. The bacteria have also been found in numerous 
other mammals, including birds, reptiles and arthropods. Thus, abattoir workers, farmers, 
and veterinarians are at higher risk than the general population of contracting Q 
fever(Russell-Lodrigue, Zhang et al. 2006). 
 
Humans are infected primarily through inhalation of aerosolized C. burnetti with 
as few as 10 organisms  causing disease(Waag 2007). Aerosols, or airborne particles, 
easily cause infection even without contact with infected animals, whereas person-to-
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person infection is rare (Watanabe and Takahashi 2008). Ingestion of contaminated dairy 
products or bites from infected ticks  may also lead to infection  but these modes of 
transmission are very rare(Russell-Lodrigue, Zhang et al. 2006). However, there have 
been some recorded cases of human Q fever caused by the consumption of unpasteurized 
goat milk products(Watanabe and Takahashi 2008). 
 
In most cases, infection is asymptomatic. The most common acute clinical 
manifestations are febrile illnesses (self controlled after few weeks), granulomatous 
hepatitis, and pneumonia.  Febrile eruptions, myocarditis, pericarditis, and 
meningoencephalitis have been reported in many cases. However, asymptomatic forms 
and fatal forms such as myocarditis can be observed in the same outbreak incident. Most 
cases of chronic Q fever are manifested as endocarditis(La Scola, Lepidi et al. 1997).   
 
As in humans, acute Q fever in guinea pigs may be a life-threatening disease, 
although some infectious foci are cleared of microorganisms rapidly and effectively. 
Moreover, guinea pigs are comparatively more susceptible than other experimental 
animals to infection by C. burneti i(Baca 1991; La Scola, Lepidi et al. 1997). It has been 
shown that guinea pigs inoculated intraperitoneally exhibit dose dependent fever showing 
pathologic changes associated with the liver, whereas those inoculated intranasally have 
greater involvement of the lungs(Russell-Lodrigue, Zhang et al. 2006). 
 
 The Center for Disease Control and Prevention (CDC) has classified C. burnetii 
as a category B biological terrorist agent because it consistently causes disability,  can be 
manufactured on a large scale,  remains stable under production, storage, and 
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transportation conditions,  can be efficiently disseminated and  remains viable for years 
after dissemination(Madariaga, Rezai et al. 2003). 
 
Although it has potential for large-scale production, it lacks capacity for the 
massive fatalities potentially caused by category A agents such as variola major 
(smallpox) , or Bacillus anthracis (anthrax), Yersinia pestis (plague)(Madariaga, Rezai et 
al. 2003). 
 
In this study, controlled dose data from experimental trials with mice, and guinea 
pigs were fit to dose response models in order to establish a human dose-response model. 
From the developed dose-response models, differences in response between different 
species of pathogens and host animals and between subpopulations among the same 
species with differing sensitivities could be explored. Results from this analysis may be 
used in the formulation of risk-based surveillance programs or public health measures 
that protect the population at large and sensitive subgroups.  
 
 
7.3  Data and methods 
 
7.3.1 Dose-Response Data Source 
 
Many researchers have reported the response of animals to different doses of C. burnetii 
in order to develop effective vaccines and to study the pathology of infected animals. 
Many studies have computed a median infectious dose (ID50) i.e., the dose that infects   
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50 % of the animals; fewer studies published the actual raw data sets on which their 
estimates were based. The aim of this study was to extract usable data from the literature 
and model the dose-response relationship.  Criteria for data used in our analysis are 
summarized in Table 7.1. 
 
Table 7.1 Criteria for Selecting Dose-Response Data 
General Criteria Criteria specific to this study 
Mode of exposure is explicitly stated Exposure via inhalation (aerosol, 
intraperitoneal) 
Methods for exposure assessment are 
described clearly 
yes 
The number of subjects for each dose 
group is stated explicitly 
yes 
The number of positive responses for each 
exposure route is explicitly stated 
yes 
The criteria used to define a positive 
endpoint are stated 
Endpoint was death or clinical symptoms  
Pathogen is described in detail (source, 
strain) 
Only virulent strains were considered 
The mode of preparation of pathogenic 
organisms is described  
yes 
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Russell-Lodrigue et al. (2006) studied the exposure of guinea pigs to C. burnetii 
and explored clinical and pathological changes in the animals. Six to eight week old 
female out-bred Hartley guinea pigs were challenged to six different doses of C. burnetii 
(Nine mile I strain)  via aerosol exposure(Russell-Lodrigue, Zhang et al. 2006). 
 
 
In 2003, Andoh et al. studied the lethality of Q fever in severe combined 
immunodeficient (SCID) mice using the Nine mile I strain of C. burnetii.  Severe 
combined immunodeficient (C.B-17/Icr-scid/scid) mice and immunocompetent (C.B-
17/Icr-+/+) mice were use to determine suitable and more sensitive animal models to 
clarify the pathogenicity. Each group of six animals were inoculated interperitoneally 
with 10
-5
 to 10
4
 tissue culture infectious doses (TCID50 ) of C. burnetii and mortality of 
mice were recorded(Andoh, Naganawa et al. 2003). 
 
Scott et al. in 1987 examined the susceptibility of inbred mice to infection by C. 
burnetii.  As many as 47 strains of inbred mice were evaluated. A group of 10 mice of 
each strain were first inoculated intraperitoneally with 10 
6.5
 C. burnetii. The animals 
were classified into different groups based on sensitivity to infection. Then groups of 
resistant C57BL/6J and susceptible A/J mice were inoculated with mean doses ranging 
from 10
-1.3
 to 10
7
organisms. The mortalities at various doses were recorded(Scott, 
Williams et al. 1987). 
 
Williams et al. (1981) interperitoneally inoculated groups of C57BL/10ScN male 
mice  with 11 different doses of C. burnetii phase I Ohio strain in order to develop a 
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vaccine against Q fever(Williams and Cantrell 1982).  All studies reviewed here had 
endpoint of response was mortality for the test subjects. The dose response data garnered 
from these sources are given in Table 7.2. 
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Table 7.2 Data Used 
 
 
Bacteria and 
Strain Study 
Mode of 
 inoculation 
 
 
Test Organism/  
Reponses end point  
 
Dose  
(No. organism) 
Number of 
Test 
Animals 
Positive 
Responses 
Negative 
Responses 
C.burnetii 
(Nine mile 
phaseI)** 
(Russell-
Lodrigue, 
Zhang et al. 
2006) 
aerosol 
Out-bred Guinea pigs/ 
Fever 
 
20 3 2 1 
200 3 3 0 
2000 3 3 0 
20000 3 3 0 
200000 3 3 0 
    2000000 3 3 0 
    TCID50/0.5ml $    
C.burnetii 
(Nine mile 
phaseI) 
(Andoh, 
Naganawa et 
al. 2003) 
Intraperitoneal 
SCID mice/ Mortality  
 
 
 
0.00001 6 1 5 
0.0001 6 4 2 
0.001 6 4 2 
0.01 6 6 0 
0.1 6 6 0 
    1 6 6 0 
    10 6 6 0 
    100 6 6 0 
    1000 5 5 0 
    10000 6 6 0 
    (No. organism)    
C.burnetii 
(Nine mile 
phaseI) 
(Scott, 
Williams et al. 
1987) 
Intraperitoneal 
C57BL/6J mice/ 
Mortality  
0.05 10 0 10 
0.5 10 0 10 
5 10 0 10 
50 10 0 10 
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    501 10 0 10 
    5010 10 0 10 
    50100 10 0 10 
    501000 10 0 10 
    5010000 10 0 10 
    50100000 10 0 10 
    501000000 10 1 9 
    5.01E+09 10 3 7 
    5.01E+10 10 9 1 
    (No. organism)    
 
C.burnetii 
(Nine mile 
phaseI)** 
(Scott, 
Williams et al. 
1987) 
Intraperitoneal 
A/J mice / 
Mortality  
0.05 10 0 10 
0.5 10 0 10 
5 10 0 10 
50 10 0 10 
    501 10 0 10 
    5010 10 0 10 
    50100 10 0 10 
    501000 10 0 10 
    5010000 10 0 10 
    50100000 10 0 10 
    501000000 10 0 10 
 
    5010000000 10 0 10 
 
    50100000000 10 0 10 
    (No. organism)    
 
C.burnetii 
$
 
(Phase1Ohio) 
(Williams and 
Cantrell 1982) 
 
Intraperitoneal 
 
C57BL/10ScN / 
Mortality 
 
 
0.7 30 0 30 
7 20 0 20 
70 30 0 30 
7000 30 0 30 
700000 30 0 30 
7000000 20 1 19 
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    70000000 30 6 24 
    700000000 30 16 14 
    7000000000 30 23 7 
    70000000000 20 19 1 
    GPID
@
    
C.burnetii 
(Phase1AD) 
(Tigertt and 
Benenson 
1956) 
Aerosol Young adult male (Human)/ 
Clinical signs  
0.1 2 0 2 
1 5 2 3 
5 3 3 0 
15 5 4 1 
150 5 4 1 
1500 3 3 0 
@ Guinea Pig Infectious Dose 
$   
Endpoint of response was not clearly described
  
** Insufficient data (responses) 
$TCID50 - 50% Tissue culture infectious dose  
 
    
 
 
An early study was published in 1956 by Tigertt and Benenson investigating 
human response to AD strain of C. burnetii. Groups of two to five young adult male 
volunteers were exposed to aerosolized C. burnetti with response defined as clinical signs 
of disease(Tigertt and Benenson 1956). However, the authors did not specifically detail 
which symptoms were included in their positive response; hence the human dose-
response analysis was excluded in this study.   
 
7.3.2 Analysis method 
 
Dose response relationships were fit to data using the method of maximum likelihood 
estimation (MLE) as described in Haas,Rose, Rose et al. (1999) (Haas, Rose et al. 1999).  
The statistical programming language, “R” (www.r-project.org) was used for this 
computation. Although there are many dose-response models such as Beta binomial, 
fractional polynomials, log normal etc  being used by different researchers in quantitative 
risk assessment, only three dose response models were used in this study(Haas, Rose et 
al. 1999): the exponential (equation 1), Beta-Poisson (equation 2) and log-probit 
(equation 3).  The Exponential and Beta-Poisson models are mechanistic and based on 
the assumption that samples of organisms from a source are Poisson distributed and that 
the probability of infection at a particular dose is binomial or beta distributed (Haas, Rose 
et al. 1999; Teunis, Nagelkerke et al. 1999; Teunis and Havelaar 2000). Empirical models 
such as log-probit, fractional, polynomials, log normal, and beta binomial were not used 
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in this study,(Faes, Geys et al. 2003; Faes, Aerts et al. 2007)  predominantly because they 
have been shown not to take into account host-pathogen interactions.  However, a log-
probit model was quantified and included as an empirical model for comparison.  
  
 
MLE estimates were made using the BFGS algorithm and Log-probit estimates 
were made using Nelder-Mead algorithm. Confidence intervals to the best fit models 
were determined via bootstrapping with 10000 bootstrap iterations.  
 
kdedP 1)(                                                    (1) 
where P (d) is the probability of response at dose d and k is the probability that a single 
organism can survive and initiate infection.  
 
1211)(
1
50N
d
dP                                  (2) 
where N50 is the median infective dose and α is the slope parameter for Beta Poisson 
model.  
 
12
ln
1
)(
q
d
q
dP                                  (3) 
where q2 is the probit slope, q1 is the location parameter and  denotes the normal 
cumulative distribution function of the standard normal distribution. 
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Goodness of fit for all models was determined by comparing the optimal value of 
the deviance to the critical value of the 
2
 distribution at degrees of freedom equal to the 
number of doses minus the number of optimized parameters and a 95% confidence level.  
In order to use a two parameter model, it must provide a statistical improvement in the 
model’s fit to the data compared to that of the single parameter model. Improvement was 
assessed by comparing the reduction in minimized deviance with the critical 
2
 value at 1 
degree of freedom.   
 
Pooling analyses were performed for the different animals and bacterial species to 
ascertain whether the data set could be described by the displaying the same dose-
relationship or not(Haas, Rose et al. 1999). A likelihood ratio test was used to determine 
if data could be pooled. 
 
7.4 Results 
 
7.4.1 Dose-response model fitting 
Dose-response SCID mice exposed intraperitoneally with C. burnetii (Andoh, Naganawa et al. 
2003) 
The best fit dose response model for mortality in intraperitoneally inoculated SCID mice 
was the Beta-Poisson model. Results of the three model fits to the animals are 
summarized in Table 7.3 and best fit model with confidence interval is shown in Figure 
7.1. 
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Table 7.3 Model Fit Comparison for Mortality in Peritoneally Exposed SCID mice 
(Andoh, Naganawa et al. 2003) 
Data set 
Number of  
Doses 
Model 
Minimized 
Deviance 
Degrees 
of 
Freedom 
χ2α,n-k
 
 
Parameters 
 
C .burnetii 
Nine mile Phase I 
(Dose as TCID50) 
 
      10 
 
Exponential 
 
10.72 
 
9 
 
16.91 
 
k=7.79 
  
10 
 
Beta Poisson* 
 
2.353 
 
8 
 
15.50 
α = 0.492 
N50= 6.77e-5 
 
10 
 
Log probit 
 
1.911 
 
 
8 
 
15.50 
q1=2.642998  
q1=8.943e-05  
* Best fit model 
 
 
Figure 7.1 Dose Response Data and Beta-Poisson Model Fits for Mortality in 
Peritoneally Exposed SCID mice to C. burnetii. 
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Dose-response of C57BL/6J mice exposed intraperitoneally with C. burnetii  
 (Scott, Williams et al. 1987) 
 
The best fit dose response model for mortality in peritoneally inoculated 
C57BL/6J was the exponential model. Results of the three model fits to the animal are 
summarized in Table 7.4 and the best fit model with confidence interval is shown in 
Figure 7.2.  
 
Table 7.4 Model Fit Comparison for Mortality in Peritoneally Exposed C57BL/6J 
mice (Scott, Williams et al. 1987) 
 
Data set 
 
Number 
of  Doses 
 
Model 
 
Minimized 
Deviance 
Degrees 
of 
Freedom 
 
χ2α,n-k
 
 
Parameters 
 
C .burnetii 
Nine mile Phase I 
 
C57BL/6J mice 
 
13 Exponential* 1.62 12 21.02 k=5.70e-11 
 
 
13 
 
Beta Poisson 
 
0.693 
 
11 
 
19.67 
α = 1.57 
N50= 8.73e9 
 
13 
 
Log probit 
 
0.908 
 
11 
 
19.67 
q1=1.740  
q1=7770608308 
* Best fit model 
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Figure 7.2 Dose Response Data and Exponential Model Fits for Mortality in 
Peritoneally Exposed C57BL/6J mice to C. burnetii. 
 
 
Dose-response of C57BL/10ScN mice exposed intraperitoneally with C. burnetii  
(Williams and Cantrell 1982) 
 
The best fit dose response model for mortality in peritoneally inoculated C57BL/10ScN 
mice was the Beta-Poisson model. Statistics of the three model fits to the animal data are 
summarized in Table 7.5 and the best fit model and confidence interval are shown in 
Figure 7.3. 
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Table 7.5 Model Fit Comparison for Mortality in Peritoneally Exposed 
C57BL/10ScN mice (Williams and Cantrell 1982) 
Data set 
Number of  
Doses 
Model 
Minimized 
Deviance 
Degree of  
Freedom 
χ2α,n-k
 
Parameters 
 
C .burnetii 
Ohio  Phase I 
 
C57BL/10ScN mice 
 
 
10 
 
Exponential 
 
73.865 
 
9 
 
16.92 
 
k=2.355e-10  
 
10 
 
Beta Poisson* 
 
1.109 
 
 
8 
 
15.50 
α = 0.356 
N50= 4.925e8 
  
10 
 
Log probit 
 
0.676 
 
8 
 
15.50 
q1=2.777  
q1=723309475  
* Best fit model 
 
 
Figure 7.3 Dose Response Data and Beta-Poisson Model Fits for Mortality in 
Peritoneally Exposed C57BL/10ScN mice to C. burnetii 
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7.4.2 Pooling analysis 
 
Neither the data of different animals with the same exposure route nor the entire 
set of data could be pooled. The experimental data for the three different tests on SCID 
mice, C57BL/6J mice, and C57BL/10 ScN mice all intraperitoneally inoculated with C. 
burnetii failed to pass the criteria for an acceptable fit in pooling. The minimum deviance 
provided by the Beta-Poisson model was 181.25, which was greater than the critical 
value at 31 degrees of freedom (44.98). Similarly, an attempt to pool the two data sets for 
C57BL/6J mice and C57BL/10ScN mice was attempted. The difference in deviances 
between the individual tests’ best fits and the pooled best fit was 15.61, which measured 
greater than
2
1,05.0 . Therefore, the data sets could not be pooled. The summary and 
statistics of the pooling analysis are shown in Table 7.6 and Table 7.7. 
Table 7.6 Pooling data- All Intraperitoneally inoculated animals 
 
 
Data set 
 
Number of  
Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
χ2 p-value 
 
SCID mice  
 
10 
 
Beta-Poisson 
 
2.353 
 
8 
 
15.50 
 
0.968 
       
C57BL/6J mice  
13 
 
Exponential 
 
1.62 
 
12 
 
21.06 
 
0.999 
       
C57BL/10ScN 
mice 
 
10 
 
Beta-Poisson 
 
1.10 
 
8 
 
15.50 
 
0.997 
       
Pooled data  
33 
 
No acceptable fit  
 
181.25 
 
31 
 
44.98 
 
0.686 
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Table 7.7 Pooling data- C57BL/6J  mice and C57BL/10ScN mice 
 
 
Data set 
 
Number of  
Doses 
 
 
Best fit Model 
 
Minimized 
Deviance 
 
 
D.O.F 
 
 
χ2α,n-k
 
 
 
χ2 p-value 
C57BL/6J mice  
13 
 
Exponential 
 
1.62 
 
12 
 
21.06 
 
0.999 
       
C57BL/10ScN 
mice 
 
10 
 
Beta-Poisson 
 
1.10 
 
8 
 
15.50 
 
0.997 
       
Pooled data  
23 
 
Beta-Poisson 
 
18.32 
 
21 
 
33.92 
 
0.686 
 
7.5  Discussion 
 
The study of guinea pigs challenged with aerosolized C. burnetii had insufficient data for 
use in dose-response modeling. There were only three animals per dose group while the 
responses were either 100% or 66%.  
 
The best fit model for the severe combined immunodeficient (SCID) mice 
exposed intraperitoneally to C.burnetii was the Beta-Poisson.  The doses were in units of 
50% tissue culture infectious dose (TCID50). Roughly estimation of one TCID50 is 
equivalent to 0.69 PFU (Plaque forming unit) and one PFU is equivalent to 3.4X10
7 
organisms (Nine mile I) (Moos and Hackstadt 1987; López-Vázquez, Dopazo et al. 
2006).  The LD50 for the SCID mice was 1.61X10
3
 indicating that immunodeficient mice 
were most susceptible among the animal models.    
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The C57BL/6J mice exposed intraperitoneally to C. burnetii were more resistant 
to infection than the C57BL/10ScN mice. The LD50 for the C57BL/6J was 1.22 10
10 
and 
that of C57BL/10ScN was 1.76 10
8
. The high doses needed for mortal responses in mice 
may be due to different routes of exposure.  
 
A comparison of the virulence of C. burnetii phase I strain for C57Bl/6J mice and 
C57Bl/10scN mice exposed intraperitoneally is shown in Figure 7.4.  These results show 
significant differences in susceptibility at low doses even for closely related animal 
models. 
 
Figure 7.4 Comparative Low Dose in Different strains of Mice 
 
 
 
155 
 
 
 
7.6  Conclusions 
 
 
Based on the differences in the dose-response models’ fit to the data for different strains 
of mice, SCID mice were clearly more sensitive to intraperitoneal exposure to C. burnetii 
than the C57BL/6J and C57BL/10ScN mice.  The 50% average lethal dose (LD50) for 
SCID mice was 1.61x10
3
 organisms, whereas the LD50 doses were 1.26 x10
10
 and 
2.83x10
7
 for the C57BL/6J and C57BL/10ScN mice respectively. A level of risk of 
1/10,0000, corresponding doses for C57BL/6J mice and C57BL/10ScN will be 1755 and 
for 231organisms respectively.  As immunodeficiency is a major factor in the 
development of chronic Q fever,(Raoult, Marrie et al. 2005)  the dose-response model for 
SCID mice might be a good model to study. The route of infection has vital role in 
determining minimum inoculum size, the severity of the disease and clinical 
manifestations.(Raoult, Marrie et al. 2005)  The natural routes of infection of C. burnetii 
is inhalation, ingestion or through skin abrasions.  The animal models presented in this 
study represent a rare mode of infection. To predict the risk of human infection, 
experimental data on aerosol exposure-response data are required.  Estimating the risk for 
secondary transmission would require additional data on the period during which infected 
persons produce aerosols with infectious C. burnetii and the fate and transport of C. 
burnetii in various environments. The results of these studies would be invaluable for 
advancing our understanding of the transmission of infectious agents in the population. 
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8. DOSE-RESPONSE MODEL FOR BURKHOLDERIA PSEDUMALLEI 
(MELIODOISIS)
4
  
 
8.1 Abstract  
 
Aims: The objective of this study was to fit the dose-response model of B. pseudomallei 
in different animal hosts and to analyze the result from the best fit model. The data sets 
for the modeling were taken from the open literature. 
Methods and Results: All data sets were initially tested for a trend between dose and 
outcome using the Cochran- Armitage test. Only data showing a statistically significant 
trend were subjected to further analysis (fitting with parametric dose response 
relationships).  Dose response relationships were fit to data using the method of 
maximum likelihood estimation (MLE). Exponential, Beta-Poisson and Log-probit 
models were considered in MLE. 
Conclusions: Dose-response analysis showed that BALB/c mice exposed intranasally 
(i.n.) and guinea pigs exposed intraperitoneally (i.p.) are significantly more sensitive to B. 
pseudomallei than C57BL/6 mice exposed i.n. and diabetic rats exposed i.p.  
Significance and Impact of the study: the results confirmed finding from a study of 
outbreak data that the diabetic population is more susceptible than general population. 
The low dose prediction from best fit dose-response models can be used to draw 
                                                 
4
 This chapter has been published under the same title in Journal of Applied Microbiology, 2008, Vol. 
105(5). The authors are Sushil B. Tamrakar and Charles N. Haas 
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guidelines for the public health decision making processes, including consideration of 
sensitive subpopulations. 
Key words: Melioidosis, Burkholderia pseudomallei, B.mallei, dose-response models,   
C57BL/6 mice, BALB/c mice, Diabetic rats. 
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8.2 Introduction 
 
Melioidosis is an infectious life threatening disease occurring in human and animals, 
caused by the bacterium, Burkholderia pseudomallei.  B. pseudomallei are mostly found 
in soil and water.  This bacterium  is a flagellated Gram-negative saprophyte found in 
many tropical regions including Southeast Asia, northern Australia; Central and South 
America, Caribbean and Africa (Leakey, Ulett et al. 1998; Liu, Loh et al. 2006).  The 
infection  of B. pseudomallei is acquired through skin abrasions (subcutaneous infection ) 
inhalation or ingestion of contaminated food (soil, water) or aerosols (Barnes and 
Ketheesan 2005; Ulett, Labrooy et al. 2005). 
 
Clinical signs of the disease in human can vary from sub acute infections to 
chronic suppurative (discharging pus) infections. After getting infected, a person can be 
in an asymptomatic state, or develop benign pneumonia, acute or chronic pneumonia, and 
acute septicemia (Liu, Koo et al. 2002; Stevens, Haque et al. 2004). Both B. pseudomallei 
and its close species relative Burkholderia mallei (causative agent of glanders) are 
considered potential biological weapons and are listed as category  “B”  biothreat agents 
(Jeddeloh, Fritz et al. 2003; Schell, Ulrich et al. 2007).  
 
B. mallei is a close phylogentic relative of B. pseudomallei and is the causative 
agent of the disease glanders in animals.  Glanders is one of the oldest diseases known. 
Horses, donkeys, and mules are the natural host animals for B.mallei.  However, infection 
can occur in other animal species including camels, goats and felines. Human infection 
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with glanders is very rare and the majority of human cases have resulted from 
occupational contact with infected animals (Schell, Ulrich et al. 2007). 
 
B. pseudomallei and B. mallei  were previously designated as Pseudomonas 
pseudomallei, P.mallei ,  Malleomyces pseudomallei, and M. mallei (Leakey, Ulett et al. 
1998; Sprague and Neubauer 2004; Anonymous 2007) 
 
Compared with other bioterror agents, the study of dose response and immunity 
for B. pseudomallei  is a difficult task because of the highly variable nature of the disease 
and   wide ranges of virulence of different strains of the bacteria. There are as many as 65 
strains isolated from different geographical areas and different media (Ulett, Currie et al. 
2001; Thibault, Hernandez et al. 2004; Taweechaisupaponga, Kaewpab et al. 2005; Ulett, 
Labrooy et al. 2005). 
 
8.3 Data and methods 
8.3.1 Dose response data source  
Many investigators have studied the response of animals to different doses of B. 
pseudomallei and B. mallei bacteria in order to develop effective vaccines and to study 
the pathology of infected animals. Many studies have reported the lethal dose (LD50) that 
kills (infected) 50 % of the animals; fewer studies published the data sets on which their 
estimates were based. 
160 
 
 
 
Leaky et al. (1998) inoculated five groups of five BALB/c mice intravenously 
with 850, 85, 8, and 1 colony forming unit (CFU) of B.pseudomallei.  Similarly,   four 
groups of five C57BL/6 mice were inoculated intravenously with 1.3x 10
5
, 1.3x10
4
, 
1.3x10
3
 and 130 of B. pseudomallei. The authors reported the responses (death) and 
bacterial loads in vital organs of the animal (Leakey, Ulett et al. 1998). In a similar 
experiment, Jeddeloh et al. (2003) exposed mice to aerosols of B. pseudomallei for future 
evaluation of biodefense vaccine candidates. Ullet et al. (2005) developed a model of 
immunity to B. pseudomallei inoculating intravenously different doses of different 
bacterial strains to BALB/c mice (Ulett, Labrooy et al. 2005). 
 
Brett et al. (1997) administered different doses of B. pseudomallei to 6-8 weeks 
old   Syrian golden hamsters via the intraperitoneal route. The dose range was 10 CFU to 
10x10
7
 CFU. Based on responses, the LD50 for different strains were determined (Brett, 
DeShazer et al. 1997). Ling et al. also studied the hamster model to identify virulence 
gene (Ling, Moore et al. 2006).  
 
Similarly, many investigators have studied pathogenecity of B. mallei. Fritz et al. 
(2000) inoculated B. mallei intraperitoneally to BALB/c and C57BL/6 mice. 
Histopathologic changes were observed and established that mice are viable models of 
sub lethal and lethal glanders. Unfortunately, the authors did not publish dose-response 
data (Fritz, Vogel et al. 2000). A study was conducted by Lever et al.  (2003), in which 
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BALB/c mice were infected with different doses via inhalation (Lever, Nelson et al. 
2003).   
 
A search of the open literature identified three usable dose response studies of 
B.pseudomallei and one of B. mallei. Liu and his co-authors studied infection through the 
intranasal route in a murine model to mimic infection through inhalation. Two strains of 
mice - BALB/c and C57BL/6 - were used to explore intraspecies differences in dose-
response characteristics to B. pseudomallei. Five doses of bacteria were given to 5 to 6 
week old female BALB/c and C57BL/6 mice. The virulent strain KHW of B. 
pseudomallei used in the study was isolated from a person who died from melioidosis in 
Singapore. The bacteria were cultured  on trypticase soy agar (TSA) (Liu, Koo et al. 
2002). BALB/c and C57BL/6 mice were found to be suitable animal models for the 
different forms of human melioidosis;  according to Leaky et al. (1998), the course of 
infection in BALB/c  was similar to acute melioidosis in human and the C57BL/6 was 
appeared to be chronic melioidosis (Leakey, Ulett et al. 1998). 
 
Miller et al. (1947) explored the virulence of several strains of B. pseudomallei 
and B. mallei and their infectivity in several laboratory animals. Six doses of B. 
pseudomallei (strain W294) were injected intraperitoneally to guinea pigs. Similarly, six 
doses of B. mallei (strain C7) were intraperitoneally inoculated in guinea pigs. Mortality 
as the end point of response was used in both cases (Miller, Pannel et al. 1947). 
162 
 
 
 
In another study carried out by Brett et al. (1996), groups of 10 diabetic rats were 
inoculated intraperitoneally with B. pseudomallei  (strain 316c) ranging  from 3x10
3
 CFU 
to 3x10
7
 CFU. Sprauge Dawley rats weighing approximately 30 g were made diabetic by 
streptozotocin administration. Mortality rate of diabetic rats were recorded (Brett and 
Woods 1996). This study is particularly important given that epidemic data of 
melioidosis from different parts of the world show that a significant portion of the 
population are diabetic (Currie, Fisher et al. 2000) and that diabetics are especially 
susceptible to melioidosis (Woods 1995). 
 
Schell et al. (2007) studied the virulence of B. mallei in hamsters. Groups of 5 
female Syrian hamsters were infected intraperitoneally by 16 different strains of B. mallei 
and responses as death of animal were recorded (Schell, Ulrich et al. 2007).   
 
8.3.2 Analysis Method 
 
All data sets were initially tested for a trend between dose and outcome using  the 
Cochran- Armitage test (Neuhauser and Hothorn 1999).  Only data showing a statistically 
significant trend were subjected to further analysis (fitting with parametric dose response 
relationships).  Dose response relationships were fit to data using the method of 
maximum likelihood estimation (MLE) as described in Haas et al. (1999).   
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All the data sets are shown in Table 8.1. The statistical programming language, 
“R” (www.r-project.org) was used for this computation. Three dose response models 
(exponential, Beta-Poisson and Log-probit) were used (Haas, Rose et al. 1999).  
The exponential dose-response model is given by the equation 1 
kdedP 1)(                                                    (1) 
where P (d) is the probability of response at dose d and k is the probability that a single 
organism can survive and initiate infection.  
The Beta-Poisson model is given by equation (2) 
 
1211)(
1
50N
d
dP                                  (2) 
where N50 is the median infective dose and α is the slope parameter for Beta Poisson 
model.  
 
The Log-probit model is given by equation (3) 
12
ln
1
)(
q
d
q
dP                                  (3) 
Where q2 is the probit slope, q1 is the location parameter and  denotes the normal 
cumulative distribution function of the standard normal distribution. 
 
Goodness of fit for all models was determined by comparing the optimal value of 
the deviance with the critical 
2
 value at degrees of freedom equal to the number of doses 
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minus the number of fitted parameters and a 95% confidence.   Assessment of the 
statistical significance of improvement of fit that 2 parameter models provide over 1 
parameter models was made by comparing the reduction in minimized deviance with the 
critical 
2
 value at 1 degree of freedom. Confidence intervals for the best-fit model were 
estimated via bootstrapping (Haas, Rose et al. 1999). For the bootstrapping, at least 1000 
replicates were used for simulation.  
 
Pooling analysis was performed for the different animals and bacterial species to 
ascertain whether the data set had the same underlying distributions. A likelihood ratio 
test was used to determine if data could be pooled. 
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Table 8.1Data Used 
Bacteria and 
Strain 
Study 
Mode of 
inoculation 
Test 
Animal 
Dose 
(CFU) 
Number 
of Test 
Animals 
Positive 
Responses 
Negative 
Responses 
B. pseudomallei 
(KHW) 
(Liu, Koo et 
al. 2002) 
Intranasal 
BALB/c 
mice 
405 6 6 0 
135 6 4 2 
45 4 3 1 
15 6 0 6 
5 6 0 6 
B. pseudomallei 
(KHW) 
(Liu, Koo et 
al. 2002) 
Intranasal 
C57BL/6 
mice 
 
 
 
12150 6 3 3 
4050 6 3 3 
1350 6 1 5 
450 6 1 5 
150 6 0 6 
B. mallei* 
SR1 (Schell, 
Ulrich et al. 
2007) 
Intraperitoneal 
Syrian 
hamster  
10000 5 5 0 
1000 5 5 0 
100 5 5 0 
10 5 4 1 
B. mallei* 
tssE
-
/tssE
+
 (Schell, 
Ulrich et al. 
2007) 
Intraperitoneal 
Syrian 
hamster 
10000 5 5 0 
1000 5 5 0 
100 5 5 0 
10 5 3 2 
B. pseudomallei 
W294 
 
 
(Miller, 
Pannel et al. 
1947) 
 
Intraperitoneal 
 
Guinea 
pigs 
 
 
 
 
4400000 5 4 1 
440000 5 5 0 
44000 5 5 0 
4400 5 4 1 
440 5 3 2 
44 5 1 4 
B. mallei* 
C7 
 
 
 
 
 
(Miller, 
Pannel et al. 
1947) 
Intraperitoneal Guinea 
pigs 
 
2600000 4 3 1 
260000 4 3 1 
26000 4 2 2 
2600 4 3 1 
260 4 3 1 
26 4 2 2 
 
B. pseudomallei 
316c 
 
 
(Brett and 
Woods 1996) 
Intraperitoneal Diabetic 
rats 
30000000 10 10 0 
3000000 10 10 0 
300000 10 7 3 
30000 10 7 3 
3000 10 6 4 
* Failed test of trend. 
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8.4 Results 
 
 
8.4.1 Cochran- Armitage test of trend 
 
The Cochran-Armitage test showed the existence of a dose- dependent response for 
intranasal exposure of BALB/c and C57BAL/6 mice to B. pseudomallei.  The Z critical 
values ( Zca)  were 4.14 and 2.33 respectively and the values  were greater than 1.64 
which was above the upper 5
th
 percentile of the normal distribution.  
 
 
Dose-response data for B. pseudomallei inoculated intraperitoneally in guinea 
pigs also showed a positive trend. The Zca value was 2.36. Similarly, data of diabetic rats 
inoculated with B.pseduomallei had a positive trend (Zca as 2.75). Hence, the null 
hypothesis of lack of trend is rejected in those cases. 
 
   On the other hand, B. mallei exposed to guinea pigs (Zca was 1.01) and both the 
data set of B. mallei exposed to Syrian hamsters (Zca were 1.26 and -3.65) showed lack of 
trend (Z critical value of 1.64). As the result, a quantitative dose-response analysis of 
those data is not justified. 
 
Dose-response of BALB/c mice  
The best-fit dose response model for mortality in intranasally inoculated BALB/c mice 
was the exponential model. Although the two parameter models had smaller minimized 
deviances, the improvement in fit provided by those models was not statistically 
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significant. Statistics of the three model fits to the animals are summarized in Table 8.2 
and best fit model with confidence interval is shown in Figure 8.1. 
 
Table 8.2 Model Fit Comparison for Mortality in Intranasal Exposed BALB/c 
mice@ 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
Parameters 
 
Burkholderia 
pseudomallei 
BALB/c 
 
 
 
5 
 
Exponential* 
 
5.250 
 
 
4 
 
k=0.010448 
 
 
5 
 
 
Beta Poisson 
 
5.250 
 
3 
α = 1.0062e7 
N50= 66.339 
 
5 
 
Log-probit 
 
     4.077  
 
 
3 
q1=0.932 
q2=58.024 
*Accepted best fit model 
@ (Liu, Koo et al. 2002) 
 
 
Figure 8.1 Dose Response Data and Exponential Model Fits for Mortality in BALB/c 
mice 
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Dose-response of C57BL/6 mice  
The best fit dose response model for mortality in intranasally inoculated C57BL/6 mice was again 
the exponential model. Statistics of the three model fits to the animals are summarized in Table 
8.3 and best fit model with confidence interval is shown in Figure 8.2. 
 
Table 8.3 Model Fit Comparison for Mortality in Intranasal Exposed C57BL/6 
mice@ 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
Parameters 
 
Burkholderia 
pseudomallei 
C57BL/6 
 
 
 
5 
 
Exponential* 
 
3.345 
 
4 
 
k=0.0001004336 
 
 
5 
 
Beta Poisson 
 
1.192 
 
3 
 
α = 0.317 
N50= 8204.71 
 
5 
 
Log probit 
 
1.284 
 
3 
q1=2.271 
q2=7831.219 
*Accepted best fit model 
@(Liu, Koo et al. 2002) 
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Figure 8.2 Dose Response Data and Exponential Model Fits for Mortality in 
C57BL/6 mice Intranasally Exposed to B. pseudomallei. 
 
Leaky et al. have demonstrated that BALB/c mice were more susceptible to B. 
pseudomallei than C57BL/c mice. An experiment on BALB/c and C57BL/6 mice with 
various doses of B.pseudomallei showed that contrasting susceptibility levels in those 
mouse strains. Rapidly increasing bacteremia in BALB/c mice and absence of variable 
bacteria  in the blood of  C57BL/6 mice after 96 hours of inoculation showed the 
contrasting  susceptibility (Leakey, Ulett et al. 1998).  BALB/c mice died due to 
septicemic disease with towering bacterial loads in organs such as liver, spleen, lungs and 
blood, supplemented by organ inflammation and necrosis a few days after infection. It 
reflects a failure of the host innate immune response to contain the infection. In the 
organs of infected BALB/c mice, early infiltration and accumulation of neutrophils was 
evident, whereas in C57BL/6 mice, macrophage accumulation was more evident. Hence, 
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the better control of infection in C57BL/6 mice is possibly due to macrophages. 
Moreover, the resistance mechanisms are inadequate in BALB/c mice, resulting in 
bacterial growth and inflammation (Ulett, Ketheesan et al. 1998; Gan 2005).   
The low dose predictions and comparative virulence is given in Figure 
8.3.
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Figure 8.3 Low Dose Prediction and Comparative Dose-Response of BALB/c and 
C57BL/6 mice (Intranasal exposure) 
 
Dose-response of guinea pigs 
The best fit dose response model for mortality in peritoneally inoculated guinea pigs was 
the Beta-Poisson model. Statistics of the three model fits to the animal is summarized in 
Table 8.4 and the best fit model and confidence interval are shown in Figure 8.4. 
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Table 8.4 Model Fit Comparison for Mortality in Peritoneally Exposed Guinea 
pigs@ 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedom 
 
Parameters 
 
Burkholderia 
pseudomallei 
KHW 
 
 
6 
 
Exponential 
 
70.72928 
 
5 
 
k=0.0007450 
 
 
6 
 
Beta Poisson* 
 
3.973655 
 
4 
α = 0.25060 
N50= 192.264 
 
6 
 
Log-probit 
 
5.167541  
 
 
4 
q1=5.990 
q1=116.044 
*Accepted best fit model 
@(Miller, Pannel et al. 1947) 
 
Figure 8.4  Dose Response Data and Beta-Poisson Model Fits for Mortality in 
Peritoneally Exposed Guinea pigs to B. pseudomallei 
 
Dose-response of diabetic rats 
For diabetic rats exposed to B. pseudomallei, both the Beta-Poisson and Log- probit 
models provided statistically acceptable fits. However, the Beta-Poisson model was 
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preferred to Log-probit. The Beta-Poisson model has been used to describe dose-response 
of many other infectious agents.  Second, the Beta-Poisson can be derived from 
mechanistic principles describing the action of infectious agents, while the Log-probit is 
nonmechanistic and purely empirical. The Beta-Poisson model describes the host dose  
response relationships to microorganism and it takes into account the variation that exist 
in pathogen  host interactions (Haas 1983; Haas, Madabusi et al. 2000). Statistics of the 
fits of the dose-response models are shown in Table  8.5 and the best fit model with 
confidence intervals is shown in Figure 8.5.  At very low doses (well below the observed 
range), the Log-probit model predicts higher responses than the Beta-Poisson model. The 
comparative low dose predictions are shown in Figure 8.6.  However the two curves 
deviate well below the observed range, and so targeted studies at very low dose would be 
required to differentiate between these alternative models. 
 
Table  8.5  Model Fit Comparison for Mortality in Peritoneally Exposed Diabetic 
rats@ 
 
 
Data set 
 
Number of  
Doses 
 
 
Model 
 
Minimized 
Deviance 
 
Degrees 
of 
Freedo
m 
 
 
χ2α,n-k
 
 
Parameters 
 
Burkholderia 
pseudomallei 
Diabetic rats 
 
 
5 
 
Exponential 
 
43.38476  
 
 
4 
 
9.488 
 
k=1.231171e-05 
 
5 
 
Beta Poisson* 
 
4.392305  
 
 
3 
 
7.815 
α = 0.2649 
N50= 2273.10 
 
5 
 
Log-probit 
 
3.435624  
 
 
3 
 
7.815 
q1= 4.628007  
q1= 2293.720 
*Accepted best fit model 
@ (Brett and Woods 1996) 
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Figure 8.5 Dose Response Data and Beta-Poisson Model Fits for Mortality in 
Peritoneally Exposed Diabetic rats to B. pseudomallei. 
 
 
Figure 8.6 Low Dose Predictions for Log-probit and Beta-Poisson Models for 
Diabetic rat exposed to B.  pseudomallei. 
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8.4.2 Pooling analysis 
The data for the two strains of mice (BALB/c and C57BL/6) exposed intranasally to B. 
pseudomallei could not be pooled indicating that they were not from same distribution, 
although the routes of infection were the same. But the pooling was possible in data sets 
from different animals and different strains of bacteria. The data for C57BL/6 mice 
exposed intranasally to B. pseudomallei could be pooled with the data for diabetic rats 
exposed intraperitoneally to B. pseudomallei (Figure 8.7). Similarly, the data for guinea 
pigs 60exposed intraperitoneally to B. pseudomallei could be pooled with the data for 
diabetic rats exposed intraperitoneally to B. pseudomallei (Figure 8.8).  
 
Figure 8.7 Combined set of dose response points of C57BL/6 mice exposed 
intranasally and Diabetic rats exposed intraperitoneally to B. pseudomallei, and 
pooled best fit model (Beta-Poisson) 
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Figure 8.8 Combined set of dose response points of Diabetic rats and Guinea pigs 
exposed intraperitoneally to B. pseudomallei, and pooled best fit model (Beta-
Poisson) 
 
The comparative study of virulence in different hosts 
The comparative low dose predictions for C57BL/6 mice model and Diabetic rat model 
are shown in Figure 8.9. The comparative virulence B. pseudomallei in different hosts 
(BALB/c mice, C57BL/6 mice and Diabetic rats) were summarized in Figure 8.10. The 
virulence of bacteria in the host guinea pigs was almost similar to BALB/c mice as 
shown in Figure 8.10. 
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Figure 8.9 Dose Prediction for Diabetic rats and C57BL/6 mice model exposed to B. 
pseudomallei.  (  ) Diabetic rats- Beta Poisson model, ( ), C57BL/6 
mice-Exponential model 
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Figure 8.10  Comparative Low Dose Prediction of B. pseudomallei for BALB/c mice, 
C57BL/6 mice, Diabetic rats and Guinea pigs, ( ) Guinea pigs, ( ) 
BALB/c mice, ( ) Diabetic rats, ( ) C57Bl/6 mice.  
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8.5 Discussion 
[ 
Different strains of B. pseudomallei are found to vary widely in virulence in the same 
animal host and the same strain of B. pseudomallei can have very different virulence 
depending on the animal host. The reported LD50 for the intravenous route of exposure is  
in the range of  3 CFU to 4.43x10
6  
CFU in BALB/c mice (Ulett, Currie et al. 2001) Some 
of the virulence in different animals are shown in Table 8.6. Both the strains of mice 
showed similar responses in term of dose-response model as both of them resulted in 
Exponential dose response. However, the virulence of the bacteria in those two host 
strains was markedly different. The data for B. pseudomallei in two strains of mice 
(BALB/c and C57BL/6) could not be pooled supporting the fact that they were not from 
same distribution and having different sensitivity factors. The biological reasons were 
unknown but the reason behind it might be huge differences in susceptibility of infection 
in these two strains. In intraperitoneally inoculated Guinea pigs, the response was best fit 
by the Beta-Poisson distribution. In contrast to above models, the diabetic rats inoculated 
with B. pseudomallei  intraperitoneal route showed both Log-probit  and Beta-Poisson 
responses. However, as discussed earlier, Beta-Poisson was preferred to Log-probit. 
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Table 8.6 Hosts, Routes of Infection and Virulence 
  Host 
  BALB/c mice C57BL/6 mice Guinea pigs Diabetic rats 
R
o
u
te
s o
f In
fe
ctio
n
 
i.p. 
LD50= 12 to 4.7x10
5  (CFU) 
(Barnes and Ketheesan 2005) 
LD50=9.73x10
5 to 2.1x107 (CFU) ‡ 
(Barnes and Ketheesan 2005) 
LD50=4854 (CFU) 
best fit model=Beta-Poisson 
α=0.250, N50=192.264 
(Miller, Pannel et al. 1947) 
LD50=196 (CFU), 
best fit model= Beta-Poisson, 
α=0.265, N50=2273.10 * ‡ 
(Brett and Woods 1996) 
i.n. 
LD50=45 (CFU), 
best fit model= exponetial, 
k=0.010 
(Liu, Koo et al. 2002) 
LD50=4854 (CFU), 
best fit model= exponential 
k=0.010 * 
(Liu, Koo et al. 2002)   
i.v. 
LD50= <10 to 9x10
3  (CFU) 
(Barnes and Ketheesan 2005) 
LD50= 5x10
3 to 6x106  (CFU) 
(Barnes and Ketheesan 2005)   
s.c. LD50= 1000 to 9x10
2 (CFU) 
LD50= 900 to >10
8  (CFU) 
(Barnes and Ketheesan 2005)   
Oral 
LD50= 7.2x10
3 to 4.8x106  (CFU) 
(Barnes and Ketheesan 2005) 
LD50= 1.8x10
6 to >108  (CFU) 
(Barnes and Ketheesan 2005)   
* Data can be pooled 
‡  Data can be pooled 
i.p.= intraperitoneal, i.n.= intranasal, i.v.= intravenous, s.c.= subcutaneou
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Many studies have shown that a higher risk of melioidosis is associated with 
Diabetes mellitus. Woods et al. demonstrated that insulin markedly inhibits the growth of 
B. pseudomallei (Woods, DeShazer et al. 1999). A significant percentage of melioidosis 
patients have been found to be  diabetic ranging from 36 % of total infected populations 
(Currie, Fisher et al. 2000)  to 60% (Suputtamongkol, Chaowagul et al. 1999). One of the 
reasons for the association between diabetes and melioidosis is that the innate immunity 
of  diabetic person is suppressed especially the neutrophil function (Gan 2005) . The 
figure is well supported by the analysis of outbreak of Melioidosis in Northern Australia 
by Marianos and coauthors (Merianos, Patel et al. 1993). This outbreak in Northern 
Territory of Australia from November 1, 1990 to June 30, 1991 showed that the 
individual attack rate of melioidosis was 3.42x10
-4
 per year and that of diabetic 
population was 2.283x10
-3
, indicating diabetic population is 6.67 times more susceptible 
than general population. 
 
Interestingly, although the routes of infection are different, the data of B. 
pseudomallei exposed to C57BL/6 mice (intranasal) and Diabetic rats (intraperitoneal) 
can be pooled as shown in Figure 8.7. The pooling simply implies that they may be from 
the same distribution and the predicted responses will be the same regardless the animals 
and routes of infection. However the experimental results and dose-response analysis 
showed markedly different responses. Dannenberg et al. (1958) studied that 
pathogenecity of B. pseudomallei in different hosts and different routes of the infection. 
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The experimental results showed that there were significant bacterial loads in lungs in 
both routes of inoculation (intraperotoneal and intranasal). In case of respiratory route, 
the average bacterial titers 2 hours after inoculation were 9.5x10
4
 in the lung of mice 
when inoculum dose was 1.6x10
6
 to 1,7x10
7
 organisms. In the case of intraperitoneal 
route of inoculation, the titers 3-4 hours after injection were 2.3x10
6
 when inoculum dose 
was 1,1x10
8
 organisms (Dannenberg and Scott 1958a). In both cases, pulmonary lesions 
developed swarmed with bacteria and large abscesses were present in lungs (Dannenberg 
and Scott 1958b). This may be case of acute pulmonary form of disease characterized by 
high fever and pulmonary distress which is followed by visceral abscesses and death 
within few days (Brett and Woods 2000).  Another explanations behind the possible 
pooling of the two different routes of infection may be the motility of the organism (Brett 
and Woods 2000).  The flagellated bacteria are too motile to reach the target organs 
regardless of the routes of infection before the host immune system to act.  
 
However, the comparative virulence, shown in Figure 8.10, clearly indicates that 
diabetic rats are more susceptible to B .pseudomallei than C57BL/6 mice at lower doses 
less than 10000 CFU. At 10x
4
 CFU, the responses were almost same (0.63 and 0.65), 
whereas at 1 CFU, the response in diabetic rats were 15 times that of C57BL/c mice. 
Similarly at 100 CFU, responses in diabetic rats were 11 times higher than that of mice. 
These figures are consistent with the results of outbreak data analysis of outbreak of 
melioidosis in Northern territory of Australia. 
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One means of comparing the risks in two strains of mice and diabetic rat infection 
from B.pseudomallei, as shown in Figure 8.10, is to compute the doses which result in a 
risk of 1/1000; the corresponding doses for BALB/c mice, C57BL/6 mice and diabetic rat 
are 0.1, 10 and 1.0 organisms respectively. In other words, BALB/c mice need 10 times 
less doses of B. pseudomallei (exposed intranasally) than diabetic rats (exposed 
intraperitoneally) and C57BL/6 mice need 10 times more doses ( exposed intranasally) to 
have risk of 1/1000. The observations are drawn regardless the routes of infection. Barnes 
and Ketheesan (2005) demonstrated that different routes of infection had different 
virulence in the hosts. The experiments showed that LD50 of intraperitoneal infection was 
almost 10 times less than intransal infection in mice (Barnes and Ketheesan 2005). The 
response of guinea pig to B. pseudomallei is almost similar to response of BALB/c mice 
and highly susceptible at low and high doses.  
 
Similarly, the data set of B. pseudomallei exposed to Guinea pigs and Diabetic 
rats both of them inoculated intraperitoneally, can also be pooled (shown in Figure 8.8), 
despite different hosts, indicating the animals belong to the same distribution. But the 
differences in susceptibility tell another side of story that they are not. 
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8.6 Conclusions 
 
Based on differences in dose-response models fit to data for BALB/c mice, C57BL/6 
mice, guinea pigs, and diabetic rats, BALB/c mice (exposed intranasally) and guinea pigs 
( exposed intraperitoneally) are significantly more sensitive to B. pseudomallei than 
C57BL/6  mice (exposed intranasally) and diabetic rats (exposed intraperitoneally). 
Because of lack of data availability in open literature, the virulence of same strain of B. 
pseudomallei to different hosts could not be compared. However, in spite of pooling of 
result suggests that the dose-responses may be same in both cases, the individual results 
from dose-response analysis and outbreak data analysis support the fact that diabetic 
population is more susceptible than general people. But we were unable to compare the 
dose-response in non diabetic and diabetic animals for the same strains of bacteria.  This 
study demonstrates the need for experiments in which greater numbers of animals are 
exposed to different strains of bacteria and for experiments conducted with all the 
relevant exposure routes. 
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9. DOSE-RESPONSE ANALYSIS FOR LASSA VIRUS5 
 
9.1 Abstract  
 
This chapter develops dose-response models for Lassa fever virus using data sets found 
in the open literature. Dose-response data were drawn from two studies in which guinea 
pigs were given subcutaneous and aerosol exposure to Lassa virus.  In one study, six 
groups of inbred guinea pigs were inoculated subcutaneously with doses of Lassa virus 
and five groups of out-bred guinea pigs were similarly treated.  We found that the out-
bred subcutaneously exposed guinea pig did not exhibit a dose-dependent trend in 
response. The inbred guinea pigs data were best fit by an exponential dose-response 
model. In a second study, four groups of out-bred guinea pigs were exposed to doses of 
Lassa virus via the aerosol route.  In that study, aerosol diameter was less than 4.5 µm 
and both mortality and morbidity were used as end points. The log-Probit dose-response 
model provided a somewhat better fit than the Beta-Poisson model for data with mortality 
as the endpoint, but the beta-Poisson is considered the best fit model because it can be 
derived using biological considerations.  Morbidity data were best fit with an exponential 
dose-response model.  
 
Key words: Lassa fever virus, dose-response, microbial risk assessment, Exponential 
model, Beta-Poisson model, log Probit model. 
 
                                                 
5
This chapter has been published under the same title in Human and Ecological Risk Assessment, 2008, 
Vol.14 (4). The authors are Sushil B. Tamrakar and Charles N. Haas.  
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9.2 Introduction 
 
Lassa virus is the causative agent of a highly fatal form of hemorrhagic fever, occurring 
mostly in West Africa.  In humans, it is characterized by an acute illness of 1-4 weeks 
duration with  high fever, sore throat, severe muscle aches, skin rash with hemorrhages, 
headache, abdominal pain, vomiting, and diarrhea . The disease was first described in the 
1950s, however the virus causing the disease was not identified until 1969  (Jahrling, 
Clarence et al. 1984; WHO 2005). It is endemic in Guinea (Conakry), Liberia, Sierra 
Leone and parts of Nigeria and other West African countries.  Since the first and initial 
identification   of the disease in 1969, several outbreaks with different rates of mortality 
in human have been documented (Stephenson et al, 1984). It is estimated that Lassa virus 
infects over 200,000 people per year causing more than 3,000 deaths  with a mortality 
rate of about 15 %  among  the hospitalized cases (Djavani, Yin et al. 2000; Geisbert, 
Jones et al. 2005). The virus is a single-stranded RNA virus belonging to the virus family 
Arenaviridae.  
 
Generally, arenaviruses are transmitted between rodents and human beings by 
blood or mucosal exposure (Rodas et al 2004), but transmission by direct person to 
person contact can occur via virus contaminated blood, pharyngeal secretion and urine of 
patients. Thus, direct or indirect contact are the possible mode of frequent transmission of 
Lassa virus from person to person or rodent to man (Stephenson, Larson et al. 1984). 
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The U.S. Centers for Diseases Control and Prevention (CDC) has classified Lassa fever 
as category “A” bioterrorist agent (Rotz, Khan et al. 2002). Specific characteristics 
supporting this designation include: high mortality and morbidity rate; potential for 
person to person transmission; high infectivity dose and significance of the aerosol route 
of exposure; effective vaccine unavailable or available in limited supply; potential to 
cause public and healthcare worker anxiety; availability of pathogen; feasibility of large 
scale production; and environmental stability. Hemorrhagic fever viruses have been 
weaponized by the former Soviet Union, Russia and the United States.  Until 1992, the 
former Soviet Union and Russia had pilled up a huge quantities of hemorrhagic fever 
viruses including Lassa Virus (Borio, Inglesby et al. 2002). 
 
9.3 Data and methods  
 
Many investigators have studied the response of animals to a single dose of the Lassa 
virus in order to develop effective vaccines and to study the pathology of infected 
animals. Lange et al. subcutaneously injected 10 
3.48
  PFU (Plaque Forming Unit) to 
Rhesus monkeys to find out the effect of virus in different organs of the monkeys (Lange, 
Mitchel et al. 1985). McCormick et al.  experimented with 10
4
 PFU Lassa virus 
subcutaneously injected to inactivated viral vaccinated Rhesus monkeys(McCormick, 
Mitchel et al. 1992). In experiments performed by Lukashevich et al., inbred guinea pigs 
and rhesus monkeys were inoculated with cloned MOPV(Mopeia virus)  and  ML29        
( mixture of RNA from MOPV and Lassa Virus ) then challenged with Lassa virus of 
dose 10
3
 PFU (Lukashevich, Patterson et al. 2005). Geisbert et al. also experimented with 
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recombinant vesicular stomatitis virus vaccine(VSV) intramuscularly to cynomolgus 
macaques and challenged intramuscularly with 10
4
 PFU Lassa virus (Geisbert, Jones et 
al. 2005). Sbrana et al inoculated Syrian Golden hamsters intraperitoneally with 10
4
 PFU 
Lassa virus and examined the various virological and pathological changes in animals 
(Sbrana, Mateo et al. 2006). Ignatyev et al (2000) conducted an intracerebral challenge of 
10
2
 PFU to mice to test possible treatment of hemorrhagic fever. Similarly, Jahrling used 
a 10 
3.4
 PFU inoculation in guinea pigs to produce infection and then treated with Lassa 
immune plasma from Rhesus monkeys (Jahrling 1983). 
 
9.3.1 Literature Review 
 
 A search of the open literature identified two usable dose-response experimental 
data sets for Lassa viruses.  The criteria for usable data in the peer reviewed literature 
included: 
 Quantification of dose 
 Specific characterization of endpoint and specification of number of hosts 
exposed and number with defined endpoin 
 Specification of host organism and pathogen strain used 
 
Jahrling and his co-authors (Jahrling, Smith et al. 1982) used inbred and out-bred 
guinea pigs to explore dose-response characteristics to subcutaneous exposure to Lassa 
virus. Six doses of Lassa were given to inbred and 5 doses to out-bred guinea pigs.  
Inbred guinea pigs were strain 13 guinea pigs, weighing between 450 and 600g and 
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raised at the USAMRIID (United States Army Medical Research Institute of Infectious 
Diseases) facilities.  Out-bred guinea pigs were of the Hartley strain, weighed between 
400 and 500 g, and were obtained from a farm in New York.  All guinea pigs were 
inoculated via subcutaneous injection of virus suspension diluted with Eagle minimum 
essential medium with Earle salts plus 10% calf serum. 
 
Similarly, Stephenson et al. studied the dose responses of aerosolized virus as 
well as the fate of aerosol at different temperatures and humidity (Stephenson, Larson et 
al. 1984).  The out-bred guinea pigs were Hartley strain guinea pigs (180-300 g).  All 
guinea pigs were exposed to four doses of Lassa virus using dynamic aerosol aerators 
generating aerosols of 4.5 µm or less in diameter. 
 
9.3.2 Analysis Methods 
 
All data sets were initially tested for a trend between dose and outcome using  the 
Cochran- Armitage test (Neuhauser and Hothorn 1999).  Only data showing a statistically 
significant trend were subjected to further analysis using parametric dose response 
relationships.  Dose response relationships were fit to data using the method of maximum 
likelihood estimation (MLE) as described in Haas et al. (1999).   
 
Both data sets are shown in Table  9.1. The statistical programming language, 
“R” (www.r-project.org) was used for this computation. Three dose response models 
(exponential, beta-Poisson and log-probit) were used (Haas, Rose et al. 1999).  
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The exponential dose-response model is given by the equation (1) 
kdedP 1)(                                                    (1) 
Where P (d) is the probability of response at dose d and k is the probability that a 
single organism can survive and multiply in order to produce the response.  
 
 The beta-Poisson model is given by equation (2) 
1211)(
1
50N
d
dP                                  (2) 
Where N50 is the median infective dose and α is the slope parameter for beta Poisson 
model.  
 
The Log probit model is given by equation (3) 
12
ln
1
)(
q
d
q
dP                                  (3) 
Where q2 is the probit slope, q1 is the location parameter and  denotes the normal 
cumulative distribution function. 
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Table  9.1 Data Used 
Study 
Mode of 
inoculation Test Animal 
Dose 
(PFU) 
Number 
of Test 
Animals 
Positive 
Responses 
Negative 
Responses 
(Jahrling, 
Smith et al. 
1982) 
Subcutaneous 
Guinea pig 
(inbred) 
240,000 5 5 0 
2,400 15 15 0 
24 10 10 0 
2  10 10 0 
0.2 10 4 6 
0.02 10 1 9 
(Jahrling, 
Smith et al. 
1982) 
Subcutaneous 
Guinea pig ( out-
bred)** 
 
 
 
240,000 30 9 21 
2,400 20 6 14 
24 19 6 13 
2 30 10 20 
0.2 25 4 21 
(Stephenson, 
Larson et al. 
1984) 
Aerosol 
exposure 
Guinea pig ( out-
bred) 
Mortality as end 
point 
5370 8 4 4 
724 8 3 5 
48 8 1 7 
5 8 1 7 
(Stephenson, 
Larson et al. 
1984) 
Aerosol 
exposure 
Guinea pig (out-
bred) 
Morbidity as end 
point 
5370 8 8 0 
724 8 8 0 
48 8 7 1 
5 8 1 7 
 
 
Goodness of fit for all models was determined by comparing the optimal value of 
the deviance (Y) with the 
2
 distribution (at degrees of freedom equal to the number of 
doses minus the number of fitted parameters).   Assessment of the statistical significance 
of improvement of fit from the use of 2 parameter models was made by comparing the 
reduction in minimized deviance with the 
2
 distribution (at 1 degree of freedom). 
Confidence intervals for the best-fit model were estimated via bootstrapping (Haas, Rose 
et al. 1999). For the bootstrapping 1000 to 10000 replicates were used for simulation.  
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 Pooling analysis was performed to ascertain whether inbred and out-bred species 
responses had the same underlying distributions. A likelihood ratio test was used to 
determine if data could be pooled. 
 
9.4 Results 
9.4.1 Cochran- Armitage test of trend 
 
The Cochran-Armitage test showed the existence of a dose- dependent response of the 
subcutaneously exposed inbred guinea pigs and out-bred guinea pigs and aerosol exposed 
out-bred guinea pigs. The Z critical value ( Zca)of subcutaneously exposed inbred guinea 
pigs and aerosol exposed out-bred guinea pigs were 1.947 and 5.055 respectively and 
those values were greater than 1.64 which  was above the upper 5
th
 percentile of the 
normal distribution.   Hence, the null hypothesis of lack of trend is rejected. On the other 
hand, subcutaneously exposed out-bred guinea pigs showed the lack of trend as the Zca 
value was 0.653. As the result, a quantitative dose-response analysis of subcutaneously 
exposed out-bred guinea pigs is not justified.  
Dose-response of subcutaneously exposed inbred guinea pigs 
 
The best fit dose response model for mortality in subcutaneously inoculated inbred 
guinea pigs was the exponential model. Statistics of the three model fits to the inbred 
guinea pig subcutaneous exposure are summarized in Table 9.2 and the best fit model 
with confidence interval is shown in Figure 9.1. 
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Table 9.2  Model Fit Comparison for Mortality in Subcutaneously Exposed Inbred 
Guinea Pigs@ 
Data set 
No of 
doses 
Model 
Minimized 
Deviance 
Degrees 
of 
Freedom 
χ2α,n-k 
χ2 p-
value 
Parameters 
Inbred 
Guinea pig 
( mortality 
as end point) 
 
6 
 
Exponential* 
 
0.4195 
 
5 
 
11.070 
 
0.9947 
 
k= 2.948 
 
6 
 
Beta Poisson 
 
0.4195 
 
4 
 
9.488 
 
0.9808 
α = 798 
N50=0.235 
 
6 
 
Log Probit 
 
1.815 
 
4 
 
9.488 
 
0.7697 
q1=1.388 
q2=0.185 
    @ (Jahrling, Smith et al. 1982) 
    *(accepted as the best fit model) 
 
Figure 9.1  Dose-response Data and Exponential Model Fits for Mortality in 
Subcutaneously Exposed Inbred Guinea Pigs 
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Dose-response of subcutaneously exposed out bred guinea pigs 
 
Due to the lack of trend of dose-response, fitting of dose response models to this data set 
was not appropriate. 
  
Dose-response of aerosol exposed guinea pigs (Mortality as response) 
 
For aerosol exposure of out-bred guinea pigs (mortality as end point), both the beta-
Poisson and Log probit models provided statistically acceptable fits. However, the beta-
Poisson model was preferred to Log probit. The beta-Poisson model has been used to 
describe dose response of many other infectious agents (e.g., Haas et al., 1999; Madabusi 
et al. 2000).  Second, the beta-Poisson can be derived from basic principles describing 
the mechanism of action of infectious agents, while the log-Probit is nonmechanistic and 
purely empirical  (Haas 1983; Haas, Madabusi et al. 2000). Statistics of the fits of the 
dose-response models are shown in Table 9.3 and the best fit model with confidence 
intervals is shown in Figure 9.2.   The broad confidence bands are due to the very 
shallow dose-response (the value of , the slope parameter, is 0.08) which reflects a very 
heterogeneous distribution of microorganism-host interaction probabilities.  
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Table 9.3 Model fit Comparison for Mortality in Aerosol Exposed Out-bred Guinea 
pigs ** 
 
Data set 
Number 
of  
Doses 
 
Model 
 
Minimized 
Deviance 
Degrees 
of 
Freedom 
 
χ2α,n-k
 
χ2 p-
value 
 
Parameters 
 
Aerosol 
exposure-death 
as end point) 
4 Exponential 14.44 3 7.81 0.0023 k=0.00025 
 
4 
 
beta Poisson* 
 
0.63 
 
2 
5.99  
0.729 
α = 0.08 
N50= 1.422×104 
 
4 
 
Log probit 
 
0.32 
 
2 
 
5.99 
 
 
0.852 
q1=5.339 
q2=5650.26 
**(Stephenson, Larson et al. 1984) 
*Accepted best fit model 
 
 
Figure 9.2 Dose Response Data and beta Poisson Model Fits for Mortality in Aerosol 
Exposed Out-bred Guinea Pigs. 
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At very low doses, the log Probit model predicts higher responses than the beta-
Poisson model. The comparative low dose predictions are shown in Figure 9.3.  However 
the two curves deviate well below the observed range, and so targeted studies at very low 
dose would be required to differentiate between these alternative models. 
 
 
Figure 9.3  Low Dose Predictions of log Probit and beta-Poisson Models for 
Mortality in Aerosol Exposed Out-bred Guinea Pigs 
 
Dose-response of aerosol exposed guinea pigs (morbidity as response) 
 
The best fit dose response model for morbidity of out-bred guinea pigs with an aerosol 
exposure was the exponential model.  The two parameter models failed to provide a 
statistically significant improvement in fit.  A summary of fits of the three dose-response 
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models to the aerosol exposure is shown in Table 9.4 and the best fit model with 
confidence intervals is shown in Figure 9.4.  
 
Table 9.4 Model fit Comparison for Morbidity in Aerosol Exposed Out-bred  
Guinea pigs± 
  ±(Stephenson, Larson et al. 1984) 
   *Accepted best fit model. 
 
 
 
Data set 
Number 
of  
Doses 
 
Model 
 
Minimized 
Deviance 
Degrees 
of 
Freedom 
 
χ2α,n-k
 
 
χ2 p-
value 
 
Parameter 
 
Aerosol exposure-
Morbidity  as end 
point 
 
4 
 
Exponential* 
 
 0.2193024  
 
3 
 
 
 
0.974 
 
k= 0.039 
 
4 
 
beta Poisson 
 
 0.2193024  
 
 
2 
 
5.99 
 
0.974 
α = 638.99 
N50= 17.60 
 
4 
 
Log probit 
 
0.0007 
 
2 
 
5.99 
 
0.999 
q1=-0.019 
q2=2.738 
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Figure 9.4 Dose Response Data and Exponential Model Fits for Morbidity in 
Aerosol Exposed Out-bred Guinea Pig 
 
  
9.5 Discussion  
 
For subcutaneous exposure to Lassa virus, inbred and out-bred guinea pig populations 
had markedly different responses.  The exposure of inbred animals to subcutaneously 
administered Lassa virus resulted in a steep exponential dose-response. Exposure of out-
bred animals to the same regime resulted in no significant dose response.  This shows the 
substantial influence of heterogeneity in population responses.  Out-bred animals 
administered Lassa virus by aerosol showed a beta Poisson response, indicative of 
heterogeneity as well, although (in contrast to the subcutaneous route) a statistically 
significant dose-response is discernable albeit with high population heterogeneity. 
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The fitted dose-response relationships could be used to infer particular levels of concern 
or acceptability for human exposure if we assume that the dose-response model for out-
bred guinea pigs exposed to aerosol containing Lassa virus is similar to the human dose-
response relationship.  A level of risk of 1/10,000 would correspond to an exposure of 
0.003 organisms (for the beta-Poisson best fit) or 1.35x10
-5
 organisms (for the log-probit 
best fit).  The confidence limits from either model are wider than the deviation between 
the models at this low dose.  Given this estimate, and the duration of exposure and 
inhalation rate, an air concentration corresponding to this risk can be computed.  This 
could be useful for examining potential detection systems, or clearance levels post-
cleanup.  
 
9.6 Conclusions 
 
Based on differences in dose-response models fit to data for inbred and out-bred guinea 
pigs, inbred guinea pigs are significantly more sensitive to subcutaneous exposure to 
Lassa virus than their out-bred counterparts.  Because data for response to aerosol 
exposure to Lassa virus were available only for out-bred guinea pigs, no conclusions can 
be drawn regarding the relative sensitivity of inbred and out-bred guinea pigs to aerosol 
exposure to Lassa virus or the influence on exposure route on susceptibility.  This study 
demonstrates the need for experiments in which greater numbers of animals are exposed 
to Lassa virus and for experiments conducted with all the relevant exposure routes 
(subcutaneous, aerosol and ingestion). 
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10. CONCLUSIONS, SIGNIFICANCES AND FUTURE RESEARCH WORKS 
 
10.1 General Conclusions 
 
Given the present scenario of growing terrorist threats like the anthrax attack on Capitol 
Hill in 2001, the research works in this thesis regarding dose-response modeling of 
bioterrorism agents will have significant contribution to decision makers.  This 
dissertation has developed dose-response models for some of the Rickettsia species and 
other biological agents of concern. These models are, in most cases, the first models that 
have been proposed for the pathogens and as such provide a valuable set of tools for use 
in QMRA, responses to outbreaks, or development of policy 
 
Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii, is one of 
the most severe infectious tick borne diseases. More than 1250 cases were reported in the 
United States between the years 1993 and 1996 with the annual incidence rate of 2.2 per 
million (Lacz, Schwartz et al. 2006). Several dose-response models have been developed 
based on available data in open literature including human and other primates. As data of 
human volunteers inoculated intradermally with R. rickettsii and aerosol exposed rhesus 
monkeys could be pooled, aerosol exposure of R. rickettsii to humans has similar risk 
compare to tick bite infection. The dose-response model of intradermally inoculated 
humans can also describe the aerosol exposure scenario. The best fit estimate of 50% 
infectious dose (ID50) is 23 organisms (1 to 88 organisms with 95% confidence). A single 
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bacterium can infect an average of 5% of an exposed population. This estimation will be 
useful for the first responders and decision makers in case of accidental as well as 
intentional release of Rickettsial pathogens. 
 
The murine typhus caused by Rickettsia typhi is one of the most widely 
distributed tick borne diseases and causes a relatively mild febrile illness. The dose-
response models developed in the chapter 3 support the fact that the murine typhus is one 
of the infectious diseases that a person could be infected with the fewest number of 
pathogens. Intradermally or subcutaneously inoculated rats (adult and newborn) models 
suggest that less than 1 PFU (1.33 to 0.38 in 95 % confidence limits) of the pathogen is 
enough to seroconvert 50 % of the exposed population in an average. The time post 
inoculation model of BALB/c mice shows that higher the number of pathogens, sooner 
the seroconversion. The dose-response models of neonatal rats of different age groups 
suggest that there is no significant effect of age on serocenversion. Seroconversion does 
not necessarily represent an infection, there could be symptomatic infection or the active 
immune system might overcome the infection. However, due to lack of data sets with 
response other than seroconversion, the seoconversion was assumed as the infection.  
 
Infection by different routes results in different patterns of exposure to the  host 
immune system and may subsequently influence response (Barnes and Ketheesan 2005). 
This thesis has motivated development of a multi-route dose-response model for 
Rickettsial diseases. Starting from the basic exponential dose-response model (Haas et 
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al., 1999) and prior work of Bartrand et al. (2009) (Bartrand and Haas 2009), a correction 
factor “s” was introduced in the basic equations. The modified dose-response model with 
correction factor ”s” also provided statistically acceptable fits.  The intraperitoneal route 
of infection is more effective than subcutaneous route in all the cases. The correction 
factor also helps the investigators to estimate unknown quantity of the pathogens for 
different route of exposure.  
 
The dose-response models of RMSF for different rodents and primates including human 
showed remarkable variation in responses. The risk of infection may be varied in 
different population as shown by dose-response models of different rodents. Different 
exposure routes may be associated with widely different infectious doses based on 
rodents models e.g. interaperitoneal route is more effective than subcutaneous route.  
Different host species are generally associated with different dose-response models, 
though primates appear to be good models for human infection. 
 
Based on available dose-response models and attack rate, the estimated number of 
pathogens supposed to be exposed during an outbreak was back calculated. The outbreak 
analysis shows that the rickettsial infection is rare but a small number of pathogens can 
cause a large outbreak.  
 
Dose-response models of both rickettsial pathogens show that there are 
consistencies in routes of exposure. Although intraperotoneal exposure route is not a 
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common mode of an infection in case of RMSF diesease, the dose-response models of 
various rodents infer intraperitoneal route is more effective than subcutaneous or 
intradermal route. Some comaparisons have been described in Chapters 4 and 5. Oral 
exposure to R.typhi is less effective than subcutaneous or intradermal in rat. Obviously, 
oral route is not a natural route and there are many steps to be overcome to reach small 
blood vessels through oral medium.  
 
Pooling analysis was used to compare interspecies susceptibility. Various 
combinations of different pathogen, different isolate, different host, and different route of 
exposure were pooled to analyze. Different behavior of a different strain or isolate is 
inferred, if different strain or isolates of pathogens have different dose-response 
relationships. If the same organism has the same dose-response in different animals, 
dose-response for new animal or human could be extrapolated (Haas, Rose et al. 1999).        
 
In summary, this dissertation has provided a spectrum of different aspects of 
dose-response models for Rickettsia species and other biological agents of concern. The 
dose-response models developed in this study are the unique one as for the first time an 
the rickettsiae as whole has been analyzed and various animals models have been 
developed.  Moreover, for the first time, human dose-response model for Rocky 
Mountain spotted fever has been developed and pooling human data and monkey data 
was successful to establish the underlying facts.  Differences in dose-response that may 
result from host, pathogen species or strain, and exposure routes differences have been 
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described and provide guidance in estimation of dose-response for as-yet-unknown 
species or isolates of the pathogen. 
 
10.2 Further Research    
 
 
Dose-response modeling is a critical step in QMRA because it links the environmental hazard 
to the quantity of interest – human health. Dose-response data or model is used to estimate 
the risk and to describe risk characterization. Hence, an improved dose-response model or in 
the case of Rickettsial pathogens, any dose-response model, is always desired.   Future 
research work should focus on next generation dose-response models which should include:  
 
1. Epidemiological risk parameters- Parameters such as length of infectious period, 
contact rate between infectious and susceptible individuals, virulence and 
recovery rates and inversely related to the transmission rate etc.(Soto and Lotz 
2001; Harris, Travis et al. 2008) 
 
2. Sub-population susceptibility factor- Inter-individual variation in human 
responses to various microbes indicates that some subpopulations are at increased 
risk for the particular pathogen and routes. Some factors are : immune 
competency, nutrition and age (Parkin, Soller et al. 2003) 
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3. Vaccinated or unvaccinated population- Unvaccinated population are higher in 
risk while exposed to most of the pathogens (Wesley 2007). So it is desired goal 
to establish dose-response model that incorporate both the cases.  
 
4. Animal experiment with low dose inoculation- Most of the data set with animal 
experiments contain high doses only. The developed model is being used to 
extrapolate. For more accurate and realistic dose-response modeling, 
experimentation with low doses is required.  
 
5. Repeated low dose exposure versus single large dose – Although repeated doses 
also results into dose-dependent responses, the reapted doses versus a equivalent 
single dose need to be distinguished and hence there should be different dose-
response relationships.  
 
Much of this research can be done with existing data. However, future animal 
experiments could be re-designed according to desired output. In some cases such a 
redesigned experiment may not be consistent with a researcher’s needs.  For example, in 
vaccine experiments it is advantageous to the researchers to expose animal models to 
relatively high doses of pathogens to ensure conditions for infection are present and to 
test the efficacy of the vaccines. 
 
In chapter 4, a multi-route correction factor “S” is introduced. The correction factor 
will be helpful to predict risk from another route of exposure.  Additional research could 
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be carried out to improve determinants of dose in human studies includes additional 
individual-level data such as diet, living environment etc.  Parameters and understanding 
development as a result of these experiments has the potential to lead to mechanistic 
dose-response models more highly-resolved than the models described in this 
dissertation.  Such models might be used to generate dose-response models for pathogens 
for which no experimental dose-response studies have generated data suitable for dose-
response analysis. 
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